ࡱ> []NOPQRSTUVWXYZ'` R!bjbjrr)&@(@(@(@(((()\y\y\y8y4~)?"ғғғؕD$->/>/>/>/>/>/>$ChFS>("ؕS>@(@(ғғ>z@(ғ(ғ->->(6(ғ @D-WJ\yv:IV>0?!zF FlF(& 2S>S>^?))dt)D))t))))@(@(@(@(@(@( Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.q\qge兡N gPlQSShandong Xinhua Pharmaceutical Company Limiteda joint stock company established in the People s Republic of China with limited liability Stock Code: 0719 2013 ANNUAL RESULTS ANNOUNCEMENTThe board of directors (the  Board ) and directors (Directors) of Shandong Xinhua Pharmaceutical Company Limited (the Company) hereby announce the audited consolidated results of the Company and its subsidiaries (the Group) for the year ended 31 December 2013. The following financial information has been prepared in accordance with Hong Kong Generally Accepted Accounting Principles (HKGAAP) and the Peoples Republic of China (PRC) accounting standards. This results announcement (the Announcement) is summarised from the annual report (the Annual Report) and investors are advised to read the full text of the Annual Report to understand the full details. The Announcement is published in Chinese and English. If there are any discrepancies between the Chinese version and the English version, the Chinese version shall prevail. I. Financial summary(i) Prepared in accordance with HKGAAP (Audited)Consolidated Statement of Profit or LossItem2013 RMB0002012 RMB000 2011RMB000Revenue3,118,7812,932,1162,917,860Profit before tax49,32233,51591,272Income tax expense (12,028)(8,499)(13,302)Profit for the year37,294 25,01677,970Non-controlling interests1,5642,5993,595Profit for the year attributable to owners of the Company35,730 22,41774,375Consolidated Statement of Financial PositionItem2013RMB0002012 RMB0002011 RMB000Total assets3,858,5413,639,4903,017,412Total liabilities(2,055,934)(1,855,699)(1,259,624)Non-controlling interests(37,290)(39,701)(39,807)Equity attributable to owners of the Company1,765,3171,744,0901,717,981Prepared in accordance with PRC accounting standards (Audited) Principal Financial DataItem2013 RMB 2012RMBChange as compared to the last year (%)2011RMBTotal operating income3,169,653,150.692,971,519,619.906.67 2,937,528,055.33 Operating profit(43,862,377.19)(18,705,181.33)-71,927,673.11Profit before taxation50,515,857.1834,981,068.9844.4193,211,526.67Profit attributable to the equity holders of the Company36,745,414.3823,663,577.9655.2876,023,665.57Profit attributable to the equity holders of the Company after extraordinary loss(46,009,462.38)(20,394,764.53)-54,823,601.21Net cash flow from operating activities92,636,929.7237,817,990.39144.9597,083,018.85ItemAs at 31 December 2013RMBAs at 31 December 2012RMBChange as compared to the end of last year (%)As at 31 December 2011RMBTotal assets 3,849,353,234.203,628,270,364.036.093,004,190,190.68Total liabilities2,052,533,235.111,851,281,249.0110.871,254,451,169.37Total equity attributable to equity holders of the Company1,759,529,934.581,737,287,914.321.281,709,932,330.07Capital (share)457,312,830.00457,312,830.00-457,312,830.00Principal Financial IndicatorsItem2013RMB2012RMBChange as compared to the last year (%)2011RMBBasic earnings per share0.080.0560.000.17Diluted earnings per share0.080.0560.000.17Basic earnings per share after extraordinary loss0.10 (0.04)-0.12Return on equity of weighted average% 2.091.38 NGS0.71*N~vRp4.46Return on equity of weighted average after extraordinary loss% 2.62 (1.19) NM1.43*N~vRp3.22Net cash flow from operating activities per share0.200.08150.000.21ItemAs at 31 December 2013RMBAs at 31 December2012RMBChange as compared to the end of last year (%)As at 31 December 2011RMBNet assets per share attributable to equity holders of the Company3.853.801.323.74Asset-liability ratio (%)53.3251.02 NGS2.30*N~vRp41.76(iii) Reconciliation of accounts prepared in accordance with PRC accounting standards and HKGAAPProfit attributable to owners of the CompanyRMBNet assetsRMB20132012As at 31 December 2013As at 1 January 2013Prepared under HKGAAP35,730,000.0022,417,000.001,765,317,000.001,744,090,000.00Prepared under PRC accounting standards36,745,414.3823,663,577.961,759,529,934.581,737,287,914.32HKGAAP adjustments:Deferred taxation177,585.62221,422.04(1,021,934.58)(1,199,914.32)Provision for education fund(1,193,000.00)(1,468,000.00)6,809,000.00 8,002,000.00 HKGAAP adjustments total(1,015,414.38)(1,246,577.96)5,787,065.42 6,802,085.68  Note: Explanation of the difference between the PRC accounting standards and HKGAAP:1. Education expenses are regarded as actual expenditure without the need of provision under HKGAAP. As at 31 December 2013, the balance of education expenses was RMB6,809,000.00 under the PRC accounting standards, and the education expenses were RMB1,193,000.00 for 2013;2. The aforesaid difference also led to the difference in the Companys deferred income tax, with the difference in accumulated deferred income tax being RMB1,021,934.58 and the deferred income tax of the current period being RMB177,585.62.II. DIVIDENDSThe Board has announced and proposed a final dividend for the year ended 31 December 2013 of RMB0.02 per share in the Company (the Share) (approximately HK$0.025 per Share, including income tax) on 307,312,830 A Shares and 150,000,000 H Shares in issue. The proposed dividend is subject to approval by the shareholders of the Company at the Companys annual general meeting for the year 2013. In respect of the book closure period of the proposed dividend, please see the announcement dated 28 March 2014 headed 2013 Final Dividend Distribution and Enterprise Income Tax Withholding of Overseas Non-resident Enterprises for details. III. MAIN BUSINESS AND FINANCIAL SITUATIONThe Group is mainly engaged in the development, production and sale of bulk pharmaceuticals, preparations, chemical products and other products. The profit of the Group is mainly attributable to its principal operations.Analysis of financial situation and operating results in accordance with PRC accounting standardsTotal assets of the Group as at 31 December 2013 was approximately RMB3,849,353,000, increased by approximately RMB221,083,000 or 6.09%, as compared with the figure of approximately RMB3,628,270,000 at the beginning of the year. The increase in total assets was mainly due to the increase of loans.Cash of the Group as at 31 December 2013 was approximately RMB380,722,000, decreased by approximately RMB41,422,000 or 9.81%, as compared with the figure of approximately RMB422,144,000 at the beginning of the year. The decrease in cash was mainly due to the continuous expenditure on relocation projects.Total equity attributable to the shareholders of the Company as at 31 December 2013 was approximately RMB1,759,530,000, increased by approximately RMB22,242,000 or 1.28%, as compared with the figure of approximately RMB1,737,288,000 at the beginning of the year. This increase was mainly attributable to the profits this year.The total liabilities of the Group as at 31 December 2013 were approximately RMB2,052,533,000, representing an increase of approximately RMB201,252,000 or 10.87%, as compared with the figure of approximately RMB1,851,281,000 at the beginning of the year. The increase was mainly attributable to the objective of the Group to ensure sufficient supply of funds for production, operation and projects, leading to an increase in loans.Operating loss of the Group amounted to approximately RMB43,862,000 for the year of 2013 and approximately RMB18,705,000 last year. The main reasons for the change include the formation of fixed assets in the new park area which resulted in an increase in depreciation charges, an increase in costs caused by the fluctuating raw material and power consumption during the initial production stage of production lines, a foreign exchange loss caused by an appreciation of the RMB and an increase in financial expenses due to increased borrowings. Net profit attributable to the Companys shareholders for 2013 amounted to approximately RMB36,745,000, representing an increase of 55.28% as compared to that of the previous year during the same period. The increases were mainly attributable to the increase in income from disposal of non-current assets and increase in government subsidies during this period.The Groups net decrease in cash and cash equivalents for the year of 2013 was approximately RMB92,722,000. The decrease in currency funds was mainly attributable to the continuous expenditure on relocation projects. Analysis under HKGAAPAs at 31 December 2013, the current ratio and the quick ratio of the Group was 135.60% and 91.05% respectively, and the rate of accounts receivable turnover (rate of accounts receivable turnover = revenue/average trade and bill receivables100%) and the rate of stock turnover (rate of stock turnover = cost of sales/average inventories100%) were 857.91% and 554.57% respectively.The Groups demand for working capital did not show significant seasonal fluctuation throughout the year.The Groups main source of funds was loans. As at 31 December 2013, the total amount of outstanding loans was approximately RMB1,364,433,000. As at 31 December 2013, cash on hand and in bank of the Group amounted to approximately RMB380,722,000 (including bank acceptance drafts deposits of approximately RMB97,901,000). As at 31 December 2013, the Group put the land use rights in Hutianzhen, Zhangdian on charge with a bank for loans. The total original value of the land use rights is RMB73,109,000, net value is RMB66,651,000. The Group pledged accounts receivable US$10,100,000 to a bank for a loan of US$10,100,000. There was no other charge on the Groups assets except the above charged assets. The Group has stringent internal control systems for cash and fund management to strengthen its financial management. The Group maintained a good level of liquidity and had strong debt repayment ability.The Company invested US$1,500,000 in cash to establish Shandong Xinhua Pharmaceutical (USA) Company Limited in 2013.In 2013, the local government purchased and put into reserves parts of the relocated idle land of the Company together with the fixture thereon in the old factory area, generating an income of approximately RMB49,188,000.Apart from the above transactions, the Group did not have material acquisitions and sales of assets, nor any material mergers and acquisitions during the reporting period.As at 31 December 2013, the number of staff employed by the Group was 6,093, and the total amount of salaries and wages for 2013 was approximately RMB238,612,000.The debt-to-capital ratio of the Group was 77.29% (debt-to-capital ratio = total borrowings / equity attributable to owners of the Company 100%).The bank balance of the Company will mainly be used as working capital for project construction and relocation of the Company.The assets and liabilities of the Group were mainly recorded in Renminbi. For the year ended 31 December 2013, the revenue from the Groups exports was approximately US$185,003,000, which exposed the Group to certain risks associated with the fluctuation of exchange rates. Therefore, the Group has taken the following measures to lower the risks from the fluctuation of exchange rates: (1) the Group has increased the price of its export products to decrease the risks from the fluctuation of exchange rates; (2) the Group has made arrangements with overseas customers when entering into significant export contracts that the risks associated with the fluctuation in exchange rates shall be borne by both parties if the fluctuation exceeds the range of exchange rate fluctuation agreed by both parties; (3) Foreign currency accounts receivable pledge loans, reducing the risk of exchange rate fluctuations.IV. business reviewIn 2013, the Group overcame the influences of adverse factors such as relocation of the Park, bidding of basic medicines, low demand and increasing environment protection pressure, and focused and actively carried out work on aspects such as marketing, management, innovation and Park construction, and achieved all established goals. The major business review is set out below:1. Carefully organize relocation work and ensure smooth progressNew production lines in Aspirin Hutian Park were put into full operation, the old production lines stopped as scheduled, with production transfer realized smoothly. New products were put into production in multi-function industrialization center, with a batch of new products meeting commercial production conditions. Wu An relocation project (Wu An refers to the projects relating to guarantees of agriculture, health, disaster relief, endowment insurance and education) went on as planned.2. Place emphasis on marketing, showing new sales highlightsThe product market of dominated pharmaceutical raw material was further consolidated, with market shares of Metomizole sodium, Aspirin, Ibuprofen, levodopa etc. further enhanced, and market control capability obviously strengthened. The sales amount of Phenobarbital, meloxicam and other pharmaceutical raw material increased by over 80%. Greater preparation strategy was further pushed, and five strategic preparation products including rabeprazole sodium enteric-coated tablets gained a sales growth of over 30%. 3. Attach importance to innovation and make technological breakthroughs in scientific researchThe Company received clinical approvals for 4 medicines and production approvals for 2 healthcare products, and 1 commissioning production license, and obtained 11 reception document numbers. The topics and projects such as Improvement of Ibuprofen Process, one of the third batch of 11th Five-year Plan of the national key technology projects, undertaken by the Company has passed the acceptance, and Ibuprofen process project won the third prize of the Shandong Province Science and Technology Progress Prize. The Company was granted 22 patents in 2013, including 16 invention patents, and applied for 26 patents, including 20 invention patents.4. Make new progress in global strategy by looking ahead to the futureWhile facing the downturn in exports in China, the Group witnessed a growth rate of 5.6% in earning foreign exchange through import. The cooperation between the Company and internationally known companies was even closer.European and US subsidiaries kept a healthy and rapid development trend; the progress of international cooperation projects were accelerated, and the annual sales amount of commissioned processing of preparations exceeded RMB 100 million; the direct export of preparation products to EU markets rose dramatically; the cooperation projects between the Company and transnational companies and international organizations were advanced smoothly.5. Lay solid foundation and achieve new enterprise management performancesIn 2013, the Company successfully passed site examinations of EDQM (European Directorate for Quality Medicines) to Levodopa, Ibuprofen and trimethoprim, with EU GMP certificates granted, passed site examinations of KFDA (Korean Food and Drug Administration) to meloxicam products, and site examinations of IDA (International Dispensary Association) to injection workshops, becoming the approved vendor conforming to WHO-GMP standards; moreover, the Company has successfully passed over 100 domestic and foreign audits in 2013, and smoothly passed Chinas GMP certifications (new edition) of all sterile preparations, soft pastes and solid preparations in 2013. The Company took the building of intrinsic safety enterprise as the target, intensified basic safety works, with no major safety accident occurred in 2013, and the target of zero environment pollution accident was also realized. 33 energy conservation projects were implemented, with energy consumption for every RMB10,000 was reduced by 4.2%.V. ProspectsIn 2014, the Group still faces grave issues due to the external environment. Environment protection difficulties and cost pressures increase, medicine market competition remains severe, and the bidding of basic medicines results in limitations on development. Influenced by exchange rate change, fund shortage and increasing labor cost, especially the increased depreciation expenses and overheads after putting into operation of Hutian Park, the Companys growth in profitability is restrained. World economy continuously and moderately recover, especially in Europe and North America, and Chinese economy continuously grows, major pharmaceutical raw material variety markets are stable, with increasing demand, and the prices of major chemical materials and raw and auxiliary materials run in low levels, creating a good opportunity for the healthy development of the Group. Therefore, major works of the Group in 2014 are as follows:1. Strengthen marketing and nurture new economic growth pointsGreat attention will be paid to the exploration of emerging markets around the world while consolidating the sale of leading varieties and efficient varieties of pharmaceutical raw material in the traditional markets in Europe and North American. The sale in domestic market will be carefully maintained, and the market controlling capability will be strengthened. New products will enter the industrialization center more rapidly, the market exploration of characteristic pharmaceutical raw material products will be intensified, and new growth points will be nurtured. Differential focus strategy will be implemented to preparation strategy varieties, feasible market exploration measures and incentive measures will be formulated to realize the target of sales amount of over RMB 100 million for single preparation product as early as possible; bidding work of basic medicine products will be strengthened to realize the breakthrough in winning the bid in basic medicines; brand licensing manner will be utilized to introduce more varieties, to try to obtain approvals of new medicines as soon as possible, providing strong support for the breakthrough in preparations.2. Strengthen technology advances and enhance development potentialApproval documents for calcium polycarbophil and for new preparation medicines will be obtained as quickly as possible, attentions will be paid to the production transformation of 9 new products, dynamic audit for 8 projects will be completed, more than 10 reception document numbers will be obtained, to ensure over 14 new products to be entered into registration lines. Technology advances of existing products will be accelerated, to ensure more than 10 technology breakthroughs to be made in 2014, and endeavour to reduce material consumption. 3. Further promote global strategy and strengthen variety deploymentThe Companys production advantages in pharmaceutical raw material will be employed to speed up the commissioned processing projects of transnational companies, striving to realize the breakthrough in export of injection and infusion products through the opportunity of IDA examination. The key functions of European and US subsidiaries as gateways will be fully utilized to actively push on international R&D and encourage medicines to be ADNA registered in Europe and the US while strengthening international sales of products, and to enable the Groups independently branded preparation products to enter the European and US market as soon as possible. Efforts will be made to enable all pharmaceutical raw material products of the Company to pass the certifications of European and US markets etc. as soon as possible, to speed up foreign registration of the Companys preparations and international certifications of preparation production lines, and to advance the development of the Company through internationalization of preparations.4. Facilitate relocation work properly and plan the park construction scientificallyEfforts will be made to realize the designed production capability and efficiency of relocating products in Hutian Park and to create the historically best level. The construction plan of the second multi-functional industrialization center will be actively researched, to create conditions for new products of subsequent pharmaceutical raw material. The development work of the innovation park in the headquarters will be strengthened to fully utilize the functions of Shandong University Biomedicine Institute in the Park, a national level hi-tech industry hatcher, and to accelerate the speed of new product research.5. Realize innovative development, actively advance enterprise reformTo continue to focus on the feasibility study for merger and acquisitions of relevant enterprises, actively communicate about merger and acquisition resources, to grasp the new round of merger and acquisition opportunity of the medicine industry, and to create new progress in enterprise merger and acquisition based on participating in the acquisition of 40% equity of Xinda Pharmaceutical. Internal market operation of enterprises will be implemented to enhance the rapid response ability to the market, reduce consumption and improve overall economic efficiency.6. Consolidate development base by laying good foundationThe human resource reform with six-specific management as major contents will be sped up, to improve the performance assessment system of total employees, intensify assessment forces, stimulate employee initiatives and creativities, and reduce the costs significantly.Expenditures will be strictly controlled to link the indexes with the leaders in charge of the Company, and make assessment and report the results regularly. Risk control will be strengthened; credit standing, respectability and receivable management will be intensified to effectively decrease operation risks. The Company will ensure the smooth passing of all domestic and international examinations, certifications and customer audits, to actively build an intrinsic safety enterprise and ensure no major accident will occur in 2014. The Company will also strengthen environment protection measures and environment protection basis management, to ensure there is no major pollution accident. Moreover, energy conservation investment will be increased to promote the applications of new technologies, new materials, new processes and new equipment, to intensify energy conservation management.In 2014, the Group will actively carry out works according to the overall requirements to change the way, adjust the structure, promote the reform, switch the mechanism, strengthen the management and lay good foundation, and work hard to accelerate enterprise development to a new stage.VI. Important IssuesStaff and RemunerationThe Groups staff remuneration was determined in accordance with State policies, the Companys profit in the corresponding period and the average income of local residents.As at 31 December 2013, the number of staff employed by the Group was 6,093, and the total amount of their salaries and wages for the year 2013 was approximately RMB238,612,000.Purchase, Sale or Redemption of the Companys Listed SecuritiesDuring the year ended 31 December 2013, the Company did not redeem the Companys listed securities. Neither the Company nor its subsidiaries, purchased, sold or redeemed any of the Companys listed securities.Connected TransactionsSignificant connected transactions carried out in the normal course of the Groups business are summarised as follows:Item2013 RMB0002012 RMB000With holding company and its subsidiariesSale of water, electricity, steam and waste materials7,68011,973Sale of bulk pharmaceuticals and chemical raw materials60,97263,141 Purchase of raw materials 68,70372,744 Payment of annual trademark licence fee10,0007,500Acquisition of land use rights8,399Total of transactions approved in general meeting147,355 163,757 Design fees income66Rental expenses500500Others total500566With ultimate holding company Interest expenses of loan40,85029,150Underwriting expenses of loan2,1001,500Total42,95030,650With associatesPurchase of raw materials1,0161,076Sale of water, electricity and steam456377Total1,4721,453With minority shareholders Sale of bulk pharmaceuticals and chemical raw materials141,659137,816 Purchase of chemical raw materials and water, electricity, steam2,439-0Total144,098137,816Grand total 336,375334,242 In the opinion of the Directors (including the independent non-executive Directors), the above transactions were carried out in the ordinary and usual course of the Groups business and on normal commercial terms. The aggregate amount of the above transactions for each of the years 2012 and 2013 did not exceed the annual cap approved in the general meeting of the Company.AuditorsThe accounts of the Company and the Group for this year prepared in accordance with HKGAAP and PRC accounting standards have been audited by SHINEWING (HK) CPA Limited (practicing certified public accountants in Hong Kong) and ShineWing Certified Public Accountants (certified public accountants in the PRC) respectively.The Company intends to re-appoint SHINEWING (HK) CPA Limited and ShineWing Certified Public Accountants as international auditors and PRC auditors of the Company respectively for the year 2014 at the annual general meeting for the year 2013 to be held in 2014.Corporate Governance Code The Directors (including the independent non-executive Directors) are of the opinion that for the year ended 31 December 2013, the Company complied with all code provisions set out in the Corporate Governance Code contained in Appendix 14 to the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.The Company has always strived to comply with the best corporate governance practices in the Corporate Governance Code. Material Litigation and ArbitrationThe Group was not involved in any material litigation or arbitration and no material litigation or arbitration is pending or threatened or was made against the Group during the reporting period.Sale of AssetsIn 2013, the local government purchased and put into reserves parts of the relocated idle land of the Company together with the fixture thereon in the old factory area, generating an income of approximately RMB49,188,000.Apart from the above transactions, the Group did not have material acquisitions and sales of assets, nor any material mergers and acquisitions during this reporting period.Amendments to the ArticlesDuring the reporting period, there were no amendments to the articles of association of the Company.Audit CommitteeThe audit committee has, together with the management, reviewed the accounting principles, practices and methods adopted by the Group and has reviewed the auditing, internal control and financial reporting of the Group. The audit committee has convened four meetings to review the audited financial statements for 2012, the unaudited 1st quarterly financial statements for 2013, the unaudited interim statements for 2013 and the unaudited 3rd quarterly financial statements for 2013.The audit committee convened a meeting on 27 March 2014 to review the 2013 audited accounts and annual results announcement.VII. FINANCIAL REPORTSThe financial reports of the Company and the Group for the financial year ended 31 December 2013 have been audited by SHINEWING (HK) CPA Limited (practicing certified public accountants in Hong Kong) and ShineWing Certified Public Accountants (certified public accountants in the PRC) in accordance with HKGAAP and PRC accounting standards respectively. In their respective auditors reports there was no qualified opinion.1. financial statement and notes Prepared Under PRC Accounting StandardsConsolidated and the Companys Income Statement for the year 2013 (AUDITED) Unit: RMBItem20132012Consolidated The CompanyConsolidatedThe Company1.Total operating income3,169,653,150.691,844,099,811.492,971,519,619.901,752,796,478.56 Includes: Operating income3,169,653,150.691,844,099,811.492,971,519,619.901,752,796,478.562.Total operating costs3,220,635,032.141,889,128,808.562,996,016,283.801,725,454,400.94 Includes: Operating cost2,656,288,958.581,585,474,107.982,447,201,083.031,453,204,111.04 Taxes and surcharges17,664,147.4612,210,662.9515,429,035.699,305,384.52 Selling expenses224,074,461.3030,114,871.00239,897,943.2929,066,464.92 Administrative expenses223,237,796.63176,832,754.79215,688,194.67171,459,300.11 Financial expenses86,539,662.6081,093,357.4860,254,240.0059,629,956.92 Assets impairment loss12,830,005.573,403,054.3617,545,787.122,789,183.43 Add: Gain or loss from changes in fair value---- Investment gain or loss7,119,504.2611,387,695.315,791,482.579,254,512.71 Includes: Investment gain or loss from related ventures and joint ventures2,742,373.582,742,373.583,202,592.713,202,592.713. Operating profit(43,862,377.19)(33,641,301.76)(18,705,181.33)36,596,590.33 Add: Non-operating income111,417,087.4595,277,819.5866,954,709.0637,760,293.44 Less: Non-operating cost17,038,853.0813,874,658.3413,268,458.7510,231,507.92 Includes: Loss from the disposal of non-current assets8,501,878.698,495,831.896,807,412.806,714,600.834. Profit before taxation50,515,857.1847,761,859.4834,981,068.9864,125,375.85 Less: Income tax expense12,206,608.228,320,104.998,718,849.878,237,041.935. Profit after taxation38,309,248.9639,441,754.4926,262,219.1155,888,333.92 Includes: Profit attributable to the equity holders of the Company36,745,414.38-23,663,577.96- Minority interest1,563,834.58-2,598,641.15-6. Earnings per share 1) Basic earnings per share0.080.090.050.12 2) Diluted earnings per share0.080.090.050.127.Other comprehensive income(25,013,114.90)(24,557,452.00)17,527,259.5017,196,207.208. Total comprehensive income13,296,134.0614,884,302.4943,789,478.6173,084,541.12 Includes: Total comprehensive income attributable to the equity holders of the Company11,815,148.56-41,074,969.15- Total comprehensive income attributable to minority interest1,480,985.50-2,714,509.46-Financial Notes:1. During this reporting period, Shandong Xinhua Pharmaceutical (USA) Company Limited was included in the scope of consolidated financial statements of the Company.2. CONSOLIDATED financial statements AND NOTES PREPARED UNDER HKGAAPCONSOLIDATED STATEMENT OF PROFIT OR LOSSNOTES20132012RMB000RMB000Revenue3,118,7812,932,116Cost of sales(2,626,865)(2,427,711)Gross profit491,916 504,405Investment income7,4155,592Other income112,02466,465Other expenses(32,452)(15,341)Distribution and selling expenses(224,074)(239,897)Administrative expenses(236,942)(231,907)Finance costs4(71,307)(59,004)Share of profit of an associate2,7423,202Profit before tax49,32233,515Income tax expense5(12,028)(8,499)Profit for the year637,29425,016Profit for the year attributable to:Owners of the Company35,73022,417Non-controlling interests1,5642,59937,29425,016Earnings per share basic and diluted8RMB0.078RMB0.049CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOMENOTES20132012RMB000RMB000Profit for the year37,29425,016Other comprehensive (expense) incomeItems that maybe reclassified subsequently to profit or loss:Exchange differences arising on translation of a foreign operation(456)330Fair value (loss) gain arising on available-for-sale financial assets (28,891)20,231Income tax relating to components of other comprehensive income4,334(3,035)Other comprehensive (expense) income for the year, net of tax(25,013)17,526Total comprehensive income for the year12,28142,542Total comprehensive income attributable to:Owners of the Company10,80039,828Non-controlling interests1,481 2,71412,28142,542CONSOLIDATED STATEMENT OF FINANCIAL POSITIONNOTES20132012RMB000RMB000Non-current assetsIntangible assets13,24814,686Property, plant and equipment1,409,6251,426,187Construction in progress540,030273,977Prepaid lease payments on land use rights249,532235,658Investment properties63,92668,906Interest in an associate24,91024,963Available-for-sale financial assets127,412156,303Deferred tax assets18,70519,168Goodwill2,7162,716Prepayments for acquisition of land use rights15,40063,5552,465,5042,286,119Current assetsInventories 457,676489,673Properties under development74,316-Trade and other receivables9460,425428,468Prepaid lease payments on land use rights6,3635,840Amounts due from fellow subsidiaries9,7173,971Tax recoverable3,8173,275Restricted bank balances97,90146,600Bank balances and cash282,822375,5441,393,0371,353,371Current liabilitiesTrade and other payables10540,533522,747Dividend payables5,3115,311Amounts due to fellow subsidiaries4,6071,484 Amount due to an associate25514Amount due to ultimate holding company-13,500Tax payable1,190883Borrowings 475,666493,3701,027,3321,037,809Net current assets365,705315,562Total assets less current liabilities2,831,2092,601,681Capital and reservesShare capital457,313457,313Reserves1,298,8581,282,204Proposed final dividend9,1464,573Equity attributable to owners of the Company1,765,3171,744,090Non-controlling interests37,29039,701Total equity1,802,6071,783,791Non-current liabilitiesDeferred tax liabilities7,03412,331Loan from ultimate holding company694,300496,500Borrowings194,467221,147Deferred income132,80187,9121,028,602817,8902,831,2092,601,681NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS UNDER HKGAAP1. BASIS OF PREPARATIONThe audited consolidated financial statements are prepared in accordance with Hong Kong Financial Reporting Standards (HKFRSs), Hong Kong Accounting Standards (HKASs) issued by Hong Kong Institute of Certified Public Accountants (HKICPA) and the disclosure requirements of Appendix 16 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.2. APPLICATION OF NEW AND REVISED HONG KONG FINANCIAL REPORTING STANDARDS (HKFRSs)In the current year, the Group has applied the following new and revised HKFRSs, which include HKFRSs, Hong Kong Accounting Standards (HKAS(s)) and Interpretations (Int(s)), issued by the Hong Kong Institute of Certified Public Accountants (the HKICPA).Amendments to HKFRSsAnnual Improvements 2009 2011 Cycle issued in 2012Amendments to HKFRS 7Disclosures Offsetting Financial Assets and Financial LiabilitiesAmendments to HKFRS 10, HKFRS 11 and HKFRS 12Consolidated Financial Statements, Joint Arrangements and Disclosures of Interests in Other Entities: Transition GuidanceAmendments to HKAS 1Presentation of Other Comprehensive IncomeHKFRS 10Consolidated Financial StatementsHKFRS 11Joint ArrangementsHKFRS 12Disclosure of Interests in Other EntitiesHKFRS 13Fair Value MeasurementHKAS 19 (as revised in 2011)Employee BenefitsHKAS 27 (as revised in 2011)Separate Financial StatementsHKAS 28 (as revised in 2011)Investments in Associates and Joint VenturesHong Kong (International Financial Reporting Interpretation Committee) (HK (IFRIC)) Interpretation (Int) 20Stripping Costs in the Production Phase of a Surface MineExcept as described below, the application of the new and revised HKFRSs in current year has had no material impact on the Groups financial performance and position for the current and prior years and/or on the disclosures set out in these consolidated financial statements. New and revised standards on consolidation, joint arrangements, associates and disclosuresIn the current year, the Group has applied for the first time the package of five standards on consolidation, joint arrangements, associates and disclosures comprising HKFRS 10 Consolidated Financial Statements, HKFRS 11 Joint Arrangements, HKFRS 12 Disclosure of Interests in Other Entities, HKAS 27 (as revised in 2011) Separate Financial Statements and HKAS 28 (as revised in 2011) Investments in Associates and Joint Ventures, together with the amendments to HKFRS 10, HKFRS 11 and HKFRS 12 regarding transitional guidance.HKAS 27 (as revised in 2011) is not applicable to the Group as it deals only with separate financial statements.The impact of the application of these standards is set out below.Impact on the application of HKFRS 10 HKFRS 10 replaces the parts of HKAS 27 Consolidated and Separate Financial Statements that deal with consolidated financial statements and HK (SIC)-Int 12 Consolidation Special Purpose Entities. HKFRS 10 changes the definition of control such that an investor controls an investee when (a) it has power over an investee, (b) it is exposed, or has rights, to variable returns from its involvement with the investee and (c) has the ability to use its power to affect its returns. All three of these criteria must be met for an investor to have control over an investee. Previously, control was defined as the power to govern the financial and operating policies of an entity so as to obtain benefits from its activities. Additional guidance has been included in HKFRS 10 to explain when an investor has control over an investee. HKFRS 13 Fair Value MeasurementThe Group has applied HKFRS 13 for the first time in the current year. HKFRS 13 establishes a single source of guidance for, and disclosures about, fair value measurements. The scope of HKFRS 13 is broad: the fair value measurement requirements of HKFRS 13 apply to both financial instrument items and non-financial instrument items for which other HKFRSs require or permit fair value measurements and disclosures about fair value measurements, except for share-based payment transactions that are within the scope of HKFRS 2 Share-based Payment, leasing transactions that are within the scope of HKAS 17 Leases, and measurements that have some similarities to fair value but are not fair value (e.g. net realisable value for the purposes of measuring inventories or value in use for impairment assessment purposes).HKFRS 13 defines the fair value of an asset as the price that would be received to sell an asset (or paid to transfer a liability, in the case of determining the fair value of a liability) in an orderly transaction in the principal (or most advantageous) market at the measurement date under current market conditions. Fair value under HKFRS 13 is an exit price regardless of whether that price is directly observable or estimated using another valuation technique. Also, HKFRS 13 includes extensive disclosure requirements.HKFRS 13 requires prospective application. In accordance with the transitional provisions of HKFRS 13, the Group has not made any new disclosures required by HKFRS 13 for the 2012 comparative period. Other than the additional disclosures, the application of HKFRS 13 has not had any material impact on the amounts recognised in the consolidated financial statements.Amendments to HKAS 1 Presentation of Items of Other Comprehensive IncomeThe Group has applied the amendments to HKAS 1 Presentation of Items of Other Comprehensive Income. Upon the adoption of the amendments to HKAS 1, the Groups statement of comprehensive income is renamed as the statement of profit or loss and other comprehensive income. Furthermore, the amendments to HKAS 1 require additional disclosures to be made in the other comprehensive income section such that items of other comprehensive income are grouped into two categories: (a) items that will not be reclassified subsequently to profit or loss and (b) items that may be reclassified subsequently to profit or loss when specific conditions are met. Income tax on items of other comprehensive income is required to be allocated on the same basis the amendments do not change the option to present items of other comprehensive income either before tax or net of tax. The amendments have been applied retrospectively, and hence the presentation of items of other comprehensive income has been modified to reflect the changes. Other than the above mentioned presentation changes, the application of the amendments to HKAS 1 does not result in any impact on profit or loss, other comprehensive income and total comprehensive income.New and revised HKFRSs issued but not yet effectiveThe Group has not early applied the following new and revised HKFRSs that have been issued but are not yet effective:Amendments to HKFRSsAnnual Improvements to HKFRSs 2010-2012 Cycle2Amendments to HKFRSsAnnual Improvements to HKFRSs 2011-2013 Cycle2HKFRS 9 Financial Instruments3 HKFRS 14Regulatory Deferral Accounts4Amendments to HKFRS 9 and HKFRS 7Mandatory Effective Date of HKFRS 9 and Transition Disclosures3Amendments to HKFRS 10, HKFRS 12 and HKAS 27Investment Entities1Amendments to HKAS 19 Defined Benefit Plans - Employee Contributions2Amendments to HKAS 32 Offsetting Financial Assets and Financial Liabilities1Amendments to HKAS 36Recoverable Amount Disclosures for Non-Financial Assets1Amendments to HKAS 39Novation of Derivatives and Continuation of Hedge Accounting1HK(IFRIC) Int 21Levies11 Effective for annual periods beginning on or after 1 January 2014, with earlier application permitted.2 Effective for annual periods beginning on or after 1 July 2014, with earlier application permitted.3 HKFRS 9, as amended in December 2013, amended the mandatory effective date of HKFRS 9. The mandatory effective date is not specified in HKFRS 9 but will be determined when the outstanding phases are finalised. However, application of HKFRS 9 is permitted.4 Effective for annual periods beginning on or after 1 January 2016, with earlier application permitted.Annual Improvements to HKFRSs 2010-2012 CycleThe Annual Improvements to HKFRSs 2010-2012 Cycle include a number of amendments to various HKFRSs, which are summarised below.The amendments to HKFRS 2 (i) change the definitions of vesting condition and market condition; and (ii) add definitions for performance condition and service condition which were previously included within the definition of vesting condition. The amendments to HKFRS 2 are effective for share-based payment transactions for which the grant date is on or after 1 July 2014.The amendments to HKFRS 3 clarify that contingent consideration that is classified as an asset or a liability should be measured at fair value at each reporting date, irrespective of whether the contingent consideration is a financial instrument within the scope of HKFRS 9 or HKAS 39 or a non-financial asset or liability. Changes in fair value (other than measurement period adjustments) should be recognised in profit and loss. The amendments to HKFRS 3 are effective for business combinations for which the acquisition date is on or after 1 July 2014.The amendments to HKFRS 8 (i) require an entity to disclose the judgements made by management in applying the aggregation criteria to operating segments, including a description of the operating segments aggregated and the economic indicators assessed in determining whether the operating segments have similar economic characteristics; and (ii) clarify that a reconciliation of the total of the reportable segments assets to the entitys assets should only be provided if the segment assets are regularly provided to the chief operating decision-maker.The amendments to the basis for conclusions of HKFRS 13 clarify that the issue of HKFRS 13 and consequential amendments to HKAS 39 and HKFRS 9 did not remove the ability to measure short- term receivables and payables with no stated interest rate at their invoice amounts without discounting, if the effect of discounting is immaterial. The amendments to HKAS 16 and HKAS 38 remove perceived inconsistencies in the accounting for accumulated depreciation/amortisation when an item of property, plant and equipment or an intangible asset is revalued. The amended standards clarify that the gross carrying amount is adjusted in a manner consistent with the revaluation of the carrying amount of the asset and that accumulated depreciation/amortisation is the difference between the gross carrying amount and the carrying amount after taking into account accumulated impairment losses.The amendments to HAKS 24 clarify that a management entity providing key management personnel services to a reporting entity is a related party of the reporting entity. Consequently, the reporting entity should disclose as related party transactions the amounts incurred for the service paid or payable to the management entity for the provision of key management personnel services. However, disclosure of the components of such compensation is not required. The directors of the Company do not anticipate that the application of the amendments included in the Annual Improvements to HKFRSs 2010-2012 Cycle will have a material effect on the Groups consolidated financial statements.Annual Improvements to HKFRSs 2011-2013 CycleThe Annual Improvements to HKFRSs 2011-2013 Cycle include a number of amendments to various HKFRSs, which are summarised below.The amendments to HKFRS 3 clarify that the standard does not apply to the accounting for the formation of all types of joint arrangement in the financial statements of the joint arrangement itself.The amendments to HKFRS 13 clarify that the scope of the portfolio exception for measuring the fair value of a group of financial assets and financial liabilities on a net basis includes all contracts that are within the scope of, and accounted for in accordance with, HKAS 39 or HKFRS 9, even if those contracts do not meet the definitions of financial assets or financial liabilities within HKAS 32.The amendments to HKAS 40 clarify that HKAS 40 and HKFRS 3 are not mutually exclusive and application of both standards may be required. Consequently, an entity acquiring investment property must determine whether:(a) the property meets the definition of investment property in terms of HKAS 40; and(b) the transaction meets the definition of a business combination under HKFRS 3.The directors of the Company do not anticipate that the application of the amendments included in the Annual Improvements to HKFRSs 2011-2013 Cycle will have a material effect on the Groups consolidated financial statements.HKFRS 9 Financial Instruments HKFRS 9 issued in 2009 introduces new requirements for the classification and measurement of financial assets. HKFRS 9 was subsequently amended in 2010 to include the requirements for the classification and measurement of financial liabilities and for derecognition, and further amended in 2013 to include the new requirements for hedge accounting.Key requirements of HKFRS 9 are described as follows:All recognised financial assets that are within the scope of HKAS 39 Financial Instruments: Recognition and Measurement are subsequently measured at amortised cost or fair value. Specifically, debt investments that are held within a business model whose objective is to collect the contractual cash flows, and that have contractual cash flows that are solely payments of principal and interest on the principal outstanding are generally measured at amortised cost at the end of subsequent accounting periods. All other debt investments and equity investments are measured at their fair values at the end of subsequent reporting periods. In addition, under HKFRS 9, entities may make an irrevocable election to present subsequent changes in the fair value of an equity investment (that is not held for trading) in other comprehensive income, with only dividend income generally recognised in profit or loss.With regard to the measurement of financial liabilities designated at fair value through profit or loss, HKFRS 9 requires that the amount of change in the fair value of the financial liability that is attributable to changes in the credit risk of that liability is presented in other comprehensive income, unless the recognition of the effects of changes in the liabilitys credit risk in other comprehensive income would create or enlarge an accounting mismatch in profit or loss. Changes in fair value of financial liabilities attributable to changes in the financial liabilities credit risk are not subsequently reclassified to profit or loss. Under HKAS 39, the entire amount of the change in the fair value of the financial liability designated as fair value through profit or loss was presented in profit or loss. The new general hedge accounting requirements retain the three types of hedge accounting. However, greater flexibility has been introduced to the types of transactions eligible for hedge accounting, specifically broadening the types of instruments that qualify for hedging instruments and the types of risk components of non-financial items that are eligible for hedge accounting. In addition, the effectiveness test has been overhauled and replaced with the principle of an economic relationship. Retrospective assessment of hedge effectiveness is also no longer required. Enhanced disclosure requirements about an entitys risk management activities have also been introduced.The directors of the Company anticipate that the adoption of HKFRS 9 in the future will not have significant impact on amounts currently reported in respect of the Groups financial assets and financial liabilities.Amendments to HKFRS 10, HKFRS 12 and HKAS 27 Investment EntitiesThe amendments to HKFRS 10 introduce an exception to consolidating subsidiaries for an investment entity, except where the subsidiaries provide services that relate to the investment entitys investment activities. Under the amendments to HKFRS 10, an investment entity is required to measure its interests in subsidiaries at fair value through profit or loss.To qualify as an investment entity, certain criteria have to be met. Specifically, an entity is required to:obtain funds from one or more investors for the purpose of providing them with professional investment management services;commit to its investor(s) that its business purpose is to invest funds solely for returns from capital appreciation, investment income, or both; andmeasure and evaluate performance of substantially all of its investments on a fair value basis.Consequential amendments to HKFRS 12 and HKAS 27 have been made to introduce new disclosure requirements for investment entities. The amendments to HKFRS 10, HKFRS 12 and HKAS 27 are effective for annual periods beginning on or after 1 January 2014, with early application permitted. The directors of the Company anticipate that the application of the amendments will have no effect on the Group as the Company is not an investment entity.The directors of the Company anticipated that the application of other new and revised standards, amendments or interpretation would have no material impact on the results and the financial position of the Group. 3. SEGMENTAL INFORMATIONThe Groups operating segments, based on information reported to the board of directors of the Company, being the chief operating decision maker, for the purposes of resource allocation and assessment of segment performance focuses on the types of goods supplied. The principal types of goods supplied are bulk pharmaceuticals, preparations, chemical and other products and commerce circulations. The Groups reportable segments under HKFRS 8 are as follows:Bulk pharmaceuticals:Development, production and sales of bulk pharmaceuticalsPreparations:Development, production and sales of preparations (e.g. tablets and injections)Chemical and other products:Production and sales of chemical and other products Commerce circulations:Trading of pharmaceutical products (including retail and wholesale)Information regarding the above segments is reported below. Segment revenues and resultsThe following is an analysis of the Groups revenue and results by reportable segment.For the year ended 31 December 2013Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other productsEliminationsTotalRMB000RMB000RMB000RMB000RMB000RMB000REVENUE External sales1,518,928549,426810,525239,902-3,118,781Inter-segment sales9,034279,16625,536308,372(622,108)-Total 1,527,962828,592836,061548,274(622,108) 3,118,781Segment profit61,7368,3171,57914,84686,478Unallocated income63,861Unallocated expenses(32,452)Finance costs(71,307)Share of profit of an associate2,742Profit before tax 49,322For the year ended 31 December 2012Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other productsEliminationsTotalRMB000RMB000RMB000RMB000RMB000RMB000REVENUE External sales1,422,469586,292718,835204,520-2,932,116Inter-segment sales6,822357,55711,852277,524(653,755)-Total 1,429,291943,849730,687482,044(653,755)2,932,116Segment profit (loss) 108,804  9,967  (17,964) (20,797)80,010Unallocated income28,954Unallocated expenses(19,647)Finance costs(59,004)Share of profit of an associate3,202Profit before tax 33,515The accounting policies of the reportable segments are the same as the Groups accounting policies. Segment profit represents the profit earned by each segment without allocation of investment and other income (exclude government grants), other expenses, depreciation for investment properties, finance costs and share of profit of an associate. This is the measure reported to the chief operating decision maker for the purposes of resource allocation and performance assessment. Inter-segment sales are charged at prevailing market rates.Segment assets and liabilitiesThe following is an analysis of the Groups assets and liabilities by reportable segment:At 31 December 2013Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other productsTotalRMB000RMB000RMB000RMB000RMB000Segment assets1,689,688594,002189,506765,8523,239,048Unallocated corporate assets619,493Consolidated assets3,858,541Segment liabilities226,19584,01862,860173,282546,355Unallocated corporate liabilities 1,509,579Consolidated liabilities2,055,934At 31 December 2012Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other productsTotalRMB000RMB000RMB000RMB000RMB000Segment assets1,600,335569,590135,428639,3782,944,731Unallocated corporate assets694,759Consolidated assets3,639,490Segment liabilities230,70393,82551,620162,097538,245Unallocated corporate liabilities 1,317,454Consolidated liabilities1,855,699For the purposes of monitoring segment performances and allocating resources among segments:all assets are allocated to reportable segments other than deferred tax assets, interest in an associate, available-for-sale investments, investment properties, tax recoverable, restricted bank balances, bank balances and cash. Assets used jointly by reportable segments are allocated on the basis of revenues earned by individual reportable segments; andall liabilities are allocated to reportable segments other than liabilities associated with dividend payable, deferred tax liabilities, loan from ultimate holding company, borrowings, deferred income and tax payable. Liabilities for which reportable segments are jointly liable are allocated on the basis of revenues earned by individual reportable segments. Other segment informationFor the year ended 31 December 2013Amounts included in the measure of segment profit or segment assets:Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other productsTotalRMB000RMB000RMB000RMB000RMB000Addition to non-current assets (Note) 300,04279,1133,12678,464460,745Depreciation and amortisation (excluded depreciation for investment properties)104,39130,5892,76143,102180,843Impairment losses recognised in respect of property, plant and equipment-142-148290Impairment losses recognised in respect of trade and other receivables 4141105,626256,175Reversal of impairment loss on trade and other receivables(32)(8)(1,381)(10)(1,431)Reversal of allowance for inventories(6,549)(2,007)(1,054)(3,316)(12,926)Write-down of inventories4,0861,6671,0491,0347,836Note: Non-current assets excluded financial instruments, investment properties, deferred tax assets and interest in an associate. For the year ended 31 December 2013Amounts regularly provided to the chief operating decision maker but not included in the measure of segment profit or segment assets:Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other productsTotalRMB000RMB000RMB000RMB000RMB000Interest in an associate-24,910--24,910Interest income1,8644503623613,037Gain on disposal of property, plant and equipment and prepaid lease payment on land use rights33,9238,9998942,939Finance costs(53,479)(14,190)-(3,638)(71,307)Income tax expense(8,101)(1,208)(902)(1,817)(12,028)For the year ended 31 December 2012Amounts included in the measure of segment profit or segment assets:Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other productsTotalRMB000RMB000RMB000RMB000RMB000Addition to non-current assets (Note) 284,23284,1051,093173,417542,847Depreciation and amortisation (excluded depreciation for investment properties)90,83028,7632,17441,061162,828Impairment losses recognised in respect of property, plant and equipment---9898Impairment losses recognised in respect of trade and other receivables 124379,721469,928Reversal of impairment loss on trade and other receivables(156)(47)(361)(21)(585)Reversal of allowance for inventories(884)(263)(864)(2,796)(4,807)Write-down of inventories2,2326631,8523,2127,959Note: Non-current assets excluded financial instruments, investment properties, deferred tax assets and interest in an associate. For the year ended 31 December 2012Amounts regularly provided to the chief operating decision maker but not included in the measure of segment profit or segment assets:Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other productsTotalRMB000RMB000RMB000RMB000RMB000Interest in an associate-24,963--24,963Interest income2,0085541503083,020Gain on disposal of property, plant and equipment and prepaid lease payment on land use rights9,7882,841-28512,914Finance costs(44,716)(13,291)(413)(584)(59,004)Income tax expense(6,805)(1,200)(40)(454)(8,499)Geographical informationThe Groups customers are mainly located in the PRC, Europe, America and other countries. Information about the Group's revenue from external customers is presented based on the location of the customers.Revenues from external customers20132012RMB000RMB000PRC1,876,0191,772,779Europe440,490496,242America594,071470,377Others208,201192,7183,118,7812,932,116Over 99% (2012: 99%) of the Groups non-current assets are located in the PRC and therefore the analysis of non-current assets by geographical location of the assets is not presented.Information about major customersThe Groups customer base includes a wide range of different customers. During the year ended 31 December 2013 and 2012, the Group had no single customer that contributed 10% or more of the Groups revenue. Therefore, there was no significant concentration of source of income from a particular customer.4. FINANCE COSTS20132012RMB000RMB000Interest on:- Bank loans wholly repayable within 5 years27,49828,505 Government loans wholly repayable within 5 years1,1971,265 Loan from ultimate holding company40,85030,65069,54560,420Less: interest capitalised at a rate of 5.90 6.90% per annum(3,965)(2,818)65,58057,602Discount charges on bank acceptance notes3,6271,402Other incidental borrowing costs2,100-71,30759,0045. INCOME TAX EXPENSE20132012RMB000RMB000PRC enterprise income tax (EIT) - Current10,5969,779 - Under-provision in prior years1,9321,56712,52811,346 Deferred tax(500)(2,847)12,0288,499Under the Law of the PRC on EIT (the EIT Law) and Implementation Regulation of the EIT Law, the tax rate of the PRC companies is 25% for both years. Pursuant to the relevant laws and regulations in the PRC, the Company was accredited as a high-tech enterprise. The accreditation is valid for three years. The Company is entitled to the preferential tax rate of 15% for a period of three years from 1 January 2011 to 31 December 2013.Pursuant to the relevant laws and regulations in the PRC, the Groups subsidiary, SINO-USA Zibo Xinhua - Perrigo Pharmaceutical Company Limited, operating in the PRC is entitled to exemption from the PRC income tax for the two years ended 31 December 2009, followed by a 50% reduction of the PRC income tax for the three years ended 31 December 2012. SINO-USA Zibo Xinhua - Perrigo Pharmaceutical Company Limited adopts EIT tax rate of 25% for the year ended 31 December 2013. The tax charge for the year can be reconciled to the profit before tax per the consolidated income statement as follows: 20132012RMB000RMB000Profit before tax 49,32233,515Tax at the domestic income tax rate of 25% (2012: 25%)12,3318,379Effect of preferential tax rate in the PRC(4,986)(7,067)Tax effect of share of profits of an associate(411)(480)Tax effect of income not taxable for tax purpose(1,529)(1,903)Tax effect of expenses not deductible for tax purpose6,0334,706Tax effect of additional allowance (Note)(1,126)(1,045)Tax effect of tax losses not recognised-1,036Tax effect of deductible temporary differences not recognised7353,306Utilisation of tax losses not recognised(951)-Under-provision in prior years1,9321,567Tax charge for the year12,0288,499Note: The amount represents the tax effect of additional tax allowance granted to the Group in respect of research and development expenditure as stipulated in the relevant tax rules in the PRC. 6. PROFIT FOR THE YEARProfit for the year has been arrived at after charging (crediting):20132012RMB000RMB000Depreciation for property, plant and equipment170,553154,728Depreciation for investment properties4,9804,306Amortisation of prepaid lease payments on land use rights6,4135,840Amortisation of intangible assets3,8772,260Total depreciation and amortisation185,823167,134Auditors remuneration840840Research and development costs recognised as an expense40,08730,107Operating lease rentals on land and buildings2,0081,235Impairment losses recognised in property, plant and equipment29098Impairment losses recognised in respect of trade and other receivables (Note 9)6,1759,928Reversal of allowance for inventories (included in cost of sales)(12,926)(4,807)Write-down of inventories (included in cost of sales)7,8367,959Staff costs (excluding directors and supervisors emoluments)325,687301,013Cost of inventories recognised as an expense2,626,8652,427,7117. DIVIDENDS20132012RMB000RMB000Dividends recognised as distribution during the year:- 2012 final dividend: RMB0.01 per share4,573-- 2011 final dividend: RMB0.03 per share-13,7194,57313,719For the year ended 31 December 2013, final dividend of RMB0.02 (2012: RMB0.01) per share (approximately HK$0.025 (2012: HK$0.0125) per share, including income tax of A shares) on 307,312,830 A shares and 150,000,000 H shares has been proposed by the directors of the Company and is subject to approval by shareholders at the annual general meeting and has been included as a dividend reserve in the consolidated financial statements.8. EARNINGS PER SHAREThe calculation of the basic earnings per share is based on the Groups profit for the year attributable to the owners of the Company of approximately RMB35,730,000 (2012: RMB22,417,000) and based on the weighted average number of 457,312,830 (2012: 457,312,830) shares in issue during the year.Basic earnings per share and diluted earnings per share for two years ended 31 December 2013 and 2012 are the same as there were no dilutive events existed during both years.9. TRADE AND OTHER RECEIVABLES20132012RMB000RMB000Trade and bills receivables448,272403,563Less : Allowance for doubtful debts of trade receivables(61,649)(63,125)386,623340,438Other receivables, deposits and prepayments69,58753,096VAT recoverable10,32914,737Consideration receivable on disposal of land8,00028,987Less : Allowance for doubtful debts of other receivables(14,114)(8,790)73,80288,030Total trade and other receivables460,425428,468As at 31 December 2013, included in the trade receivables of approximately RMB180,239,000 (2012: RMB127,346,000) and approximately RMB4,911,000 (2012: RMB2,071,000) is denominated in United States Dollars (USD) and Great Britain Pounds (GBP) respectively.The Groups revenue from export sales is on letter of credit or documents against payment. The credit period is agreed upon and stipulated in the sales contract. Except for some particular customers where payment in advance is normally required, the Group allows an average credit period of 30 days to its local trade customers and 90 days for local hospital customers. The following is an aged analysis of the trade and bills receivables net of allowance for doubtful debts presented based on the invoice date, which approximated to the revenue recognition dates, at the end of the reporting period.20132012RMB000RMB000Within one year384,847333,317More than one year but within two years9526,904More than two years but within three years824217386,623340,438Included in the Groups trade and bills receivable balance are debtors with aggregate carrying amount of approximately RMB14,141,000 (2012: RMB42,551,000) which are past due as at the reporting date for which the Group has not provided for impairment loss. In respect of trade and bill receivables, individual credit evaluations are performed on all customers requiring credit over a certain amount. These evaluations focus on the customers past history of making payments when due and current liability to pay, and take into account information specific to the customer as well as pertaining to the economic environment in which the customers operate. 85% (2012: 86%) of the trade and bill receivables that are neither past due nor impaired have good settlement history under the Groups individual credit evaluations. The Group does not hold any collateral over these balances.Ageing of trade receivables which are past due but not impaired20132012RMB000RMB000Within one year13,42637,802More than one year but within than two years1954,532More than two years but within than three years520217Total14,14142,551Receivables that were past due but not impaired relate to a number of independent customers that have a good track record with the Group. Based on past experience, management believes that no impairment allowance is necessary in respect of these balances as there has not been a significant change in credit quality and the balances are still considered fully recoverable. The Group does not hold any collateral over these balances.Movements in the allowance for doubtful debts of trade receivables20132012RMB000RMB000At 1 January63,12553,328Impairment losses reversed(1,391)(111)Amounts written off as uncollectible(856)-Impairment losses recognised7719,908At 31 December61,64963,125In determining the recoverability of trade receivables, the Group considers any change in the credit quality of the trade receivables from the date credit was initially granted up to the end of the reporting period. The concentration of credit risk is limited due to the customer base being large and unrelated.Included in the allowance for doubtful debts are individually impaired trade receivables with an aggregate balance of approximately RMB61,649,000 (2012: RMB63,125,000) which were found to be under severe financial difficulties. The Group does not hold any collateral over these balances.Movements in the allowance for doubtful debts of other receivables20132012RMB000RMB000At 1 January8,7909,244Impairment losses reversed(40)(474)Amounts written off as uncollectible(40)-Impairment loss recognised5,40420At 31 December14,1148,790Included in the allowance for doubtful debts are individually impaired other receivables with an aggregate balance of approximately RMB14,114,000 (2012: RMB8,790,000) which were found to be under severe financial difficulties. The Group does not hold any collateral over these balances.As at 31 December 2013, certain secured bank loans were secured by trade and bills receivables of the Group with an aggregate carrying values of approximately RMB61,579,000 (2012:62,855,000).10. TRADE AND OTHER PAYABLES20132012RMB000RMB000Trade payables353,028394,431Other payables and accrued charges68,97252,411Accrued construction expenses118,53375,905540,533522,747The following is an aged analysis of trade payables presented based on the invoice date at the end of the reporting period. 20132012RMB000RMB000Within one year344,789 382,711More than one year but less than two years3,396 6,294More than two years but less than three years2,098 1,707Over three years 2,745 3,719353,028394,431The average credit period on purchases of goods is approximately 30 days. The Group has financial risk management policies in place to ensure that all payables are settled within the credit timeframe.11. RELATED PARTY TRANSACTIONS(a) Except as disclosed elsewhere in the consolidated financial statements, the other significant related party transactions, which were carried out in the normal course of the Groups business are detailed as follows:20132012RMB000RMB000Immediate holding company:SXPGC:- Payment of annual trademark licence fee (Note i)10,0007,500- Rental expense500500- Acquisition of land use rights-8,399Ultimate holding company:Hualu Holdings Co., Ltd.:- Interest expenses of loan from ultimate holding company40,85029,150- Share of underwriting expenses of loan from ultimate holding company2,1001,500Fellow subsidiaries: - Sale of water, electricity, steam and waste materials7,68011,973- Sale of bulk pharmaceuticals and chemical products60,97263,141- Purchase of raw materials68,70372,744- Design fee income-66Associate:- Sale of water, electricity, steam456377- Purchase of raw materials1,0161,076Non-controlling interest shareholders:- Purchase of customer list2,439-- Sale of bulk pharmaceuticals and chemical raw materials141,659137,816Notes:On 7 December 1996, the Group was granted the exclusive right to use the trademark Xinhua (Trademark) by SXPGC for its existing and future products in and outside the PRC at an initial annual fee of RMB600,000 increasing at the rate of an extra RMB100,000 per year until the annual fee reaches the cap amount of RMB1,100,000, which shall stay as such until the agreement is terminated. The terms of the agreement shall continue to have effect during the validity period of the Trademark, being 28 February 2013, subject to further renewal of the registration of the Trademark.On 23 March 2012, the Group entered into the supplemental trademark licence agreement with SXPGC, pursuant to which the annual licence fee to use the Trademark is RMB10,000,000 for the period between 1 April 2012 to 31 December 2014. Other terms of the trademark licence agreement remain unchanged.The Group operates in an economic environment predominated by enterprises directly or indirectly owned or controlled by the PRC government through its numerous authorities, affiliates or other organisations (collectively State-owned Enterprises). During the year ended 31 December 2013, the Group had transactions with State-owned Enterprises including, but not limited to, sales of pharmaceutical products and purchases of raw materials. The directors of the Company consider that transactions with other State-owned Enterprises are activities in the ordinary course of business, and that dealings of the Group have not been significantly controlled or owned by the PRC government. The Group has also established pricing policies for products and such pricing policies do not depend on whether orq r s   x z . 0 2 4 T V ٿ٧vgvgT;T1h_W:hmB*CJOJPJQJaJnHphtH%h_W:hmB*CJOJQJaJphh_W:hmCJOJQJaJh_W:hmCJOJQJaJh_W:hm5CJOJQJaJ"h_W:hm5CJOJQJaJo(.h_W:h45CJOJPJQJaJnHo(tH2jh_W:h~,5CJOJQJUmHnHo(uh_W:hm5CJOJQJo(+h_W:hm6KHOJPJQJaJnHtHq r t u v  x 2 X qr !67hi^T^`^ $dT^a$ $UDb]a$$a$ V X \ ^ ` b  A ` ͯ͂oVoVoCo(4h_W:hfyB*CJOJPJQJaJnHo(phtH%h_W:h4B*CJOJQJaJph1h_W:hmB*CJOJPJQJaJnHphtH%h_W:hmB*CJOJQJaJphh_W:hmB*OJQJph:h_W:h Z5B*CJOJPJQJ\aJnHo(phtH:h_W:hfy5B*CJOJPJQJ\aJnHo(phtH+h_W:hm5B*CJOJQJ\aJph7h_W:hm5B*CJOJPJQJ\aJnHphtH dnoPoqrҷҞ҅҅҅jjO@h_W:hmCJOJQJaJ4h_W:h=NhB*CJOJPJQJaJnHo(phtH4h_W:hB*CJOJPJQJaJnHo(phtH1h_W:hmB*CJOJPJQJaJnHphtH1h_W:htB*CJOJPJQJaJnHphtH4h_W:htB*CJOJPJQJaJnHo(phtH%h_W:hmB*CJOJQJaJph4h_W:hB*CJOJPJQJaJnHo(phtH !7;EhivҿmO1:h_W:hm5B*CJOJPJQJ\aJnHo(phtH:h_W:h:5B*CJOJPJQJ\aJnHo(phtH:h_W:h>H5B*CJOJPJQJ\aJnHo(phtH+h_W:hm5B*CJOJQJ\aJphh_W:hmCJOJQJaJh_W:hmCJOJQJaJ%h_W:hmB*CJOJQJaJph%h_W:hmB*CJOJQJaJph4h_W:h>HB*CJOJPJQJaJnHo(phtH ´veZH6#h_W:hCJPJaJnHo(tH#h_W:h.mNCJPJaJnHo(tHh_W:hmCJaJ h_W:hm56CJ\]aJ&h_W:hm5CJPJ\aJnHtH)h_W:h5CJPJ\aJnHo(tH)h_W:h5CJPJ\aJnHo(tHh_W:hm5CJ\aJh_W:hmCJKHaJ&h_W:hm5CJPJ]aJnHtH7h_W:hm5B*CJOJPJQJ\aJnHphtHmb $$1$Ifa$xkd$$Ifl,\3 EW! p9!644 la$1$IfWDd` $$1$Ifa$ ˾˾}p\B\B3h_W:h+CJKHOJPJQJ^JaJnHo(tH'h_W:h6CJKHOJQJ^JaJo(h_W:h6CJKHaJ#h_W:h6CJPJaJnHo(tH#h_W:hCJPJaJnHo(tH#h_W:hCJPJaJnHo(tHh_W:hmCJaJh_W:hmCJKHaJh_W:hm6CJ]aJ&h_W:hm6CJPJ]aJnHtH#h_W:hmCJPJaJnHo(tH uj $$1$Ifa${kd$$Ifl,\3 EW! p9!644 layt6$$1$Ifa$gd6 %&'/08@ABUV]^eklmӳӳӳӳӳr#h_W:h:CJPJaJnHo(tH$h_W:h6CJKHPJaJnHtH h_W:h6CJPJaJnHtHh_W:h6CJaJh_W:h6CJKHaJ$h_W:h6CJKHOJQJ^JaJ'h_W:h6CJKHOJQJ^JaJo(0h_W:h6CJKHOJPJQJ^JaJnHtH+'08Axjjj$$1$Ifa$gd6 $$1$Ifa${kd$$Ifl,\3 EW! p9!644 layt6ABV^elxjjj$$1$Ifa$gd6 $$1$Ifa${kd$$Ifl,\3 EW! p9!644 layt6lmxjjj$$1$Ifa$gd6 $$1$Ifa${kd<$$Ifl,\3 EW! p9!644 layt6n```$$1$Ifa$gd6v$ $Ifa${kd$$Ifl,\3 EW! p9!644 layt6ԴmW9:h_W:hi5B*CJOJPJQJ\aJnHo(phtH+h_W:h]4fCJOJPJQJaJnHo(tH+h_W:hmCJOJPJQJaJnHo(tH(h_W:hmCJOJPJQJaJnHtH7h_W:hm5B*CJOJPJQJ\aJnHphtHh_W:h6CJKHaJ$h_W:h6CJKHOJQJ^JaJ'h_W:h6CJKHOJQJ^JaJo(h_W:h6CJaJh_W:h6CJaJo(}llllG%<TPL HD@< ^TQ ^{kd`$$Ifl,\3 EW! p9!644 layt6#$&'(˭vbWI4)h_W:h5CJPJ\aJnHo(tH)h_W:hi5CJPJ\aJnHo(tHh_W:hm5CJ\aJh_W:hmCJaJ&h_W:hm5CJPJ]aJnHtH1h_W:hmB*CJOJPJQJaJnHphtH:h_W:hm5B*CJOJPJQJ\aJnHo(phtH:h_W:h*O5B*CJOJPJQJ\aJnHo(phtH:h_W:hs5B*CJOJPJQJ\aJnHo(phtH+h_W:hm5B*CJOJQJ\aJph $)17?FN;$1$IfWD`; $$1$Ifa$%<TPL HD@< ^.<TPL HD@< WD^`gd`)F ()0134567>?ABCEFMO[zlZlFl;h_W:h6CJaJ&h_W:hm6CJPJ]aJnHtH#h_W:hCJPJaJnHo(tHh_W:hm6CJ]aJ&h_W:hm5CJPJ\aJnHtHh_W:hm5CJ\aJ#h_W:hCJPJaJnHo(tH#h_W:hgICJPJaJnHo(tHh_W:hmCJaJh_W:hmCJaJ h_W:hm56CJ\]aJ/h_W:hm56CJPJ\]aJnHo(tHNO\fpz~ppp$$1$Ifa$gdU$1$Ifxkd$$Ifl,\S "b :::"644 la][\efpyz{)2345?o:h_W:h>H5B*CJOJPJQJ\aJnHo(phtH1h_W:hmB*CJOJPJQJaJnHphtH#h_W:h6CJPJaJnHo(tHh_W:h6CJaJh_W:h6CJaJ$h_W:h6CJKHOJQJ^JaJ'h_W:h6CJKHOJQJ^JaJo(h_W:h6CJaJ#z{~ppp$$1$Ifa$gdU$1$Ifxkdj$$Ifl,\S "b :::"644 la]~ppp$$1$Ifa$gdU$1$Ifxkd$$Ifl,\S "b :::"644 la])3~ppp$$1$Ifa$gdU$1$Ifxkdf$$Ifl,\S "b :::"644 la]345tuaYPP^gd`)F & Fgds%<TPL HD@< ^xkd$$Ifl,\S "b :::"644 la]?stuv˭w^J:#-h_W:h=5CJKHPJ\aJnHo(tHh_W:h=5CJKH\aJ'h_W:h=5CJKHPJaJnHtH1h_W:hmB*CJOJPJQJaJnHphtH.h_W:hO(p5B*CJOJQJ\aJo(ph:h_W:hT5B*CJOJPJQJ\aJnHo(phtH:h_W:h`)F5B*CJOJPJQJ\aJnHo(phtH:h_W:hm5B*CJOJPJQJ\aJnHo(phtH+h_W:hm5B*CJOJQJ\aJph  $$Ifa$gd*$$1$Ifa$gd=$$1$Ifa$gd* $$1$Ifa$%<TPL HD@< ^ Ѻt`R`>`*t'h_W:hCJKHPJaJnHo(tH'h_W:h(:CJKHPJaJnHo(tHh_W:h=6CJ]aJ'h_W:h=CJKHPJaJnHo(tH'h_W:hCJKHPJaJnHo(tH'h_W:h'CJKHPJaJnHo(tHh_W:h=CJKHaJ h_W:h=56CJ\]aJ,h_W:h=56CJPJ\]aJnHtH-h_W:h=5CJKHPJ\aJnHo(tH-h_W:h5CJKHPJ\aJnHo(tH123DSTcdftu&ïuuuhuuuhuuuhZuh_W:hlCJKHaJo(h_W:hlCJKHaJ'h_W:hlCJKHOJQJ^JaJo($h_W:hlCJKHOJQJ^JaJ$h_W:hlCJKHPJaJnHtH'h_W:hlCJKHPJaJnHo(tHh_W:h=CJKHaJh_W:h=CJKHaJh_W:h=6CJ]aJ'h_W:h=CJKHPJaJnHo(tH#2pbVVHV$$1$Ifa$gdU $$Ifa$gdU$$1$Ifa$gdykdb$$Ifl4r&*p#tG?644 laf423DTdftseWKKK $$Ifa$gdU$$1$Ifa$gdU$$1$Ifa$gdykd$$Iflr&*p#tG?644 latuseWKWK $$Ifa$gdU$$1$Ifa$gdU$$1$Ifa$gdykd$$Iflr&*p#tG?644 la&seYYYY $$Ifa$gdU$$1$Ifa$gdVkd$$Iflr&*p#tG?644 la&'yseYYYY $$Ifa$gdU$$1$Ifa$gdVkd4 $$Iflr&*p#tG?644 la&'TYsyz $>?űt``Ş`'h_W:hlCJKHPJaJnHo(tH*h_W:hl5CJKHPJaJnHo(tH'h_W:hl5CJKHPJaJnHtH$h_W:hlCJKHOJQJ^JaJ'h_W:hlCJKHOJQJ^JaJo(h_W:hlCJKHaJh_W:hlCJKHaJo($h_W:hlCJKHPJaJnHtHh_W:hlCJKHaJ%seWWKW $$Ifa$gdU$$1$Ifa$gdU$$1$Ifa$gdykd $$Iflvr&*p#tG?644 la  $;?seWKW=$$1$Ifa$gd(: $$Ifa$gd(:$$4$Ifa$gd(:$$1$Ifa$gd3kd $$Iflvr&*p#tG?644 la?nK=$$1$Ifa$gdykdM $$Iflvr&*p#tG?644 la $$Ifa$gd(:$$4$Ifa$gd(:$$1$Ifa$gd3YK$$1$Ifa$gdykd $$Iflr&*p#tG?644 la$$1$Ifa$gdU $$Ifa$gdU ;BMRY{˸ˤxZBx.h_W:h{kA5B*CJOJQJ\aJo(ph:h_W:hC5B*CJOJPJQJ\aJnHo(phtH:h_W:hU95B*CJOJPJQJ\aJnHo(phtHh_W:hlCJKHaJo('h_W:hlCJKHPJaJnHo(tH$h_W:hlCJKHPJaJnHtHh_W:hlCJKHaJ$h_W:hlCJKHOJQJ^JaJ'h_W:hlCJKHOJQJ^JaJo( Yj{gY$$1$Ifa$gdykd $$Iflr&*p#tG?644 la $$Ifa$gdUseWWKW $$Ifa$gdU$$1$Ifa$gdU$$1$Ifa$gdykdf$$Iflr&*p#tG?644 lasj]P]B$$1$Ifa$gd=!w ^`gd{kA ^`gdU9^gdU9kd$$Iflr&*p#tG?644 la  35ǰ{gS?1{?{h_W:h446CJ]aJ'h_W:h44CJKHPJaJnHo(tH'h_W:hCJKHPJaJnHo(tH'h_W:hoCJKHPJaJnHo(tHh_W:h44CJKHaJ h_W:h4456CJ\]aJ-h_W:h5CJKHPJ\aJnHo(tH-h_W:h445CJKHPJ\aJnHo(tHh_W:h445CJKH\aJ'h_W:h44CJKHOJQJ^JaJo('h_W:h!f05CJKHPJaJnHtH 38<=Gkd$$Ifr$<$4 ap2 $$Ifa$gd44$$1$Ifa$gd445678;<=V[`fjklõn[n[n[n[n[n[G'h_W:hXCJKHPJaJnHo(tH$h_W:hXCJKHOJQJ^JaJ'h_W:hXCJKHOJQJ^JaJo($h_W:hXCJKHPJaJnHtH$h_W:h44CJKHOJQJ^JaJh_W:h44CJKHaJh_W:h446CJ]aJ'h_W:h44CJKHPJaJnHo(tH'h_W:hCJKHPJaJnHo(tH'h_W:h`)CJKHPJaJnHo(tH=V[`fkl<kd$$Ifr$<$4 ap2 $$Ifa$gdU$$1$Ifa$gdU $1$Ifgd=!wlHkd$$Ifr$<$4 ap2$$1$Ifa$gdU $1$Ifgd=!w (*,tvxz|$,.024fnprʷ݁g݁ʷSʷ'h_W:hXCJKHPJaJnHo(tH3h_W:hXCJKHOJPJQJ^JaJnHo(tH3h_W:hRhCJKHOJPJQJ^JaJnHo(tHh_W:hXCJKHaJh_W:hXCJKHQJaJ$h_W:hXCJKHPJaJnHtH$h_W:hXCJKHOJQJ^JaJ'h_W:hXCJKHOJQJ^JaJo(h_W:hXCJKHaJo( *,|SH $1$Ifgd=!wkd$$Ifr$<$4 ap2$$1$Ifa$gdU4BPfpSH $1$Ifgd=!wkd$$Ifr$<$4 ap2$$1$Ifa$gdUpraVHHHH$$1$Ifa$gdU $1$Ifgd=!wkdv$$Ifr$<$4 ap2#347:=>Ʋo[o[oNo[oN[o[o@h_W:hXCJKHaJo(h_W:hXCJKHaJ'h_W:hXCJKHPJaJnHo(tH$h_W:hXCJKHPJaJnHtH*h_W:hX5CJKHPJaJnHo(tH3h_W:hXCJKHOJPJQJ^JaJnHo(tH'h_W:hX5CJKHPJaJnHtH$h_W:hXCJKHOJQJ^JaJ'h_W:hXCJKHOJQJ^JaJo($h_W:hXCJKHOJQJ^JaJ#5aSEE9E $$Ifa$gd44$$4$Ifa$gd44$$1$Ifa$gd=!wkdf$$Ifr$<$4 ap25:>m9kdV$$Ifr$<$4 ap2 $$Ifa$gd44$$1$Ifa$gd44$$4$Ifa$gd44"$(ŲŲŲxaXI9h_W:hmCJPJnHo(tHh_W:hmCJPJnHtHh_W:hmCJ,h_W:hmB*OJPJQJnHo(phtH+h_W:hm5B*CJOJQJ\aJph+h_W:hB\CJOJPJQJaJnHo(tHh_W:hXCJKHaJo($h_W:hXCJKHOJQJ^JaJ'h_W:hXCJKHOJQJ^JaJo('h_W:hXCJKHPJaJnHo(tH$h_W:hXCJKHPJaJnHtHHkd@$$Ifr$<$4 ap2$$1$Ifa$gdU $1$Ifgd=!w"$&(PNNAT^`kd0$$Ifr$<$4 ap2ytU$$1$Ifa$gdUHPfnpr|s`kd&$$If4FLt%u<d&    4 ahf4 $$Ifa$"6TPL HD@<%^ (Plnrvxz|İvdR߰>>v&h_W:h5CJPJQJnHo(tH#h_W:hCJPJQJnHo(tH#h_W:h0{CJPJQJnHo(tH"h_W:hm5CJPJnHo(tH&h_W:h5CJPJQJnHo(tH&h_W:hd5CJPJQJnHo(tH&h_W:hm5CJPJQJnHo(tHh_W:hmCJ#h_W:hmCJPJQJnHo(tHh_W:hmCJPJnHo(tHh_W:haoCJPJnHo(tH!"23CDElmz{ɷ|hUhUhUhUL|hUhUhUhUh_W:hXCJ$h_W:hXCJKHOJQJ^JaJ'h_W:hXCJKHOJQJ^JaJo(h_W:hXCJPJnHo(tH#h_W:hXCJPJQJnHo(tHh_W:hmCJh_W:hmCJPJnHo(tH#h_W:hCJPJQJnHo(tH#h_W:hdCJPJQJnHo(tH#h_W:hmCJPJQJnHo(tH#h_W:hCJPJQJnHo(tH"3Dxrdddd$$1$Ifa$gdU$Ifkd$$If4rLt%ud&4 ahf4DEm{{ugggg$$1$Ifa$gdU$Ifkd^$$IfrLt%ud&4 ah{u=u/$$1$Ifa$gdU7kd$$IfL%d&d&4 ah$Ifkd$$IfrLt%ud&4 ah$%34BCPQ^_`xy{1h_W:hmB*CJOJPJQJaJnHphtH%h_W:hmB*OJQJnHphtH h_W:hX$h_W:hXCJKHOJQJ^JaJ'h_W:hXCJKHOJQJ^JaJo(h_W:hXCJPJnHo(tH#h_W:hXCJPJQJnHo(tHh_W:hXCJ'%4CQ_mg$Ifkd$$IfrLt%ud&4 ah$$1$Ifa$gdU _`y{ugggg$$1$Ifa$gdU$Ifkd$$IfrLt%ud&4 ah  -!.!" "{WUUPPPUgd{kA#9TPL HD@<%^kd7$$IfrLt%ud&4 ah    ) 1 6 T ] a !!!!"!#!*!+!1!6!s!ӽӧrbrbh_W:h"FCJOJQJaJo(h_W:h"FCJOJQJaJ+h_W:hCJOJPJQJaJnHo(tHh_W:h{kACJOJQJaJo(+h_W:h{kACJOJPJQJaJnHo(tH+h_W:hmCJOJPJQJaJnHo(tH+h_W:ha.CJOJPJQJaJnHo(tH+h_W:hu6CJOJPJQJaJnHo(tH"s!t!!!!!!"""" "/"="K""""հհՠ~c~H-4h_W:hB*CJOJPJQJaJnHo(phtH4h_W:hdB*CJOJPJQJaJnHo(phtH4h_W:hdG;B*CJOJPJQJaJnHo(phtH%h_W:hmB*CJOJQJaJphh_W:hmCJOJQJaJh_W:h^"CJOJQJaJo((h_W:h"FCJOJPJQJaJnHtHh_W:h{kACJOJQJaJo(+h_W:h{kACJOJPJQJaJnHo(tH(h_W:h{kACJOJPJQJaJnHtH "."/"$$$$%%&&D'E'w(x())p+q+^gdB#$a$gd&sc*TPL HD@<^gd-/^gd-/$^`a$gdEN2^^gdi"""""""""""$#-######ҷ҃h҃҃M8(h_W:h?.B*CJOJQJaJo(ph4h_W:hdB*CJOJPJQJaJnHo(phtH4h_W:h"FB*CJOJPJQJaJnHo(phtH1h_W:hmB*CJOJPJQJaJnHphtH4h_W:hB*CJOJPJQJaJnHo(phtH4h_W:h8FB*CJOJPJQJaJnHo(phtH%h_W:hmB*CJOJQJaJph4h_W:h0<B*CJOJPJQJaJnHo(phtH##########$$$$($)$0$1$4$5$$$$$$$ѾѣѾѾu_Ph_W:hmCJOJQJaJ+h_W:hmCJOJPJQJaJnHo(tH$h_W:hiB*PJnHo(phtH4h_W:hB*CJOJPJQJaJnHo(phtH4h_W:hiB*CJOJPJQJaJnHo(phtH%h_W:hiB*CJOJQJaJph(h_W:hiB*CJOJQJaJo(ph1h_W:hiB*CJOJPJQJaJnHphtH$%%%%%%%%&&&G&H&I&J&N&ӽv[@v+(h_W:h-/B*CJOJQJaJo(ph4h_W:h"FB*CJOJPJQJaJnHo(phtH4h_W:h-/B*CJOJPJQJaJnHo(phtH%h_W:h-/B*CJOJQJaJph+h_W:hEN2CJOJPJQJaJnHo(tHh_W:hEN2CJOJQJaJh_W:hmCJOJQJaJ+h_W:ho*CJOJPJQJaJnHo(tH1h_W:hmB*CJOJPJQJaJnHphtH%h_W:hmB*CJOJQJaJphN&_&`&a&d&e&h&i&l&m&p&&&&&&&&&&&&&&&&&&&&&&&&''1'ѶsцћѶѶц%h_W:hB#B*CJOJQJaJph(h_W:h-/B*CJOJQJaJo(ph4h_W:h"FB*CJOJPJQJaJnHo(phtH4h_W:h@B*CJOJPJQJaJnHo(phtH4h_W:h8hB*CJOJPJQJaJnHo(phtH%h_W:h-/B*CJOJQJaJph$1'3'='B'D'E'I'k'r'''''''''''''(D(b(c(u(w(x((((((((((ҷ嫠҇҇l4h_W:hnB*CJOJPJQJaJnHo(phtH1h_W:h-/B*CJOJPJQJaJnHphtHh_W:h&scOJQJh_W:h&scOJQJo(4h_W:h?jB*CJOJPJQJaJnHo(phtH%h_W:h-/B*CJOJQJaJph4h_W:h-/B*CJOJPJQJaJnHo(phtH$((((((((((((()))))))))) )!)B)S)T)U)V)X)Y)\)])`))ؽlؽ뽇ؽ4h_W:h-/B*CJOJPJQJaJnHo(phtH4h_W:hnB*CJOJPJQJaJnHo(phtH4h_W:h@B*CJOJPJQJaJnHo(phtH4h_W:hB*CJOJPJQJaJnHo(phtH%h_W:h-/B*CJOJQJaJph(h_W:h-/B*CJOJQJaJo(ph#))))))))))*******-*.*L*S*W*Z*ӸӸӥooooV;4h_W:hB*CJOJPJQJaJnHo(phtH1h_W:hB#B*CJOJPJQJaJnHphtH4h_W:hB*CJOJPJQJaJnHo(phtH4h_W:hB#B*CJOJPJQJaJnHo(phtH%h_W:hB#B*CJOJQJaJph4h_W:h-/B*CJOJPJQJaJnHo(phtH%h_W:h-/B*CJOJQJaJph1h_W:h-/B*CJOJPJQJaJnHphtHZ*[*]*^*`*o***********&+'+@+M+O+]+e+h+i+n+p+q+z+ʷ巏vvv]V h_W:h41h_W:hmB*CJOJPJQJaJnHphtH1h_W:hB#B*CJOJPJQJaJnHphtH%h_W:h9B*CJOJQJaJph(h_W:hB#B*CJOJQJaJo(ph%h_W:hB#B*CJOJQJaJph4h_W:hB*CJOJPJQJaJnHo(phtH4h_W:hB#B*CJOJPJQJaJnHo(phtHz++++++++++-$-3-6--------...... .4.@.].^.b.d.x...........//@/C/E/G/]/g/h/i/j/v/꺧(h_W:h4B*CJOJQJaJo(ph%h_W:h4B*CJOJQJaJph4h_W:h4B*CJOJPJQJaJnHo(phtHh_W:h4o(h_W:h4PJnHtH h_W:h4h_W:h4PJnHo(tH8q+..////m1n1113344j5k55566l7^gd ^gdq|g^gd-1(^ ^`gd-}^gd4$7$8$G$H$a$gd4v////////000=0>0˶{`E{,1h_W:hmB*CJOJPJQJaJnHphtH4h_W:h\B*CJOJPJQJaJnHo(phtH4h_W:h^@B*CJOJPJQJaJnHo(phtH%h_W:hmB*CJOJQJaJph+h_W:hmCJOJPJQJaJnHo(tH"h_W:hm5CJOJQJ\aJ(h_W:hmCJOJPJQJaJnHtH4h_W:h4B*CJOJPJQJaJnHo(phtH1h_W:h4B*CJOJPJQJaJnHphtH >0@0A0B0D0J0L0M0O000&1+1J1K1Q1W1]1b111111ʷʷhhhM4h_W:h'B*CJOJPJQJaJnHo(phtH1h_W:hmB*CJOJPJQJaJnHphtH4h_W:h'~B*CJOJPJQJaJnHo(phtH4h_W:hT%B*CJOJPJQJaJnHo(phtH%h_W:hmB*CJOJQJaJph4h_W:h\B*CJOJPJQJaJnHo(phtH4h_W:h B*CJOJPJQJaJnHo(phtH11222X2Y2Z2]2^2a2b2e2f2g2{2|2}22پوmmmR9پ1h_W:hmB*CJOJPJQJaJnHphtH4h_W:hmB*CJOJPJQJaJnHo(phtH4h_W:h'B*CJOJPJQJaJnHo(phtH4h_W:hApB*CJOJPJQJaJnHo(phtH4h_W:h}B*CJOJPJQJaJnHo(phtH4h_W:h^@B*CJOJPJQJaJnHo(phtH%h_W:hmB*CJOJQJaJph%h_W:h-/B*CJOJQJaJph2222222222333333333ҷhҷM24h_W:hyBB*CJOJPJQJaJnHo(phtH4h_W:hmB*CJOJPJQJaJnHo(phtH1h_W:hmB*CJOJPJQJaJnHphtH4h_W:hApB*CJOJPJQJaJnHo(phtH4h_W:h'B*CJOJPJQJaJnHo(phtH4h_W:h}B*CJOJPJQJaJnHo(phtH%h_W:hmB*CJOJQJaJph4h_W:h(B*CJOJPJQJaJnHo(phtH3>3B3n3}3o4p4444K5h5i5j5k55屖jO44h_W:h#B*CJOJPJQJaJnHo(phtH4h_W:h>_B*CJOJPJQJaJnHo(phtH1h_W:hmB*CJOJPJQJaJnHphtH%h_W:hmB*CJOJQJaJph4h_W:hmB*CJOJPJQJaJnHo(phtH4h_W:hcKB*CJOJPJQJaJnHo(phtH1h_W:h-1(B*CJOJPJQJaJnHphtH4h_W:h-1(B*CJOJPJQJaJnHo(phtH5555556666666ʯʔ{`{{E*4h_W:h B*CJOJPJQJaJnHo(phtH4h_W:hmB*CJOJPJQJaJnHo(phtH4h_W:h-1(B*CJOJPJQJaJnHo(phtH1h_W:hq|gB*CJOJPJQJaJnHphtH4h_W:hq|gB*CJOJPJQJaJnHo(phtH4h_W:h>_B*CJOJPJQJaJnHo(phtH4h_W:h#B*CJOJPJQJaJnHo(phtH4h_W:h+oB*CJOJPJQJaJnHo(phtH 6666=7>7O7l77777777777渝iT94h_W:hq=B*CJOJPJQJaJnHo(phtH(h_W:hmB*CJOJQJaJo(ph1h_W:hmB*CJOJPJQJaJnHphtH4h_W:h:YB*CJOJPJQJaJnHo(phtH4h_W:h%ynB*CJOJPJQJaJnHo(phtH%h_W:hmB*CJOJQJaJph4h_W:h B*CJOJPJQJaJnHo(phtH1h_W:h B*CJOJPJQJaJnHphtHl7m78888$9%9<<<<B>C>>>u@v@@@B BBB u^gd#^gd#^gd"^gdA?^777778888 8888<8>8?8A8o8p8888ҷҁfҜK8K8%h_W:hL9!B*CJOJQJaJph4h_W:hL9!B*CJOJPJQJaJnHo(phtH4h_W:h;FB*CJOJPJQJaJnHo(phtH4h_W:hB*CJOJPJQJaJnHo(phtH4h_W:h:YB*CJOJPJQJaJnHo(phtH4h_W:h%ynB*CJOJPJQJaJnHo(phtH%h_W:hmB*CJOJQJaJph4h_W:h)>)>(h_W:h*B*CJOJQJaJo(ph(h_W:h:YB*CJOJQJaJo(ph(h_W:hhsB*CJOJQJaJo(ph1h_W:hmB*CJOJPJQJaJnHphtH4h_W:ho1B*CJOJPJQJaJnHo(phtH4h_W:h B*CJOJPJQJaJnHo(phtH4h_W:h'B*CJOJPJQJaJnHo(phtH%h_W:hmB*CJOJQJaJph4h_W:hL9!B*CJOJPJQJaJnHo(phtH9999::;<?<G<L<U<^<<<<خخs`sJ;h_W:hmCJOJQJaJ+h_W:hmCJOJPJQJaJnHo(tH%h_W:hq|gB*CJOJQJaJph%h_W:hA?B*CJOJQJaJph(h_W:hA?B*CJOJQJaJo(ph%h_W:h7DB*CJOJQJaJph(h_W:h3,B*CJOJQJaJo(ph(h_W:hC>>>u@v@@@B BBBCCCC#E$EEEEEFFHHHHrKsKLLLLҽҽҽҽҽҽzk[h_W:hlMKHPJnHo(tHh_W:hCJOJQJaJ4h_W:hB*CJOJPJQJaJnHo(phtH(h_W:h-1(B*CJOJQJaJo(ph%h_W:h-1(B*CJOJQJaJph(h_W:h#B*CJOJQJaJo(ph%h_W:h#B*CJOJQJaJph4h_W:hOB*CJOJPJQJaJnHo(phtH#BCCCC#E$EEEEEFFHHHHrKsKLLLLNN^gd#$dHG$H$a$gdlMgd^gd^gd-1(LNNKPLPPPPPSSaUbUUUWWWWXXXXįįĚt_t_D4h_W:h-1(B*CJOJPJQJaJnHo(phtH(h_W:h65B*CJOJQJaJo(ph%h_W:h65B*CJOJQJaJph%h_W:hlMB*CJOJQJaJph(h_W:hlMB*CJOJQJaJo(ph(h_W:h-1(B*CJOJQJaJo(ph%h_W:h-1(B*CJOJQJaJph(h_W:h#B*CJOJQJaJo(ph%h_W:h#B*CJOJQJaJphNKPLPPPPPSSaUbUUUWWWWXX5Y6YZZ-\.\\^gd65^gds^gd-1(^gd#XXXXXX5Y6YhYtYYYYYYY)Z-Z0Z6ZnZqZvZzZZZӸӣuuZZZAZZZ1h_W:h/B*CJOJPJQJaJnHphtH4h_W:h/B*CJOJPJQJaJnHo(phtH4h_W:hjB*CJOJPJQJaJnHo(phtH%h_W:hlMB*CJOJQJaJph(h_W:hlMB*CJOJQJaJo(ph4h_W:h-1(B*CJOJPJQJaJnHo(phtH%h_W:h-1(B*CJOJQJaJph1h_W:h-1(B*CJOJPJQJaJnHphtHZZZZZZZZZZ[[+[-[Q[p[[[[\*\+\-\.\1\;\\\\\(])]]]]]]Ѹu\1h_W:h]kB*CJOJPJQJaJnHphtH%h_W:h]kB*CJOJQJaJph4h_W:h]kB*CJOJPJQJaJnHo(phtH(h_W:hlMB*CJOJQJaJo(ph1h_W:h/B*CJOJPJQJaJnHphtH4h_W:h/B*CJOJPJQJaJnHo(phtH%h_W:hlMB*CJOJQJaJph$\\(])]]]^^<_=_``uavaaabbccCfDffggg}g~g ^` +gdy^gd-1(^gds]^^;^<^E^L^^^^^^^<_=___8`E```````uavayaaabbbcccc dҿҪggggggg4h_W:h-1(B*CJOJPJQJaJnHo(phtH(h_W:h-1(B*CJOJQJaJo(ph%h_W:h-1(B*CJOJQJaJph(h_W:hlMB*CJOJQJaJo(ph%h_W:hCiB*CJOJQJaJph%h_W:hlMB*CJOJQJaJph4h_W:hCiB*CJOJPJQJaJnHo(phtH% ddd"d(dddddTe]eCfDfffffff#g4g>g?gJgdgҿ忪t[t@4h_W:hX}B*CJOJPJQJaJnHo(phtH1h_W:hX}B*CJOJPJQJaJnHphtH4h_W:h`B*CJOJPJQJaJnHo(phtH4h_W:h5@B*CJOJPJQJaJnHo(phtH(h_W:hlMB*CJOJQJaJo(ph%h_W:hlMB*CJOJQJaJph%h_W:hB*CJOJQJaJph4h_W:hB*CJOJPJQJaJnHo(phtHdgegfgggjgkg}g~ggggXhYhZhqXq?$4h_W:hB*CJOJPJQJaJnHo(phtH1h_W:hdB*CJOJPJQJaJnHphtH1h_W:hmB*CJOJPJQJaJnHphtH%h_W:hmB*CJOJQJaJph.h_W:hm5CJOJPJQJ\aJnHtH+h_W:hyCJOJPJQJaJnHo(tHh_W:hmCJOJQJaJ+h_W:h. CJOJPJQJaJnHo(tH(h_W:hlMB*CJOJQJaJo(ph%h_W:hlMB*CJOJQJaJph~gggChDhhh7i8i j j"j#jjjjj$V$If^V`a$gd!I$T^T`a$gdC$ T^`a$gde1T^T`^ ^`Zhph{hhhhhhhhhhhh8i\i]i^i`iqYJ/q4h_W:hdB*CJOJPJQJaJnHo(phtHh_W:hmCJOJQJaJ.h_W:hm5CJOJPJQJ\aJnHtH4h_W:hB*CJOJPJQJaJnHo(phtH1h_W:hdB*CJOJPJQJaJnHphtH4h_W:h=0B*CJOJPJQJaJnHo(phtH%h_W:h8FB*CJOJQJaJph1h_W:hmB*CJOJPJQJaJnHphtH%h_W:hmB*CJOJQJaJph`iiiiiiiiiiiiii jʱʖjOjO<%h_W:h%B*CJOJQJaJph4h_W:h%B*CJOJPJQJaJnHo(phtH1h_W:hmB*CJOJPJQJaJnHphtH%h_W:hmB*CJOJQJaJph4h_W:hD B*CJOJPJQJaJnHo(phtH1h_W:hvbB*CJOJPJQJaJnHphtH4h_W:hvbB*CJOJPJQJaJnHo(phtH4h_W:hx8B*CJOJPJQJaJnHo(phtH j j"j#jjjjjjjjjjjj\N@+)h_W:hd5CJPJ\aJnHo(tHh_W:hm5CJ\aJh_W:hmPJnHo(tHh_W:h!IPJnHo(tH(h_W:hmCJOJPJQJaJnHtH+h_W:hCJOJPJQJaJnHo(tH1h_W:hL/5CJOJPJQJ\aJnHo(tH"h_W:hm5CJOJQJ\aJ1h_W:hm5CJOJPJQJ\aJnHo(tHh_W:hmCJOJQJaJ.h_W:hm5CJOJPJQJ\aJnHtHjjjjjjjjjjjjjjxdxSH2+h_W:hm5B*CJOJQJ\aJphh_W:hmnHtH h_W:hmCJPJaJnHtH&h_W:hm6CJPJ]aJnHtHh_W:hm6CJ]aJ#h_W:h=0CJPJaJnHo(tHh_W:hmCJaJh_W:hm5nHtH h_W:hm56CJ\]aJ)h_W:hm56CJPJ]aJnHtH)h_W:hm5CJPJ\aJnHo(tH)h_W:h=05CJPJ\aJnHo(tHjjjjjjjjjePP$V$If^V`a$&6TPL HD@<{$If^]kd$$IflF! $  !    4 la $V$If^V`a$jjjjjjkk!k"k'k/k0k1k9khkikokwkxkkkkkkkkkkkkkllĽrkarkrrkrrkrrkh_W:hRhaJo( h_W:hRhh_W:hRhCJKHaJh_W:hRhCJKHaJo('h_W:hRhCJKHPJaJnHo(tH$h_W:hRhCJKHPJaJnHtHh_W:hRhaJ h_W:hmh_W:hm5+h_W:hm5B*CJOJQJ\aJph:h_W:hI05B*CJOJPJQJ\aJnHo(phtH!jj"k(k/krd$$1$Ifa$gdU$$1$Ifa$gd \ v${$IfVDFWDj^`a$gdM]kdP$$IflF! $  !    4 la /k0kikpkwkrd$$1$Ifa$gdU$$1$Ifa$gd \ v${$IfVDFWDj^`a$gdM]kd$$IflF! $  !    4 la wkxkkkkzl$$1$Ifa$gdU$$1$Ifa$gd \Vi$IfVD$WD2^V`igdM]kdJ$$IflF! $  !    4 la kkkkkzl$$1$Ifa$gdU$$1$Ifa$gd \%$IfVDOWDU^%`gdK]kd$$IflF! $  !    4 la kkkklzl$$1$Ifa$gdU$$1$Ifa$gd \.$IfVDPWD^`.gdM]kdJ$$IflF! $  !    4 la ll6l>lPls$$1$Ifa$gdU$$1$Ifa$gd \{$Ifgd4e]kd$$IflF! $  !    4 la l6l=l>lPlQliljl{l~llllllllllllllllllllllllžӾӾž{mbӾVh_W:hRhCJaJo(h_W:hRhCJaJh_W:hRhhCJaJh_W:hRhh5CJaJ*h_W:hRh5CJKHPJaJnHo(tHh_W:hRh5CJKHaJo(h_W:hRh5CJKHaJ h_W:hRhh_W:hRhCJKH\aJh_W:hRhCJKHaJh_W:hRhCJKHaJo(!h_W:hRh5CJKH\aJo( PlQlelflilzl$$1$Ifa$gdU$$1$Ifa$gd \Vi$IfVD$WD2^V`igd4e]kdJ $$IflF! $  !    4 la iljl{lllzl$$1$Ifa$gdU$$1$Ifa$gd \Vi$IfVD$WD2^V`igd4e]kd $$IflF! $  !    4 la llllls$$1$Ifa$gdU$$1$Ifa$gd \{$Ifgd4e]kdJ!$$IflF! $  !    4 la lllllwd$d$If]a$gdU$d$If]a$gd;[$d$If]^a$gd4e]kd!$$IflF! $  !    4 la lllllzl$$1$Ifa$gdU$$1$Ifa$gd \.$IfVDPWD^`.gd4e]kdJ"$$IflF! $  !    4 la llm mmzl$$1$Ifa$gdU$$1$Ifa$gd \.$IfVDPWD^`.gd4e]kd"$$IflF! $  !    4 la lmm mmmmmm&m'm7m8m9m:mTmZmambmcm}mmmmmmmmmmmmmmӻӝzziӝ!h_W:hRh5CJKH\aJo('h_W:hRhCJKHPJaJnHo(tHh_W:hRhCJOJQJaJh_W:hRh5CJKH\aJh_W:hRhCJKH\aJ.h_W:hRh5B*CJOJQJ\aJo(ph h_W:hRhh_W:hRhCJKHaJo(h_W:hRhCJKHaJh_W:hRhCJaJ!mmmm&mwi[$$1$Ifa$gdU$$1$Ifa$gd \)6TPL HD@<{$If^gd4e]kdJ#$$IflF! $  !    4 la &m'm7m8m9m~o$d$Ifa$gdU$$1$Ifa$gdRhV$If^V`gd4e]kd#$$IflF! $  !    4 la 9m:mUm[mamzl$$1$Ifa$gdU$$1$Ifa$gd \Vi$IfVD$WD2^V`igd4e]kdJ$$$IflF! $  !    4 la ambmmmm|n$$1$Ifa$gdU$$1$Ifa$gd \Vi$IfVD$WD2^V`igd4e_kd$$$IflF! $  !    4 la mmmmm|$$1$Ifa$gdU$$1$Ifa$gd \ $Ifgd4e]kdN%$$IflF! $  !    4 la mmmmm}n$d$Ifa$gdU$d$Ifa$gd;[V$If^V`gd4e]kd%$$IflF! $  !    4 la mmmmmmnnnnbnlnnnnnnnnnnnnnԿsd[J!h_W:hRh5CJKH\aJo(h_W:hRhaJh_W:hRhCJKHQJaJ+h_W:hRhCJKHPJQJaJnHo(tH'h_W:hRhCJKHPJaJnHo(tHh_W:hRhCJKHaJo(h_W:hRhCJKHaJ h_W:hRh(h_W:hRhCJOJPJQJaJnHtH+h_W:hRh5CJOJPJQJaJnHtH*h_W:hRh5CJKHPJ\aJnHtHmmmnnzl$$1$Ifa$gdU$$1$Ifa$gd \$IfVDIWDj^`gd4e]kdN&$$IflF! $  !    4 la nnnnnzl$$1$Ifa$gdU$$1$Ifa$gd \$IfVDIWDj^`gd4e]kd&$$IflF! $  !    4 la nnnnnx$$1$Ifa$gdU$$1$Ifa$gd \$Ifgd4e]kdN'$$IflF! $  !    4 la nnnnnn o oooo ofohojoo}eRG4%h_W:h _B*CJOJQJaJphh_W:hmOJQJ%h_W:hmB*CJOJQJaJph/h_W:hm5B*OJPJQJ\nHphtH#h_W:hm5B*OJQJ\phh_W:hRhCJKHaJh_W:hRhCJKHaJo(-h_W:hRh5CJKHPJ\aJnHo(tH!h_W:hRh5CJKH\aJo(h_W:hRhaJ*h_W:hRhCJKHPJ\aJnHo(tHh_W:hRhCJKH\aJnnn oox$$1$Ifa$gdU$$1$Ifa$gd \$Ifgd4e]kd'$$IflF! $  !    4 la oohojo,q-q6q7qyrzrs|zqaa_qqq$d^`a$^gd _%6TPL HD@<{d<^]kdN($$IflF! $  !    4 la  oooooojpppppppppppppppq*q+q,q-q7qeqiqqqqqrr?r@rؽؽؽؽؽ؉ؽ؉paؽ؉h_W:hmCJOJQJaJ1h_W:hzg5CJOJPJQJ\aJnHo(tH1h_W:h _B*CJOJPJQJaJnHphtH4h_W:h4B*CJOJPJQJaJnHo(phtH4h_W:h _B*CJOJPJQJaJnHo(phtH%h_W:h _B*CJOJQJaJph(h_W:h _B*CJOJQJaJo(ph$@rArjrrr6s8s9s:sBsCsIsJsQsRshsisjs{s|s}sssннnnSn;.h_W:hm5CJOJPJQJ\aJnHtH4h_W:hW=B*CJOJPJQJaJnHo(phtH4h_W:h4B*CJOJPJQJaJnHo(phtH4h_W:h _B*CJOJPJQJaJnHo(phtH1h_W:h _B*CJOJPJQJaJnHphtH%h_W:h _B*CJOJQJaJph(h_W:h _B*CJOJQJaJo(ph4h_W:hHB*CJOJPJQJaJnHo(phtHssssttbucuuuKvLv[v\v:w;wwwxx^gdI^gdWO^gd65)$a$gd _^gd<gd<d^`gd< d^`sssssttt't u5u?uAuaubucuuŪ|aaI:h_W:hmCJOJQJaJ.h_W:hm5CJOJPJQJ\aJnHtH4h_W:he%B*CJOJPJQJaJnHo(phtH%h_W:hIB*CJOJQJaJph4h_W:h4B*CJOJPJQJaJnHo(phtH4h_W:h<B*CJOJPJQJaJnHo(phtH%h_W:h<B*CJOJQJaJph1h_W:h<B*CJOJPJQJaJnHphtHh_W:h<CJOJQJaJuuvvKvLv\vevw8w:w;wPwڭjjO44h_W:hIB*CJOJPJQJaJnHo(phtH4h_W:hWOB*CJOJPJQJaJnHo(phtH1h_W:h65B*CJOJPJQJaJnHphtH4h_W:h65B*CJOJPJQJaJnHo(phtHh_W:hmCJOJQJaJ.h_W:hm5CJOJPJQJ\aJnHtH)h_W:h _B*OJPJQJnHphtHh_W:h _B*OJQJph,h_W:h!B*OJPJQJnHo(phtH Pw\w_wuwwwwwwxx/xCxNxOxhxjxkx|xx泤}h}h}hR?%h_W:hmB*CJOJQJaJph+h_W:h=CCJOJPJQJaJnHo(tH(h_W:h=0B*CJOJQJaJo(ph%h_W:h=0B*CJOJQJaJph'h_W:h8 CJPJ^JaJnHo(tHh_W:hmCJOJQJaJ.h_W:hm5CJOJPJQJ\aJnHtH4h_W:hIB*CJOJPJQJaJnHo(phtH1h_W:hIB*CJOJPJQJaJnHphtHxjxkx{x|x`zazzzzz||||B}C}H}$$1$Ifa$gdT T^$^a$gdk$a$gdk ^`^gdd^ d^`^gd=0xxxxy yyQyVyyy}yyyyyyyӣӈmR=(h_W:hmB*CJH*OJQJaJph4h_W:h4B*CJOJPJQJaJnHo(phtH4h_W:h]WB*CJOJPJQJaJnHo(phtH4h_W:hB*CJOJPJQJaJnHo(phtH4h_W:h]$B*CJOJPJQJaJnHo(phtH(h_W:hmB*CJOJQJaJo(ph%h_W:hmB*CJOJQJaJph1h_W:hmB*CJOJPJQJaJnHphtHyyyzzz z4z6z\z]z^z_zezfzkzlzzzzzzzʷʷʷnS4h_W:hq@B*CJOJPJQJaJnHo(phtH4h_W:h]WB*CJOJPJQJaJnHo(phtH(h_W:hmB*CJH*OJQJaJph1h_W:hmB*CJOJPJQJaJnHphtH%h_W:hmB*CJOJQJaJph4h_W:h4B*CJOJPJQJaJnHo(phtH4h_W:hlB*CJOJPJQJaJnHo(phtHzzzzzzzzzzU{V{ʱʱpaN34h_W:hB*CJOJPJQJaJnHo(phtH%h_W:hB*CJOJQJaJphh_W:hmCJOJQJaJ h_W:hm@CJOJQJaJ(h_W:hmCJOJPJQJaJnHtH4h_W:h|B*CJOJPJQJaJnHo(phtH1h_W:hmB*CJOJPJQJaJnHphtH4h_W:hq@B*CJOJPJQJaJnHo(phtH4h_W:hmB*CJOJPJQJaJnHo(phtH V{W{{{{{||||||}}})}ҽҽҢ~~fPf8.h_W:h M5CJOJPJQJaJnHo(tH+h_W:h5CJOJPJQJaJnHtH.h_W:h5CJOJPJQJaJnHo(tH(h_W:hmCJOJPJQJaJnHtHh_W:hmCJOJQJaJ4h_W:hm5;CJOJPJQJ\aJnHo(tH(h_W:hB*CJOJQJaJo(ph%h_W:hB*CJOJQJaJph4h_W:h7)B*CJOJPJQJaJnHo(phtH)}*}+}5}8}A}C}G}H}K}L}~jVB.'h_W:h7)CJKHPJaJnHo(tH'h_W:hXCJKHPJaJnHo(tH'h_W:h<_2CJKHOJQJ\^JaJ&h_W:h<_25CJKHOJQJaJo(+h_W:hmCJOJPJQJaJnHo(tH+h_W:h,CJOJPJQJaJnHo(tH+h_W:hCJOJPJQJaJnHo(tHh_W:hm5CJOJQJaJ.h_W:h655CJOJPJQJaJnHo(tH.h_W:hX5CJOJPJQJaJnHo(tH H}M}R}S}T}b}n}{}}yn $1$IfgdTwkd($$Ifl4TF #& &J& #6    44 lagp$$1$Ifa$gdTL}M}O}P}Q}R}S}T}`}a}b}c}®qaK5*h_W:ha5CJKHPJaJnHo(tH*h_W:h<_25CJKHPJ\aJnHtHh_W:hX5CJKH\aJh_W:hX5CJKHaJ'h_W:h<_2CJKHOJQJ\^JaJh_W:h<_2CJKHh_W:h<_2CJKH\aJo('h_W:h7)CJKHPJaJnHo(tH'h_W:heCJKHPJaJnHo(tH'h_W:hXCJKHPJaJnHo(tH*h_W:h<_2CJKHPJ\aJnHo(tH c}e}f}g}m}n}z}{}|}}}}}}}}xeZG7*h_W:h|CJKHaJh_W:h|5CJKH\aJ$h_W:h|CJKHPJaJnHtHh_W:h<_2CJKH$h_W:hXCJKHPJaJnHtH'h_W:hJ0CJKHPJaJnHo(tH$h_W:hJ0CJKHPJaJnHtH'h_W:h<_2CJKHPJ\aJnHtHh_W:hXCJKHaJ*h_W:h<_25CJKHPJ\aJnHtH'h_W:hX5CJKHPJaJnHtH*h_W:hJ05CJKHPJaJnHo(tH}}}}}}WL>>2 $$Ifa$gd}r)$$1$Ifa$gd}r) $1$IfgdTkd)$$Ifl4Tr +# &&&&#644 lagp2}}}~~M8*$$1$Ifa$gd}r)L$1$IfWD^L`gdTkd*$$IflTr +#& ''''#644 lagp2 $$Ifa$gd}r)}}~%~G~H~`~~~~~~  !=XYr &B^_kl{"<=HIՁ0Mijh_W:h|CJKHaJ'h_W:he%CJKHPJaJnHo(tHh_W:h|5CJKH\aJh_W:h|CJKHaJh_W:h|5CJKHaJ$h_W:h|CJKHPJaJnHtHh_W:h|CJKH;~%~6~G~H~`~?4 $1$IfgdTkd+$$IflTr +#& ''''#644 lagp2 $$Ifa$gd}r)$$1$Ifa$gd}r)`~q~~~~~?kd,$$IflTr +#& ''''#644 lagp2 $$Ifa$gd}r)$$1$Ifa$gd}r)~~~~~ $$Ifa$gd}r)$$1$Ifa$gd}r) $1$IfgdT!/=KYN@@4 $$Ifa$gd}r)$$1$Ifa$gd}r) $1$IfgdTkd-$$IflTr +#& ''''#644 lagp2KXYrMB44$$1$Ifa$gd}r) $1$IfgdTkd/$$IflTr +#& ''''#644 lagp2 $$Ifa$gd}r)MB1 $1$IfWD` gdT $1$IfgdTkd%0$$IflTr +#& ''''#644 lagp2 $$Ifa$gd}r) ?kd:1$$IflTr +#& ''''#644 lagp2 $$Ifa$gd}r)$$1$Ifa$gd}r) &4BP^ $$Ifa$gd}r)$$1$Ifa$gd}r) $1$IfWDp^ `gdT^_{YN@@4 $$Ifa$gd}r)$$1$Ifa$gd}r) $1$IfgdTkdO2$$IflTr +#& ''''#644 lagp2M8*$$1$Ifa$gd}r) $1$IfWDp^ `gdTkdd3$$IflTr +#& ''''#644 lagp2 $$Ifa$gd}r)?4 $1$IfgdTkdy4$$IflXr +#& ''''#644 lagp2 $$Ifa$gd}r)$$1$Ifa$gd}r)"/<=?kd5$$IflTr +#& ''''#644 lagp2 $$Ifa$gd}r)$$1$Ifa$gd}r)= $$Ifa$gd}r)$$1$Ifa$gd}r) $1$IfWDp^ `gdTՁYN@@4 $$Ifa$gd}r)$$1$Ifa$gd}r) $1$IfgdTkd6$$Iflr +# ''''#644 lagp20?M8*$$1$Ifa$gd}r)D$1$IfWD^`DgdTkd7$$IflTr +#& ''''#644 lagp2 $$Ifa$gd}r)?M[ij?kd8$$IflTr +#& ''''#644 lagp2 $$Ifa$gd}r)$$1$Ifa$gd}r)j $$Ifa$gd}r)$$1$Ifa$gd}r) $1$IfWDp^ `gdTjǂȂ+,Fb~Ѓу"#,-`ahvx„؄ڄ܄݄0:DEbمGHO_'h_W:h|CJKHPJaJnHo(tHh_W:h|5CJKH\aJh_W:h|CJKHaJh_W:h|CJKHh_W:h|CJKHaJh_W:h|5CJKHaJ$h_W:h|CJKHPJaJnHtH;YD66$$1$Ifa$gd}r) $1$IfWD^` gdTkd9$$IflXr +#& ''''#644 lagp2+,FTMB4$$1$Ifa$gd}r) $1$IfgdTkd:$$IflXr +#& ''''#644 lagp2 $$Ifa$gd}r)Tbp~?4 $1$IfgdTkd <$$IflTr +#& ''''#644 lagp2 $$Ifa$gd}r)$$1$Ifa$gd}r)ÃЃу?kd!=$$IflXr +#& ''''#644 lagp2 $$Ifa$gd}r)$$1$Ifa$gd}r)у" $$Ifa$gd}r)$$1$Ifa$gd}r) $1$IfgdT"#hvxYD66$$1$Ifa$gd}r)$1$IfWD ^`gdTkd6>$$IflXr +#& ''''#644 lagp2xMB4$$1$Ifa$gd}r) $1$IfgdTkdK?$$IflTr +#& ''''#644 lagp2 $$Ifa$gd}r)„؄?4 $1$IfgdTkd`@$$IflTr +#& ''''#644 lagp2 $$Ifa$gd}r)$$1$Ifa$gd}r)؄لڄۄ܄݄?kduA$$IflTr +#& ''''#644 lagp2 $$Ifa$gd}r)$$1$Ifa$gd}r)݄  $$Ifa$gd}r)$$1$Ifa$gd}r) $1$IfWD^` gdT05:YD66$$1$Ifa$gd}r) $1$IfWD^` gdTkdB$$IflTr +#& ''''#644 lagp2:?DEbD/ $1$IfWD^` gdTkdC$$IflTr +#& ''''  #644 lagp2 $$Ifa$gd}r)br6kdD$$IflTr +#& ''''  #644 lagp2 $$Ifa$gd}r)$$1$Ifa$gd}r)˅م $$Ifa$gd}r)$$1$Ifa$gd}r) $1$IfWD^` gdTO]_P;--$$1$Ifa$gd}r) $1$IfWD^` gdTkdE$$IflXr +#& ''''  #644 lagp2_mopD/ $1$IfWD^` gdTkdG$$IflXr +#& ''''  #644 lagp2 $$Ifa$gd}r)_mopuΆІц҆ӆ݆ކǴǦېxeN51h_W:hm5CJOJPJQJ\]aJnHtH-h_W:hm5CJOJQJ\]aJnHtH%h_W:hm5CJOJQJ\]aJ/h_W:hFo56OJPJQJ\]nHo(tH+h_W:h5CJOJPJQJaJnHo(tHh_W:h|5CJKHaJ$h_W:h|CJKHPJaJnHtH'h_W:h|CJKHPJaJnHo(tHh_W:h|CJKHh_W:h|CJKHaJh_W:h|CJKHaJΆІц6kdH$$IflXr +#& ''''  #644 lagp2 $$Ifa$gd}r)$$1$Ifa$gd}r)ц҆ӆч҇{S(<TPL HD@<e C^gdrO%<TPL HD@<e C^&9TPL HD@<e C^gdk"7TPL HD@<e C^ $da$gdX T^ )?HJKLOXλxne[RR74h_W:hmB*CJOJPJQJaJnHo(phtHh_W:hQ#CJh_W:hQ#CJo(h_W:hICJh_W:hICJo(h_W:h|CJPJnHo(tHh_W:hXCJo(h_W:hXCJh_W:hQ#CJPJnHo(tHh_W:hXCJPJnHo(tH%h_W:hm5CJOJQJ\]aJ-h_W:hm5CJOJQJ\]aJnHtH4h_W:h)G5CJOJPJQJ\]aJnHo(tHЇч҇߇ѲѓuWD0'h_W:h|5B*CJOJQJo(ph$h_W:h|5B*CJOJQJph:h_W:hRv5B*CJOJPJQJ\aJnHo(phtH:h_W:hm5B*CJOJPJQJ\aJnHo(phtH=h_W:hqk5;B*CJOJPJQJ\aJnHo(phtH=h_W:hk5;B*CJOJPJQJ\aJnHo(phtH.h_W:hm5;B*CJOJQJ\aJph+h_W:hm5B*CJOJQJ\aJph   !#$%&./9BCD_jklnpq~ξΣΗthVhΆt# *h_W:h|CJPJaJnHtHh_W:h|CJaJo(#h_W:h|5CJPJaJnHtH h_W:h|CJPJaJnHtH *h_W:h|CJaJ h_W:h|'h_W:h|>*CJOJQJaJnH tH h_W:h|>*CJOJQJaJh_W:h|CJaJh_W:h|5CJaJ3h_W:hrO5B*CJOJPJQJnHo(phtHYJ$d$Ifa$gd}r)ukdI$$If\r#+vvv$44 ayt}r)%$!d$Ifa$gd}r)Zd$If^Z`gd}r)dgd| !"#$%zfWW$d$Ifa$gd}r)Zd$If^Z`gd}r)ukdI$$If\r#+vvv$44 ayt}r)$d$Ifa$gd}r)%&./9CufWW$d$Ifa$gd:$d$Ifa$gd}r)Zd$If^Z`gd}r)ukdJ$$If\r#+vvv$44 ayt}r)CDRS_kufW?$d$&dIfPa$gd:$d$Ifa$gd:$d$Ifa$gd}r)Zd$If^Z`gd}r)ukd~J$$If\r#+vvv$44 ayt:klmnopufWW$d$Ifa$gd:$d$Ifa$gd}r)Zd$If^Z`gd}r)ukdJ$$If\r#+vvv$44 ayt:pq~yjWB$}d$IfUD4]}a$gd:$nd$If]na$gd8^C$d$Ifa$gd}r)Zd$If^Zgd}r)ukdxK$$If\r#+vvv$44 ayt:LjȈ͈ΈψՈ݈ވ߈()*MRSVWXfghqyz{ܠܔ# *h_W:h|CJPJaJnHtH *h_W:h|CJaJ#h_W:h* CCJPJaJnHo(tH#h_W:h|CJPJaJnHo(tH h_W:h|CJPJaJnHtH h_W:h|h_W:h|CJaJh_W:h|CJaJo(h_W:h:CJaJo(3sdUU$d$Ifa$gd:$d$Ifa$gd}r)Zd$If^Z`gd}r)xkdK$$If\r#+vvl$ 44 ayt:LjΈufWW$d$Ifa$gd:$d$Ifa$gd}r)Zd$If^Z`gd}r)ukdL$$If\r#+vvv$44 ayt:Έψވ߈ufWD$d$Ifa$gd:$d$Ifa$gd:$d$Ifa$gd}r)Zd$If^Z`gd}r)ukdL$$If\r#+vvv$44 ayt:)ufWW$d$Ifa$gd:$d$Ifa$gd}r)Zd$If^Z`gd}r)ukdqM$$If\r#+vvv$44 ayt:)*BCMWufWW$d$Ifa$gd:$d$Ifa$gd}r)Zd$If^Z`gd}r)ukdM$$If\r#+vvv$44 ayt:WXfhqzufWW$d$Ifa$gd:$d$Ifa$gd}r)Zd$If^Z`gd}r)ukd]N$$If\r#+vvv$44 ayt:z{ufNN$d$&dIfPa$gd:$d$Ifa$gd}r)Zd$If^Z`gd}r)ukdN$$If\r#+vvv$44 ayt:ȉΉωЉۉ !%&:;KLNOTmstİ➌ĀϞn#h_W:h|5CJPJaJnHtH *h_W:h|CJaJ#h_W:h|CJPJaJnHo(tH#h_W:h* CCJPJaJnHo(tH&h_W:h|hCJPJaJnHtHh_W:h|CJaJh_W:h|5CJaJ h_W:h| h_W:h|CJPJaJnHtHh_W:h|CJaJo(+ufWW$d$Ifa$gd:$d$Ifa$gd}r)Zd$If^Z`gd}r)ukdIO$$If\r#+vvv$44 ayt:ȉωufWW$d$Ifa$gd:$d$Ifa$gd}r)Zd$If^Z`gd}r)ukdO$$If\r#+vvv$44 ayt:ωЉufNN$d$&dIfPa$gd:$d$Ifa$gd}r)Zd$If^Z`gd}r)ukd5P$$If\r#+vvv$44 ayt:ufWW$d$Ifa$gd:$d$Ifa$gd}r)Zd$If^Z`gd}r)ukdP$$If\r#+vvv$44 ayt: ufNN$d$&dIfPa$gd:$d$Ifa$gd}r)Zd$If^Z`gd}r)ukd!Q$$If\r#+vvv$44 ayt: !"#$%ufWW$d$Ifa$gd:$d$Ifa$gd}r)Zd$If^Z`gd}r)ukdQ$$If\r#+vvv$44 ayt:%&KLMNufSS$nd$If]na$gd:$d$Ifa$gd}r)Zd$If^Z`gd}r)ukdR$$If\r#+vvv$44 ayt:NOefmtwhYY$d$Ifa$gd:$d$Ifa$gd}r)d$IfVDG^gd|ukdR$$If\r#+vvv$44 ayt:tuwhPP$d$&dIfPa$gd:$d$Ifa$gd}r)d$IfVDG^gd|ukdR$$If\r#+vvv$44 ayt:tuҊߊeSIh_W:hkO5CJ"h_W:hd 5CJPJnHo(tH:h_W:hrO5B*CJOJPJQJ\aJnHo(phtH#h_W:h|CJPJaJnHo(tH#h_W:h* CCJPJaJnHo(tH#h_W:h|5CJPJaJnHtHh_W:h|5CJaJh_W:h|CJaJo(h_W:h|CJaJhh_W:h|CJaJ h_W:h|CJPJaJnHtH h_W:h|ufWW$d$Ifa$gd:$d$Ifa$gd}r)Zd$If^Z`gd}r)ukdoS$$If\r#+vvv$44 ayt:ufNN$d$&dIfPa$gd:$d$Ifa$gd}r)Zd$If^Z`gd}r)ukdS$$If\r#+vvv$44 ayt:ufWW$d$Ifa$gd:$d$Ifa$gd}r)Zd$If^Z`gd}r)ukd[T$$If\r#+vvv$44 ayt:ߊufNN#$d$&dIfPa$gd:$d$Ifa$gd}r)Zd$If^Z`gd}r)ukdT$$If\r#+vvv$44 ayt:>?@d\TTH d$Ifgd}r)dgdkOdgdrO%<TPL HD@<e C^ukdGU$$If\r#+vvv$44 ayt:(=>?@DEFJKOPQRScdfhikmn̻~j~jcWHcHcHch_W:hkOCJOJQJaJh_W:hkO>*CJaJ h_W:hkO'h_W:hkO>*CJOJQJaJnH tH h_W:hkO>*CJOJQJaJ&h_W:h>\>*CJPJaJnHo(tHh_W:hkO>*CJaJo(h_W:hkOCJaJ h_W:hkOCJPJaJnHtH"h_W:hrO5CJPJnHo(tHh_W:hkO5CJnH o(tH "h_W:hkO5CJPJnHo(tH@FKPQRS[cfZ d$Ifgd}r)ukdU$$If\r+#$44 ayt}r)%$!d$Ifa$gd}r)$d$Ifa$gd}r)cdefghsdPP%$!d$Ifa$gd}r)$d$Ifa$gd}r)$d$IfWD^`$gd}r)ukdIV$$If\r+#$44 ayt}r)hijklmsdPP%$!d$Ifa$gd}r)$d$Ifa$gd}r)$d$IfWD^`$gd}r)ukdV$$If\r+#$44 ayt}r)mnsdHH%$!d$&dIfPa$gd}r)$d$Ifa$gd}r)Zd$If^Z`gd}r)wkdaW$$If\r+#$44 ayt}r)n}yjy^Ojy?Oyh_W:hkOCJaJnH o(tH h_W:hkOCJaJnH tH h_W:hkOCJaJo(h_W:hkOCJOJQJaJ h_W:hkO(h_W:hkOCJOJPJQJaJnHtH+h_W:hkOCJOJPJQJaJnHo(tH+h_W:hkOCJOJPJQJaJhnHtH(h_W:hkOCJOJPJQJaJnHtHh_W:hkOCJaJ#h_W:hkO5CJPJaJnHtHh_W:hkO5CJaJufRR%$!d$Ifa$gd}r)$d$Ifa$gd}r)Zd$If^Z`gd}r)ukdW$$If\r+#$44 ayt}r)ufRR%$!d$Ifa$gd}r)$d$Ifa$gd}r)Zd$If^Z`gd}r)ukdX$$If\r+#$44 ayt}r)ufRR%$!d$Ifa$gd}r)$d$Ifa$gd}r)d$If^`gd}r)ukdY$$If\r+#$44 ayt}r)EFLPufRR%$!d$Ifa$gd}r)$d$Ifa$gd}r)d$If^`gd}r)ukdY$$If\r+#$44 ayt}r)-DFKLOPQ\hpՌ֌­˜­˜o­˜ح`h_W:hkOCJOJQJaJ#h_W:hkOCJPJaJnHo(tHh_W:hkOCJaJnH o(tH h_W:hkO(h_W:hkOCJOJPJQJaJnHtH(h_W:hkOCJOJPJQJaJnHtH+h_W:hkOCJOJPJQJaJnHo(tHh_W:hkOCJaJh_W:hkOCJaJo( h_W:hkOCJPJaJnHtH!PQsdPP%$!d$Ifa$gd}r)$d$Ifa$gd}r)4d$IfWDt^4`gd}r)ukd9Z$$If\r+#$44 ayt}r)sddHH%$!d$&dIfPa$gd}r)$d$Ifa$gd}r)4d$IfWDt^4`gd}r)ukdZ$$If\r+#$44 ayt}r)ufRR%$!d$Ifa$gd}r)$d$Ifa$gd}r)Zd$If^Z`gd}r)ukd][$$If\r+#$44 ayt}r)?@IPsdHH%$!d$&dIfPa$gd}r)$d$Ifa$gd}r):d$IfWD^`:gd}r)ukd[$$If\r+#$44 ayt}r)&.2?@HIOPQSTUVy}~׍ލȲȝrȝrbȝȝh_W:hkO5CJOJQJaJh_W:hkOCJOJQJaJ h_W:hkO(h_W:hkOCJOJPJQJaJnHtH(h_W:hkOCJOJPJQJaJnHtH+h_W:hkOCJOJPJQJaJnHo(tHh_W:hkOCJaJ#h_W:hkO5CJPJaJnHtHh_W:hkO5CJaJo(h_W:hkO5CJaJ&PQRSTUufRR%$!d$Ifa$gd}r)$d$Ifa$gd}r)Zd$If^Z`gd}r)ukd\$$If\r+#$44 ayt}r)UV~ufJJ%$!d$&dIfPa$gd}r)$d$Ifa$gd}r)Zd$If^Z`gd}r)ukd]$$If\r+#$44 ayt}r)ufRR%$!d$Ifa$gd}r)$d$Ifa$gd}r)Zd$If^Z`gd}r)ukd]$$If\r+#$44 ayt}r)֍x;)nd$IfWD2`ngd}r)<kd^$$Ifr#$$44 ayt}r)%!d$Ifgd}r)ukd7^$$If\r+#$44 ayt}r)֍׍ލfTnd$IfWD2`ngd}r)ukd_$$If\r+#$44 ayt}r)%$!d$Ifa$gd}r)$d$Ifa$gd}r)mYJ6%$!d$Ifa$gd}r)$d$Ifa$gd}r)Zd$If^Z`gd}r)ukd_$$If\r+#$44 ayt}r)%$!d$&dIfPa$gd}r)#$%&3ST럹w]C3h_W:hd 5B*CJOJPJQJnHo(phtH3h_W:h]N5B*CJOJPJQJnHo(phtH$h_W:h]N5B*CJOJQJph)h_W:h/5CJPJ\aJnHo(tHh_W:hkOCJOJQJaJh_W:hkOCJaJ h_W:hkO(h_W:hkOCJOJPJQJaJnHtH+h_W:hkOCJOJPJQJaJnHo(tH(h_W:hkOCJOJPJQJaJnHtH$uaR66%$!d$&dIfPa$gd}r)$d$Ifa$gd}r)Zd$If^Z`gd}r)ukd1`$$If\r+#$44 ayt}r)%$!d$Ifa$gd}r)$%&STUY11(<TPL HD@<e C^gdrO(<TPL HD@<e C^gd]NdgdDukd`$$If\r+#$44 ayt}r)TUVW[\`abfghijmqrǶ{tgWC0$h_W:h20JCJPJaJnHtH'h_W:h20J5CJPJaJnHtHh_W:h20J5CJaJo(h_W:h20JCJaJ h_W:h2*h_W:h20J5>*CJPJaJnHtH-h_W:h20J5>*CJPJaJnHo(tHh_W:h25>*CJaJ!h_W:h20J5>*CJaJo(h_W:h20J5>*CJaJh_W:h25CJ\aJ3h_W:h 5B*CJOJPJQJnHo(phtHUV\abg$d$$1&P#$/Ifa$gd/d$$1&P#$/Ifgd/ghijC00d$$1&P#$/Ifgd/kdUa$$IflVr(!" 96P1044 layt[5jrs{|-kd?b$$Iflr(!" 96P1044 layt[5$d$$1&P#$/Ifa$gd/rsv{|}~ێƸƄyhyh\yPy\yh_W:h2CJ\aJh_W:h2CJaJo( h_W:h2CJPJaJnHtHh_W:h2CJaJh_W:h20JCJaJ$h_W:h20JCJPJaJnHtH'h_W:h20JCJPJaJnHo(tHh_W:h25CJ\aJ h_W:h2'h_W:h20J5CJPJaJnHtHh_W:h20J5CJaJo(h_W:h20J5CJaJ|}~d$$1&P#$/Ifgd/C00d$$1&P#$/Ifgd/kd)c$$Iflr(!" 96P1044 layt[5d$$1&P#$/Ifgd/$d$$1&P#$/Ifa$gd/C*d$$1&P#$/IfWDd`gd/kdd$$Iflr(!" 96P1044 layt[5d$$1&P#$/Ifgd/$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/ێC*d$$1&P#$/IfWDd`gd/kdd$$Iflr(!" 96P1044 layt[5ێ܎$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/ C*d$$1&P#$/IfWDd`gd/kde$$Iflr(!" 96P1044 layt[5 GHQRYZ[\pqyzϏЏُڏۺۺۺۺۺȅ&h_W:h2CJPJ\aJnHo(tH!h_W:h2h6*0J5CJaJh_W:h20J5CJaJo(h_W:h20J5CJaJ h_W:h2h_W:h2CJaJo(h_W:h2CJaJh_W:h2CJ\aJh_W:h2CJ\aJo(/ $d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/HC*d$$1&P#$/IfWDd`gd/kdf$$Iflr(!" 96P1044 layt[5HIQRZ$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/Z[qC*d$$1&P#$/IfWDd`gd/kdg$$Iflr(!" 96P1044 layt[5qryz$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/C*d$$1&P#$/IfWDd`gd/kdh$$Iflr(!" 96P1044 layt[5$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/ЏC*d$$1&P#$/IfWDd`gd/kdi$$Iflr(!" 96P1044 layt[5Џяُڏ$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/C*d$$1&P#$/IfWDd`gd/kdyj$$Iflr(!" 96P1044 layt[5$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/C*d$$1&P#$/IfWDd`gd/kdck$$Iflr(!" 96P1044 layt[5 !NOX^_`abefgs|}~ó~rјeܘerјeWeܘ~h_W:h20JCJaJo(h_W:h20JCJaJh_W:h2CJaJo(h_W:h2CJ\aJo(h_W:h2CJ\aJ h_W:h2'h_W:h20J5CJPJaJnHtHh_W:h20J5CJaJo(h_W:h20J5CJaJh_W:h2CJaJ h_W:h2CJPJaJnHtH#h_W:h2CJPJ\aJnHtH"$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/ OC*d$$1&P#$/IfWDd`gd/kd[l$$Iflr(!" 96P1044 layt[5OPWX_$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/_`aC0d$$1&P#$/Ifgd/kdSm$$Iflr(!" 96P1044 layt[5abcde$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/efgC0d$$1&P#$/Ifgd/kdgn$$Iflr(!" 96P1044 layt[5ghrs}$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/}~C0d$$1&P#$/Ifgd/kdo$$Iflr(!" 96P1044 layt[5$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/C*d$$1&P#$/IfWDd`gd/kdp$$Iflr(!" 96P1044 layt[5$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/ϐِؐڐېܐ 45=BCDEhijnoqvwxy‘בؑյՔh_W:h2CJaJnH tH #h_W:h2CJPJaJnHo(tH#h_W:h2CJPJaJnHo(tHh_W:h2CJ\aJo(h_W:h2CJ\aJ h_W:h2h_W:h2CJaJh_W:h2CJaJo(8ϐC*d$$1&P#$/IfWDd`gd/kdq$$Iflr(!" 96P1044 layt[5ϐАאؐڐ$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/ڐېC*d$$1&P#$/IfWDd`gd/kdr$$Iflr(!" 96P1044 layt[5 $d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/ 5C*d$$1&P#$/IfWDd`gd/kds$$Iflr(!" 96P1044 layt[556<=C$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/CDiC*d$$1&P#$/IfWDd`gd/kd}t$$Iflr(!" 96P1044 layt[5ijpqw$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/wxC*d$$1&P#$/IfWDd`gd/kdmu$$Iflr(!" 96P1044 layt[5$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/C*d$$1&P#$/IfWDd`gd/kd]v$$Iflr(!" 96P1044 layt[5$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/ؑC*d$$1&P#$/IfWDd`gd/kdMw$$Iflr(!" 96P1044 layt[5ّؑ$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/C*d$$1&P#$/IfWDd`gd/kdYx$$Iflr(!" 96P1044 layt[5$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/ !"#:;=>BEGNOPQabjopq跨ܚ܈vܚgh_W:h2hCJaJo(#h_W:h2CJPJaJnHo(tH#h_W:h2CJPJaJnHo(tHh_W:h2CJ\aJo(h_W:h25CJ\aJo(h_W:h25CJ\aJh_W:h2CJaJo(h_W:h2CJaJh_W:h2CJ\aJ h_W:h2 h_W:h2CJPJaJnHtH(C*d$$1&P#$/IfWDd`gd/kdy$$Iflr(!" 96P1044 layt[5$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/ C0d$$1&P#$/Ifgd/kdz$$Iflr(!" 96P1044 layt[5 !$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/!";C*d$$1&P#$/IfWDd`gd/kd{$$Iflr(!" 96P1044 layt[5;>FGO$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/OPbC*d$$1&P#$/IfWDd`gd/kd|$$Iflr(!" 96P1044 layt[5bcijp$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/pqC*d$$1&P#$/IfWDd`gd/kd}$$Iflr(!" 96P1044 layt[5$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/C*d$$1&P#$/IfWDd`gd/kd~$$Iflr(!" 96P1044 layt[5ÒĒȒ$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/ĒǒȒɒ !+234579:;BEGPQRSUWXYjku|}~⩚⩚h_W:h25CJ\aJo(h_W:h25CJ\aJ h_W:h2CJPJaJnHtHh_W:h2CJ\aJh_W:h2CJ\aJo( h_W:h2h_W:h2CJaJo(h_W:h2CJaJ9ȒɒC*d$$1&P#$/IfWDd`gd/kd{$$Iflr(!" 96P1044 layt[5$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/C*d$$1&P#$/IfWDd`gd/kde$$Iflr(!" 96P1044 layt[5 $d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/!C*d$$1&P#$/IfWDd`gd/kdO$$Iflr(!" 96P1044 layt[5!"*+3$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/345C*d$$1&P#$/IfWDd`gd/kdU$$Iflr(!" 96P1044 layt[556789$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/9:;C*d$$1&P#$/IfWDd`gd/kd[$$Iflr(!" 96P1044 layt[5;<FGQ$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/QRSC*d$$1&P#$/IfWDd`gd/kdo$$Iflr(!" 96P1044 layt[5STUVW$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/WXkC0d$$1&P#$/Ifgd/kdu$$Iflr(!" 96P1044 layt[5kltu}$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/}~C*d$$1&P#$/IfWDd`gd/kd$$Iflr(!" 96P1044 layt[5$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/C0d$$1&P#$/Ifgd/kd$$Iflr(!" 96P1044 layt[5$d$$1&P#$/Ifa$gd/$d$$1&P#$/Ifa$gd/“ÓC3Zd$If^Z`gd}r)'$ da$gdEkd͈$$Iflr(!" 96P1044 layt[5“œǓܓ 8>CEafɔԔݔߔ &(JT[]gͿ޳ͨy޳޳޿޳޿j޳ͳ޳h_W:h25CJ\aJo(#h_W:h~81CJPJaJnHo(tH h_W:h~81CJPJaJnHtHh_W:h~81CJaJo(h_W:h~81CJaJh_W:h2CJaJo(h_W:h25CJ\aJ h_W:h2CJPJaJnHtHh_W:h2CJaJ+h_W:hEFCJOJPJQJaJnHo(tH)ÓēœƓǓܓݓޓߓiUZd$If^Z`gd}r)xkd$$Ifl\c,"/ 44 layt~81$d$Ifa$gd}r)$d$Ifa$gd}r)ߓsdUU$d$Ifa$gd}r)$d$Ifa$gd}r)d$IfVDG^gd2zkd}$$Ifl\c,"/ 44 layt~81 ufWH$d$Ifa$gd}r)$d$Ifa$gd~81$d$Ifa$gd}r)d$IfVDG^gd2xkd$$Ifl\c,"/ 44 layt~8178>DufN6$d$&dIfPa$gd}r)$d$&dIfPa$gd~81$d$Ifa$gd}r)d$IfVDG^gd2xkd$$Ifl\c,"/ 44 layt~81DEFGHIsdUU$d$Ifa$gd}r)$d$Ifa$gd}r)Zd$If^Z`gd}r)xkd+$$Ifl\c,"/ 44 layt~81IJwxsdUU$d$Ifa$gd}r)$d$Ifa$gd}r)Zd$If^Z`gd}r)xkd$$Ifl\c,"/ 44 layt~81sdLL$d$&dIfPa$gd}r)$d$Ifa$gd}r)Zd$If^Z`gd}r)xkdG$$Ifl\c,"/ 44 layt~81sdUU$d$Ifa$gd}r)$d$Ifa$gd}r)Zd$If^Z`gd}r)xkdՍ$$Ifl\c,"/ 44 layt~81ɔʔԔޔsdLL$d$&dIfPa$gd}r)$d$Ifa$gd}r)Zd$If^Z`gd}r)xkdc$$Ifl\c,"/ 44 layt~81ޔߔsdUU$d$Ifa$gd}r)$d$Ifa$gd}r)Zd$If^Z`gd}r)xkd$$Ifl\c,"/ 44 layt~81sdUU$d$Ifa$gd}r)$d$Ifa$gd}r)Zd$If^Z`gd}r)xkd$$Ifl\c,"/ 44 layt~81 'ufWW$d$Ifa$gd}r)$d$Ifa$gd}r)d$IfVDG^gd2xkd$$Ifl\c,"/ 44 layt~81'(KLT\ufW>$Hd$4$If]a$gd}r)$d$Ifa$gd}r)$d$Ifa$gd}r)d$IfVDG^gd2xkd$$Ifl\c,"/ 44 layt~81\]hiqyufWW$d$Ifa$gd}r)$d$Ifa$gd}r)d$IfVDG^gd2xkd)$$Ifl\c,"/ 44 layt~81gqxzƕϕѕҕӕسhJ:h_W:hrO5B*CJOJPJQJ\aJnHo(phtH5h_W:hEF5CJOJPJQJ\^JaJnHo(tH2h_W:hEF5CJOJPJQJ\^JaJnHtH+h_W:hEFCJOJPJQJaJnHo(tH+h_W:h2CJOJPJQJaJnHo(tHh_W:h2CJOJQJaJ h_W:h2CJPJaJnHtHh_W:h2CJaJo(h_W:h2CJaJyzufNN$d$&dIfPa$gd}r)$d$Ifa$gd}r)d$IfVDG^gd2xkd$$Ifl\c,"/ 44 layt~81ufWW$d$Ifa$gd}r)$d$Ifa$gd}r)d$IfVDG^gd2xkdE$$Ifl\c,"/ 44 layt~81n_GG$d$&dIfPa$gd}r)$d$Ifa$gd}r)%!Zd$If^Z`gd}r)xkdӒ$$Ifl\c,"/ 44 layt~81n_PP$d$Ifa$gd}r)$d$Ifa$gd}r)%!Zd$If^Z`gd}r)xkda$$Ifl\c,"/ 44 layt~81ƕЕsdLL$d$&dIfPa$gd}r)$d$Ifa$gd}r)Zd$If^Z`gd}r)xkd$$Ifl\c,"/ 44 layt~81Еѕҕӕ1uupK;7d^7`gd%<TPL HD@<e C^gdEF'$ da$gdEzkd}$$Ifl?\c,"/ 44 layt~81012 qrԘ՘ydXMB6B6Bh_W:h2CJaJo(h_W:h2CJaJh_W:hhCJaJh_W:hh5CJaJ)h_W:hrO5CJPJ\aJnHo(tHh_W:h[CJaJo(h_W:hrOCJaJo(h_W:hrOCJaJ+h_W:hrOCJOJPJQJaJnHo(tHh_W:hrO5CJ\aJo(6h_W:hrO5CJKHOJPJQJ\^JaJnHtH)h_W:h%5CJPJ\aJnHo(tHh_W:hrO5CJ\aJ12 %Z $Ifgd}r)$d8^a$gd2$d^a$gd2 d^gdh$;d^`;a$gdh$d^a$gdgdrO JZ[^_˚̚=>mn&'ݠDeɤ٨zzkzzh_W:h26CJ\]aJh_W:h2CJ\]aJh_W:h25CJ\]aJ h_W:h256CJ\]aJ4h_W:hhB*CJOJPJQJaJnHo(phtH h_W:h2h_W:h2CJaJnH tH h_W:h2CJaJ *h_W:h2\]aJh_W:h256\]aJ'Z[q=Tkdt$$Ifl0zw&.  t#644 layt}r)P$If^`Pgd}r) $Ifgd}r)Tkd$$Ifl0zw&.  t#644 layt}r)^_t $Ifgd}r)Tkdٕ$$Ifl0zw&.  t#644 layt}r)x$If^`xgd}r)Q$If^`Qgd}r)˚̚՚NTkd$$Ifl0zw&.  t#644 layt}r) $Ifgd}r)Tkd>$$Ifl0zw&.  t#644 layt}r)&=NTkdm$$Ifl0zw&.  t#644 layt}r) $Ifgd}r)Tkd$$Ifl0zw&.  t#644 layt}r)=>[mnNTkd7$$Ifl0zw&.  t#644 layt}r) $Ifgd}r)Tkdҗ$$Ifl0zw&.  t#644 layt}r)ǛhN=Q$If^`Qgd}r)Tkd$$Ifl0zw&.  t#644 layt}r) $Ifgd}r)Tkd$$Ifl0zw&.  t#644 layt}r)&'ܠxeee$;d^`;a$gd2#9TPL HD@<+{^$d^a$gd2Tkdf$$Ifl0zw&.  t#644 layt}r) ܠݠCDde^_/0de$d^a$gd2#9TPL HD@<+{^$d^a$gd2$;d^`;a$gd2ɤʤ12abɦʦ:;tuKL^.0eܰ !ⲡ▊}o}h h_W:h2h_W:h2CJH*]aJh_W:h2CJPJ aJh_W:h25CJaJh_W:h2CJaJ h_W:h256CJ\]aJ4h_W:h2B*CJOJPJQJaJnHo(phtH)h_W:h6CJPJ\]aJnHo(tHh_W:h2CJ\]aJh_W:h2CJ\]aJo((e۰ܰ !6e_kd˙$$Ifl0kW%5 t"644 lapyt}r)$7$8$H$Ifgd}r)$d^a$gd2!cdef\]^_vʲRTUƳdzȳɳʳͻͩh_W:h2CJaJh_W:h2CJaJnH tH h_W:h2hCJPJ aJ"h_W:h2CJH*]aJnH tH #h_W:h2CJH*PJ aJnH tH h_W:h2CJPJ aJnH tH h_W:h2h_W:h2CJH*]aJh_W:h2CJPJ aJ-efo1_kdÚ$$Ifl0kW%5 t"644 lapyt}r)$7$8$H$Ifgd}r)_kdG$$Ifl0kW%5 t"644 lapyt}r)˱ձ _kd?$$Ifl0kW%5 t"644 lapyt}r)$7$8$H$Ifgd}r)8I^_1_kd7$$Ifl0kW%5 t"644 lapyt}r)$7$8$H$Ifgd}r)_kd$$Ifl0kW%5 t"644 lapyt}r)_vʲ_kd$$Ifl0kW%5 t"644 lapyt}r)$7$8$H$Ifgd}r)JTU1_kd$$Ifl0kW%5 t"644 lapyt}r)$7$8$H$Ifgd}r)_kd/$$Ifl0kW%5 t"644 lapyt}r)Ukȳ_kd'$$Ifl0kW%5 t"644 lapyt}r)$7$8$H$Ifgd}r)ȳɳʳ334l\\\$7$8$H$^a$gd2#9TPL HD@<+{^$d^a$gd2_kd$$Ifl0kW%5 t"644 lapyt}r) ʳ˳3438e%&DEFfg ͿͿ͉wffXIh_W:h2CJaJnH tH h_W:h25CJ\aJ h_W:h2CJPJ aJnH tH #h_W:h2CJPJ aJnH o(tH #h_W:h25CJPJ aJnH tH h_W:h2CJPJ aJh_W:h26CJaJh_W:h2CJaJh_W:h256CJaJ4h_W:h2B*CJOJPJQJaJnHo(phtHh_W:h2CJaJh_W:h2CJH*aJ56bcgh./#9TPL HD@<+{^$d^a$gd2$7$8$H$^a$gd2/BC%&DF$Rd$G$VDb^Ra$gd2$d^a$gd2$d^`a$gd2#9TPL HD@<+{^$7$8$H$^a$gd2fgGH !bwh$d^a$gd2$7$8$H$a$gd2$Rd7$8$H$VDb^Ra$gd2 $ & Fd7$8$H$VDb^`a$gd2 $ & Fd7$8$H$VDb^`a$gd2$Sd7$8$H$VDb^S`a$gd2 !bci=>?@E[\ef(/<BC񡒄iXXXXXXMAh_W:h$CJaJo(h_W:h$CJaJ h_W:h$CJPJaJnHtH4h_W:hpMSB*CJOJPJQJaJnHo(phtHh_W:h@)5CJ\aJh_W:h@)5CJ\aJo(#h_W:h$CJPJaJnHo(tHh_W:h2PJ nH tH h_W:h2h_W:h2CJaJ h_W:h256CJ\]aJh_W:h256CJaJh_W:h2PJnHo(tHbc:K/0hi?@[d^`gd@)$d^a$gd$$ & Fd7$8$H$^`a$gd2$d7$8$H$^a$gd2$6d$G$^a$gd2[\()?yz{MQkd$$If0p#  44 aSyt}r)$nd$IfVDWD^n`a$gd$Vd$IfVD^Vgd$$d^a$gd$#9TPL HD@<+{^*?@yz|}012345JMXfHIŵ䚈v#h_W:h$>*CJPJaJnHtH#h_W:h$5CJPJaJnHtH4h_W:hkB*CJOJPJQJaJnHo(phtHh_W:h$CJ]aJnH tH h_W:h$CJ]aJ h_W:h$h_W:h$CJaJo(h_W:h$CJaJ h_W:h$CJPJaJnHtH){|}.Qkd$$Ifq0p#  44 aSyt}r)$Vd$IfVD^Va$gd$Qkd$$If0p#  44 aSyt}r)nd$IfVDWD^n`gd$1h$nd$IfVDWD^n`a$gd$Qkd`$$If0p#  44 aSyt}r)nd$IfVDWD^n`gd$Vd$IfVD^Vgd$12345L1QkdD$$If0p#  44 aSyt}r)nd$IfVDWD^n`gd$Vd$IfVD^Vgd$Qkdՠ$$If0p#  44 aSyt}r)LMq`<#9TPL HD@<+{^$dWD,`a$gd6$d^a$gd$Qkd$$If0p#  44 aSyt}r)$nd$IfVDWD^n`a$gd$Vd$IfVD^Vgd$GHlmno$d$&dIfPa$gd}r)&d$If^`&gd}r)$\dVDQ^\`a$gd$$\#dVDQ^\`#a$gd$Iklmn $%&'8ABIJQRYZ[\־־־ŒžoaUJoJUaUah_W:h]CJaJh_W:h]CJaJo(h_W:h]hewCJaJ h_W:h]CJOJ PJ QJ aJ#h_W:h]CJPJ]aJnHtHh_W:h$h CJaJh_W:h$CJ]aJ#h_W:h$CJPJ]aJnHtH h_W:h$ h_W:h$CJPJaJnHtHh_W:h$CJaJ#h_W:h$>*CJPJaJnH tH h_W:h$>*CJaJ$d$&dIfPa$gd}r)%kd($$If֞ ]9!%3nnnn0T"44 aSyt}r)$d$Ifa$gd}r)&d$If^`&gd}r)%kd$$If֞ ]9!%3nnnn0T"44 aSyt}r)$d$Ifa$gd}r)&d$If^`&gd}r)%kd$$If֞ ]9!%3nnnn0T"44 aSyt}r) !"#$%&$d$Ifa$gd}r)&d$If^`&gd}r)&'%kd$$If֞ ]9!%3nnnn0T"44 aSyt}r)'8BJRZ\f$d$Ifa$gd&d$If^`&gd}r)\efgh{ñᥚuuuhuuYh_W:h$h+CJaJo(h_W:h$CJPJaJh_W:h$CJaJo(#h_W:h$CJPJ]aJnHtH h_W:h$h_W:h$CJaJh_W:h$CJ]aJ#h_W:h]CJOJ PJ QJ aJo(h_W:h]CJ]aJ#h_W:h]CJPJ]aJnHtH h_W:h]h_W:h]CJaJh_W:h]CJaJo(!fg%kdΥ$$If֞ ]9!%3nnnn0T"44 aSyt}r)g{$d$&dIfPa$gdhd$IfVDWD^`hgd$%kd$$If֞ ]9!%3nnnn0T"44 aSyt}r)$d$Ifa$gd}r)&d$If^`&gd}r)%kd$$If֞ ]9!%3nnnn0T"44 aSyt}r)$d$&dIfPa$gd}r)hd$IfVDWD^`hgd$ $%&'-.@AEFLMNabcghlȶԍ|ԍh|&h_W:h$CJPJ]aJnHo(tH h_W:h$CJPJaJnHtHh_W:h$CJ]aJo(h_W:h$CJPJaJh_W:h$CJPJaJo(#h_W:h$CJPJ]aJnHtHh_W:h$CJ]aJ h_W:h$h_W:h$CJaJh_W:h$CJaJo(h_W:h$hewCJaJ&%kd$$If֞ ]9!%3nnnn0T"44 aSyt}r)$d$Ifa$gd}r)&d$If^`&gd}r)%kd$$If֞ ]9!%3nnnn0T"44 aSyt}r) %$d$Ifa$gd}r)$d$&dIfPa$gd}r)hd$IfVDWD^`hgd$%&%kd$$If֞ ]9!%3nnnn0T"44 aSyt}r)&'()*+,-$d$Ifa$gd}r)&d$If^`&gd}r)-.%kdt$$If֞ ]9!%3nnnn0T"44 aSyt}r).ABCDEFM$d$Ifa$gd}r)ad$If^`agd}r)MN%kde$$If֞ ]9!%3nnnn0T"44 aSyt}r)Ncdefghq$d$Ifa$gd}r)ad$If^`agd}r)lopqrpϵ֤cϵO&h_W:h$hewCJPJaJnHtHh_W:h$CJPJaJ#h_W:h$CJPJ]aJnHtH&h_W:h$CJPJ]aJnHo(tHh_W:h$hewCJaJ h_W:h$CJPJaJnHtHh_W:h$CJ]aJh_W:h$CJ]aJo( h_W:h$h_W:h$CJaJh_W:h$CJaJo(#h_W:hdCJPJaJnHo(tHqr%kdV$$If֞ ]9!%3nnnn0T"44 aSyt}r)r$d$Ifa$gd}r)ad$If^`agd}r)%kdG$$If֞ ]9!%3nnnn0T"44 aSyt}r)$d$&d4$IfPa$gd}r)$d$Ifa$gd}r)ad$If^`agd}r)%kd8$$If֞ ]9!%3nnnn0T"44 aSyt}r)$d$Ifa$gd}r)&d$If^`&gd}r)%kd)$$If֞ ]9!%3nnnn0T"44 aSyt}r)$d$&dIfPa$gd}r)$d$Ifa$gd}r)ad$If^`agd}r)%kd$$If֞ ]9!%3nnnn0T"44 aSyt}r)yIJuguguUuug#h_W:h$CJPJaJnHo(tHh_W:h$hewCJaJh_W:h$CJaJo(h_W:h$h CJaJ#h_W:h$CJPJ]aJnHtH h_W:h$CJPJaJnHtH#h_W:h$>*CJPJaJnH tH h_W:h$>*CJaJ#h_W:h$>*CJPJaJnHtHh_W:h$CJaJh_W:h$CJ]aJ h_W:h$!$d$Ifa$gd}r)&d$If^`&gd}r)%kd$$If֞ ]9!%3nnnn0T"44 aSyt}r)()*78Njklyz{$d$&dIfPa$gd}r)&d$If^`&gd}r)$\dVDQ^\`a$gd$$\.dVDQ^\`.a$gd$'&d$If^`&gd}r)kd$$If֞ ]9!%3nnnn0T"44 aSyt}r)$d$Ifa$gd}r)'&d$If^`&gd}r)kd$$If֞ ]9!%3nnnn0T"44 aSyt}r)$d$Ifa$gd}r)'&d$If^`&gd}r)kdش$$If֞ ]9!%3nnnn0T"44 aSyt}r)$d$Ifa$gd}r)'&d$If^`&gd}r)kd$$If֞ ]9!%3nnnn0T"44 aSyt}r) $d$Ifa$gd}r) $%,-34;<EFGHIJPQSXabijqryzɽ󲫽󲫽Ɍh_W:h$CJ]aJo( h_W:h$CJPJaJnHtH h_W:h$h_W:h$CJaJh_W:h$CJ]aJ#h_W:h$CJPJ]aJnHtHh_W:h$hewh_W:h$hewCJaJh_W:h$CJaJo(7 'kd$$If֞ ]9!%3nnnn0T"44 aSyt}r) %-4<FH$d$&dIfPa$gd}r)hd$IfVDWD^`hgd$HIJ'&d$If^`&gd}r)kd$$If֞ ]9!%3nnnn0T"44 aSyt}r)JKLMNOP$d$Ifa$gd}r)PQ'kd|$$If֞ ]9!%3nnnn0T"44 aSyt}r)QXbjrz$d$&dIfPa$gd}r)hd$IfVDWD^`hgd$'&d$If^`&gd}r)kdh$$If֞ ]9!%3nnnn0T"44 aSyt}r)$d$Ifa$gd}r)'kdT$$If֞ ]9!%3nnnn0T"44 aSyt}r)$d$Ifa$gd}r)$d$&dIfPa$gd}r)hd$IfVDWD^`hgd$'&d$If^`&gd}r)kd@$$If֞ ]9!%3nnnn0T"44 aSyt}r) !"#'(012?@DEMNOadnostyz{|õԕõõԕԃõo&h_W:h$hewCJPJaJnHtH#h_W:h$CJPJ]aJnHtH&h_W:h$CJPJ]aJnHo(tHh_W:h$CJaJo(h_W:h$hewCJaJ h_W:h$CJPJaJnHtHh_W:h$CJ]aJo(h_W:h$CJaJh_W:h$CJ]aJ h_W:h$+$d$Ifa$gd}r)'ad$If^`agd}r)kd,$$If֞ ]9!%3nnnn0T"44 aSyt}r)$d$Ifa$gd}r)#'ad$If^`agd}r)kd$$If֞ ]9!%3nnnn0T"44 aSyt}r)#$%&'(1$d$Ifa$gd}r)12@'ad$If^`agd}r)kd$$If֞ ]9!%3nnnn0T"44 aSyt}r)@ABCDEN$d$Ifa$gd}r)NOo'ad$If^`agd}r)kd$$If֞ ]9!%3nnnn0T"44 aSyt}r)opqrstz$d$&d4$IfPa$gd}r)$d$Ifa$gd}r)z{|'&d$If^`&gd}r)kdܿ$$If֞ ]9!%3nnnn0T"44 aSyt}r)|}~$d$Ifa$gd}r)'ad$If^`agd}r)kd$$If֞ ]9!%3nnnn0T"44 aSyt}r)$d$&dIfPa$gd}r)$d$Ifa$gd}r)Zhu<=>?ARSTUȷȫȷȫȫȷȷȷ{i]h_W:h$CJ]aJ#h_W:h$>*CJPJaJnH tH h_W:h$>*CJaJ#h_W:h$>*CJPJaJnHtH#h_W:h$5CJPJaJnHtHh_W:h$CJaJo( h_W:h$CJPJaJnHtHh_W:h$CJaJ4h_W:h$B*CJOJPJQJaJnHo(phtH h_W:h$h_W:h$CJaJ'kd$$If֞ ]9!%3nnnn0T"44 aSyt}r)>?STwdgd$$\dVDQ^\`a$gd$$\#dVDQ^\`#a$gd$dWDh`gd$$dWDh^`a$gd$$d^a$gd$#9TPL HD@<+{^ TUjkx$d$&dIfPa$gd}r)&d$If^`&gd}r)Uijwx +,=?AHIJKPQ]eistuz{ѿݿѿݿݿѿѝ)h_W:h$h^TCJPJ]aJnHtHh_W:h$CJPJaJ#h_W:h$CJPJ]aJnHtHh_W:h$CJ]aJ h_W:h$h_W:h$CJaJ h_W:h$CJPJaJnHtH::&&d$If^`&gd}r)kd$$Ifֈ/ wQ$j Hnt0!44 aSyt}r)$d$Ifa$gd}r):&&d$If^`&gd}r)kd$$Ifֈ/ wQ$j Hnt0!44 aSyt}r)$d$Ifa$gd}r):&&d$If^`&gd}r)kd$$Ifֈ/ wQ$j Hnt0!44 aSyt}r) $d$Ifa$gd}r)=:&&d$If^`&gd}r)kdx$$Ifֈ/ wQ$j Hnt0!44 aSyt}r)=>?@AI$d$&dIfPa$gd}r)$d$Ifa$gd}r)IJK:&&d$If^`&gd}r)kdj$$Ifֈ/ wQ$j Hnt0!44 aSyt}r)KLMNOP$d$Ifa$gd}r)PQe:&&d$If^`&gd}r)kd\$$Ifֈ/ wQ$j Hnt0!44 aSyt}r)efghis$d$&dIfPa$gd}r)$d$Ifa$gd}r)stu:&&d$If^`&gd}r)kdN$$Ifֈ/ wQ$j Hnt0!44 aSyt}r)uvwxyz$d$Ifa$gd}r)z{:&&d$If^`&gd}r)kd@$$Ifֈ/ wQ$j Hnt0!44 aSyt}r)$d$Ifa$gd}r):&&d$If^`&gd}r)kd2$$Ifֈ/ wQ$j Hnt0!44 aSyt}r)$d$&dIfPa$gd}r)$d$Ifa$gd}r):&&d$If^`&gd}r)kd$$$Ifֈ/ wQ$j Hnt0!44 aSyt}r) -/0DERSܽ|j^MMM h_W:h$CJPJaJnHtHh_W:h$>*CJaJ#h_W:h$>*CJPJaJnHtH h_W:h$CJPJaJnHtHh_W:h$CJaJh_W:h$CJ]aJ#h_W:h$CJPJ]aJnHtH h_W:h$h_W:h$CJaJ&h_W:h$h5CJPJaJnHtH&h_W:h$h CJPJaJnHtHh_W:h$h CJ]aJ$d$Ifa$gd}r) :&&d$If^`&gd}r)kd$$Ifֈ/ wQ$j Hnt0!44 aSyt}r) $d$&dIfPa$gd}r)$d$Ifa$gd}r):2$\#dVDQ^\`#a$gd$dgd$kd$$Ifֈ/ wQ$j Hnt0!44 aSyt}r)./0EFSi$d$&dIfPa$gd}r)&d$If^`&gd}r)dgd$$\#dVDQ^\`#a$gd$ :&&d$If^`&gd}r)kd$$Ifֈ/ wQ$j Hnt0!44 aSyt}r)$d$Ifa$gd}r):&&d$If^`&gd}r)kd$$Ifֈ/ wQ$j Hnt0!44 aSyt}r)$d$Ifa$gd}r):&&d$If^`&gd}r)kd$$Ifֈ/ wQ$j Hnt0!44 aSyt}r)#$%&+,8@DMNOPUVjqrxy|}辬辠辬辠辠辬)h_W:h$h^TCJPJ]aJnHtHh_W:h$CJ]aJ#h_W:h$CJPJ]aJnHtH h_W:h$#h_W:h$CJPJaJnHo(tH h_W:h$CJPJaJnHtHh_W:h$CJaJh_W:h$CJaJo(6$d$Ifa$gd}r):&&d$If^`&gd}r)kd$$Ifֈ/ wQ$j Hnt0!44 aSyt}r)$$d$&dIfPa$gd}r)$d$Ifa$gd}r)$%&:&&d$If^`&gd}r)kd$$Ifֈ/ wQ$j Hnt0!44 aSyt}r)&'()*+$d$Ifa$gd}r)+,@:&&d$If^`&gd}r)kd$$Ifֈ/ wQ$j Hnt0!44 aSyt}r)@ABCDN$d$&dIfPa$gd}r)$d$Ifa$gd}r)NOP:&&d$If^`&gd}r)kd$$Ifֈ/ wQ$j Hnt0!44 aSyt}r)PQRSTU$d$Ifa$gd}r)UVj:&&d$If^`&gd}r)kd$$Ifֈ/ wQ$j Hnt0!44 aSyt}r)jry$d$Ifa$gd}r):&&d$If^`&gd}r)kd$$Ifֈ/ wQ$j Hnt0!44 aSyt}r)$d$&dIfPa$gd}r)$d$Ifa$gd}r)®}qVE3#h_W:h$CJPJaJnHo(tH h_W:h$CJPJaJnHtH4h_W:h$B*CJOJPJQJaJnHo(phtHh_W:h$CJ]aJ#h_W:h$CJPJ]aJnHtHh_W:h$CJaJ&h_W:h$h5CJPJaJnHtH&h_W:h$h CJPJaJnHtHh_W:h$h CJ]aJ h_W:h$h_W:h$CJaJh_W:h$CJaJo( h_W:h$CJPJaJnHtH:&&d$If^`&gd}r)kd$$Ifֈ/ wQ$j Hnt0!44 aSyt}r)$d$Ifa$gd}r):&&d$If^`&gd}r)kd~$$Ifֈ/ wQ$j Hnt0!44 aSyt}r)$d$&dIfPa$gd}r)$d$Ifa$gd}r):#9TPL HD@<+{^kd~$$Ifֈ/ wQ$j Hnt0!44 aSyt}r)QR !"<=ab$\dVDQ^\`a$gd$$\#dVDQ^\`#a$gd$`d$VDh^`gd$ |d`gd$$d^a$gd$$ & F da$gd$dVD^gd$$`dVDh^`a$gd$%=>?cm~ !"<=>bƱ~rf[h_W:h$CJaJh_W:h$CJ]aJh_W:h$>*CJaJ#h_W:h$>*CJPJaJnHtHh_W:h$CJaJnH tH #h_W:h$5CJPJaJnHtH(h_W:h$CJOJPJQJaJnHtHh_W:h$CJaJh_W:h$CJaJo(#h_W:h$CJPJaJnHo(tH h_W:h$CJPJaJnHtH $d$&dIfPa$gd}r)&d$If^`&gd}r):&&d$If^`&gd}r)kd~$$Ifֈ Wrl $ GWr0"44 aSyt}r)/0167?^sz#$ABCDGHIJMzlllзh_W:h$CJ]aJo(h_W:h$CJPJaJo(h_W:h$CJaJhnH tH h_W:h$CJaJnH o(tH h_W:h$CJaJnH tH h_W:h$CJaJo(h_W:h$CJPJaJ#h_W:h$CJPJ]aJnHtHh_W:h$CJaJh_W:h$CJ]aJ h_W:h$*'/$d$Ifa$gd}r)/01:&&d$If^`&gd}r)kd~$$Ifֈ Wrl $ GWr0"44 aSyt}r)123456$d$Ifa$gd}r)67^:&&d$If^`&gd}r)kdx$$Ifֈ Wrl $ GWr0"44 aSyt}r)^fmsz$d$4$Ifa$gd}r)$d$Ifa$gd}r):&&d$If^`&gd}r)kdr$$Ifֈ Wrl $ GWr0"44 aSyt}r)$d$4$Ifa$gd}r)$d$Ifa$gd}r)B:&&d$If^`&gd}r)kdr$$Ifֈ Wrl $ GWr0"44 aSyt}r)BDHJNR$d$Ifa$gd}r)MNQRSTlmp~45<=DELMTU]^_xy~ĶĶĶ h_W:h$CJPJaJnHtHh_W:h$CJ]aJo(h_W:h$CJ]aJ#h_W:h$CJPJ]aJnHtH h_W:h$h_W:h$CJaJo(h_W:h$CJaJARS:&&d$If^`&gd}r)kdr$$Ifֈ lrl $ Glr0"44 aSyt}r)$d$Ifa$gd}r):&&d$If^`&gd}r)kdr$$Ifֈ lrl $ Glr0"44 aSyt}r)$d$Ifa$gd}r)5:&&d$If^`&gd}r)kdr$$Ifֈ lrl $ Glr0"44 aSyt}r)5=EMU^$d$Ifa$gd}r)^_y:&&d$If^`&gd}r)kdr$$Ifֈ lrl $ Glr0"44 aSyt}r)y$d$&d4$IfPa$gd}r)$d$&dIfPa$gd}r):#$>dVDaWD^`>a$gd$kdr$$Ifֈ lrl $ Glr0"44 aSyt}r)@A&'PQWXŪ~mbWF?W?W? h_W:h$ h_W:h$CJPJaJnHtHh_W:h$CJaJh_W:h$CJaJ h_W:h$CJPJaJnHtHh_W:h$>*CJPJaJh_W:h$>*CJaJ#h_W:h$>*CJPJaJnHtH4h_W:h$B*CJOJPJQJaJnHo(phtHh_W:h$CJaJ#h_W:h$CJPJaJnHo(tH h_W:h$CJPJaJnHtHh_W:h$CJaJo(ABx````$d$$&dIfPa$gd}r)d$$If^`gd}r)$Hd$VD^^Ha$gd$Hd$VD^^Hgd$$\#d$VDQ^\`#a$gd$#9TPL HD@<+{^$[dVDnWD^[`a$gd$  &'(I5d$$If^`gd}r)kd$$Ifֈ F % noV"44 aSyt&$d$$&dIfPa$gd}r)(08@HPQRR>d$$If^`gd}r)kd9$$Ifֈ F % noV"44 aSyt&$d$$Ifa$gd}r)RSTUVWXqR>d$$If^`gd}r)kd$$Ifֈ F % noV"44 aSyt&$d$$Ifa$gd}r)Xdgqrsyz{|}~#%&ͿͿʹͿͿ͛ʹʹʹ͛|p|p͛ʹʹʹ͛h_W:h$CJ]aJh_W:h$CJ]aJo( h_W:h$CJPJaJnHtH#h_W:h;dCJPJaJnHo(tH h_W:h$h_W:h$CJaJh_W:h$hewCJaJh_W:h$CJaJo(&h_W:h$CJPJ]aJnHo(tH#h_W:h$CJPJ]aJnHtH,qsz|~R>d$$If^`gd}r)kd$$Ifֈ F % noV"44 aSyt&$d$$Ifa$gd}r)Rkd^$$Ifֈ F % noV"44 aSyt&$d$$Ifa$gd}r)&$d$$Ifa$gd}r)sd$$IfVDWD^`sgd$&'5>GIQZaM>>>>>$d$$Ifa$gd}r)d$$If^`gd}r)kd$$Ifֈ F % noV"44 aSyt&&'5GHIPZ[mnuv}~_`axh_W:h$CJaJ h_W:h$CJPJaJnHtH"h_W:h$5CJ\aJnH tH #h_W:h$>*CJPJaJnHtHh_W:h$>*CJaJh_W:h$CJ]aJh_W:h$CJaJo(h_W:h$CJaJ#h_W:h$CJPJ]aJnHtH h_W:h$.Z[nv~aM5555$d$$&dIfPa$gd}r)d$$If^`gd}r)kd$$Ifֈ F % noV"44 aSyt&I44$\#d$VDQ^\`#a$gd$kd$$Ifֈ F % noV"44 aSyt&$d$$&dIfPa$gd}r)&<XY_$d$&dIfPa$gd}r)&d$If^`&gd}r)$`d$VDh^`a$gd$;d$WD^`;gd$ _`a8$&d$If^`&gd}r)kdH$$Ifֈ Wrl $ HXs0$" 44 aSyt}r)aiqy$d$Ifa$gd}r)8$&d$If^`&gd}r)kdM$$Ifֈ Wrl $ HXs0$" 44 aSyt}r)$d$Ifa$gd}r)8$&d$If^`&gd}r)kdL$$Ifֈ Wrl $ HXs0$" 44 aSyt}r)$d$4$Ifa$gd}r)$d$Ifa$gd}r)-./456;<ABGHIKPQRSkložвܾžh_W:h&CJ]aJo(h_W:h$CJ]aJo(#h_W:h$CJPJ]aJnHtHh_W:h$CJ]aJ h_W:h$h_W:h$CJaJh_W:h$CJaJo( h_W:h$CJPJaJnHtH#h_W:h$CJPJaJnHo(tH4.8$&d$If^`&gd}r)kdK$$Ifֈ Wrl $ HXs0$" 44 aSyt}r).5<BIQ$d$4$Ifa$gd}r)$d$Ifa$gd}r)QR8$d$$If^`gd}r)kdP$$Ifֈ Wrl $ HXs0$" 44 aSyt}r)$d$$Ifa$gd}r):&&d$If^`&gd}r)kdU$$Ifֈ lr| $ Ck n0$"44 aSyt}r)$d$Ifa$gd}r)/BGHLMRSWX]^_1U⫚h_W:h$CJaJo( h_W:h$CJPJaJnHtHh_W:h$CJaJh_W:h$CJ]aJ#h_W:h$CJPJ]aJnHtHh_W:h$CJ]aJo( h_W:h$h_W:h$CJaJo(h_W:h$CJaJ7B8$&d$If^`&gd}r)kdU$$Ifֈ lrl $ Hms0$" 44 aSyt}r)BHMSX^$d$Ifa$gd}r)^_8$&d$If^`&gd}r)kdZ$$Ifֈ lrl $ Hms0$" 44 aSyt}r)$d$Ifa$gd}r)8$&d$If^`&gd}r)kd_$$Ifֈ lrl $ Hms0$" 44 aSyt}r)$d$&d4$IfPa$gd}r)$d$&dIfPa$gd}r)d8$[d$VDnWD^[`a$gd$kdd$$Ifֈ lrl $ Hms0$" 44 aSyt}r)UXbcdefnoܵwlaPIaIaI7#h_W:h$CJPJ]aJnHtH h_W:h$ h_W:h$CJPJaJnHtHh_W:h$CJaJh_W:h$CJaJ h_W:h$CJPJaJnHtHh_W:h$CJaJnH tH h_W:h$>*CJaJ#h_W:h$>*CJPJaJnHtH4h_W:h$B*CJOJPJQJaJnHo(phtHh_W:h$CJaJo( h_W:h$CJPJaJnHtH#h_W:h$CJPJaJnHo(tHde'(5Kghn{{{{{{{$d$$&dIfPa$gd}r)d$$If^`gd}r)Hd$VD^^Hgd$$Hd$VD^^Ha$gd$$\#d$VDQ^\`#a$gd$#9TPL HD@<+{^nop:&d$$If^`gd}r)kdw$$Ifֈ F % no0V"44 aSyt}r)px$d$$Ifa$gd}r):&d$$If^`gd}r)kdc$$Ifֈ F % no0V"44 aSyt}r)$d$$Ifa$gd}r):&d$$If^`gd}r)kdI$$Ifֈ F % no0V"44 aSyt}r)(UV[\abcdghnop~εεεεεεεεεεεεεεεεڊh_W:h$CJ]aJh_W:h$CJ]aJo( h_W:h$h_W:h$hewh_W:h$CJaJh_W:h$hewCJaJh_W:h$CJaJo(#h_W:h$CJPJ]aJnHtH&h_W:h$CJPJ]aJnHo(tH6$d$$Ifa$gd}r):&d$$If^`gd}r)kd5$$Ifֈ F % no0V"44 aSyt}r)$d$$Ifa$gd}r)V:"sd$$IfVDWD^`sgd$kd/$$Ifֈ F % no0V"44 aSyt}r)V\bdho$d$$Ifa$gd}r)op~:&d$$If^`gd}r)kd)$$Ifֈ F % no0V"44 aSyt}r)~$d$$Ifa$gd}r):&d$$If^`gd}r)kd$$Ifֈ F % no0V"44 aSyt}r)!"FPŹŹŹũũօvfh_W:h$>*CJOJQJaJh_W:h$CJOJQJaJ(h_W:h$CJOJPJQJaJnHtHh_W:h$CJaJnH tH h_W:h$CJaJnH o(tH h_W:h$CJaJo( h_W:h$CJPJaJnHtHh_W:h$CJaJ h_W:h$h_W:h$CJaJh_W:h$CJaJo( $d$$&dIfPa$gd}r):,Hd$VD^^Hgd$kd$$Ifֈ F % no0V"44 aSyt}r)SUkd$$If40#& 9!44 aSf4yt}r)%$!d$&dIfPa$gd}r)$d$IfWD^`$gd}r)$RdVDb^Ra$gd$6dVDWD^`6gd$paa$d$Ifa$gd}r)$d$IfWD^`$gd}r)ekd$$IfFu#&9!    44 aSyt}r)%$!d$Ifa$gd}r) "#$+23:;<DKLSTU\djzszszsdXh_W:h$CJaJo(h_W:h$CJaJnH tH h_W:h] h_W:h]CJPJaJnHtHh_W:h]CJaJo(h_W:h]CJPJ aJh_W:h]CJaJh_W:h$CJaJ h_W:h$'h_W:h$>*CJOJQJaJnHtH*h_W:h$>*CJOJQJaJnHo(tH'h_W:h$>*CJOJQJaJnH tH  $d$Ifa$gd}r) d$Ifgd}r)ekd$$IfFu#&9!    44 aSyt}r) #p$d$Ifa$gd}r)$d$Ifa$gd d$Ifgd}r)ekd$$IfFu#&9!    44 aSyt}r)#$+3;p$d$Ifa$gd}r)$d$Ifa$gd d$Ifgd}r)ekd $$IfFu#&9!    44 aSyt}r);<DLTp$d$Ifa$gd}r)$d$Ifa$gd d$Ifgd}r)ekd$$IfFu#&9!    44 aSyt}r)TU\dlvv$d$&dIfPa$gd}r) d$Ifgd}r)ekd$$IfFu#&9!    44 aSyt}r)jklmpqr{|.?d1234<=>H~ʺʺʟʟʟʺʺʺʺʺʊ{h_W:h[5CJ\aJo()h_W:h5CJPJ\aJnHo(tHh_W:h$CJaJo(h_W:h$CJaJnH tH h_W:h$CJaJnH o(tH h_W:h$CJaJ h_W:h$ h_W:h$CJPJaJnHtH#h_W:h$CJPJaJnHo(tH+lmnop$d$Ifa$gd}r) d$Ifgd}r)ekd$$IfFu#&9!    44 aSyt}r)pqr|u]$d$&dIfPa$gd}r)$d$&d4$IfPa$gd}r) d$Ifgd}r)ekd#$$IfFu#&9!    44 aSyt}r)@Acd|||||td\dgdm d^`gd[dgd$$d^a$gd$$d^a$gd$ekd$$IfFu#&9!    44 aSyt}r) ͹t`YYH6Y#h_W:hm >*CJOJPJ QJaJ h_W:hm CJOJPJ QJaJ h_W:hm 'h_W:hm >*CJOJQJaJnHtH*h_W:hm >*CJOJQJaJnHo(tH'h_W:hm >*CJOJQJaJnH tH h_W:hm >*CJOJQJaJh_W:hm CJaJ&h_W:hm 5CJPJ\aJnHtHh_W:h[5CJ\aJo(h_W:h[5CJ\aJ)h_W:h[5CJPJ\aJnHo(tHtee$d$Ifa$gd}r)bkd/$$IflF]-#8!    44 la1yt}r)%$!d$Ifa$gd}r)Hd$If^H`gd}r)ss'$ d$Ifa$gd}r)Hd$If^H`gd}r)bkd$$IflF]-#8!    44 la1yt}r)ss'$ d$Ifa$gd}r)Hd$If^H`gd}r)bkd$$IflF]-#8!    44 la1yt}r) KPQVWX{|-238﹮﹮Ź﹮ŮŮŹŮŮ﹢h_W:hm CJaJhh_W:hm CJaJh_W:hm CJaJo( h_W:hm #h_W:hm >*CJOJPJ QJaJ h_W:hm CJOJPJ QJaJ h_W:hm CJPJaJnHtH9 {{$d$Ifa$gd}r)d$IfWDd`gd}r)bkda$$IflF]-#8!    44 la1yt}r)KQWtt$d$Ifa$gd}r) & F=d$1$If^=`gdm bkd$$IflF]-#8!    44 la1yt}r)WX|kk$d$&dIfPa$gd}r) & F=d$1$If^=`gdm bkd/$$IflF]-#8!    44 la1yt}r)$d$Ifa$gd}r) d$Ifgd}r)bkd$$IflF]-#8!    44 la1yt}r)$d$Ifa$gd}r) d$Ifgd}r)bkd$$IflF]-#8!    44 la1yt}r)ll$d$&dIfPa$gd}r)d$IfVDWD^`gdm bkdm$$IflF]-#8!    44 la1yt}r)$d$Ifa$gd}r) d$Ifgd}r)bkd$$IflF]-#8!    44 la1yt}r)$d$Ifa$gd}r) d$Ifgd}r)bkdA$$IflF]-#8!    44 la1yt}r)-39$d$Ifa$gd}r) d$Ifgd}r)bkd$$IflF]-#8!    44 la1yt}r)89:[`abcdeghiopvwxy{~ɾɾɾɾ橚wgSgS'h_W:hm >*CJOJQJaJnH tH h_W:hm >*CJOJQJaJh_W:h[5CJ\aJ)h_W:h[5CJPJ\aJnHo(tHh_W:h[5CJ\aJo()h_W:hq5CJPJ\aJnHo(tHh_W:hm CJaJh_W:hm CJaJo( h_W:hm CJPJaJnHtH h_W:hm #h_W:hm CJPJaJhnHtH 9:[acxx$d$&dIfPa$gd}r) d$Ifgd}r)bkd$$IflF]-#8!    44 la1yt}r)cdefg$d$Ifa$gd}r) d$Ifgd}r)bkd$$IflF]-#8!    44 la1yt}r)ghipwxx$d$&dIfPa$gd}r) d$Ifgd}r)bkd$$IflF]-#8!    44 la1yt}r)wxyt`LL%$!d$Ifa$gd}r)Hd$If^H`gd}r)0d^`0gdm d^`gd[dgd}r)bkdS$$IflF]-#8!    44 la1yt}r)yy$d$Ifa$gd}r)Hd$If^H`gd}r)bkd$$IflF]-#8!    44 la1yt}r)ss'$ d$Ifa$gd}r)Hd$If^H`gd}r)bkd!$$IflF]-#8!    44 la1yt}r)$%&)*+1289:;=>NQSZ[\_`;;;ݬݠݠݬݠݠݠݠ݃ݠݠ *h_W:hm CJaJ h_W:hm CJPJaJnHtHh_W:hm CJaJo(#h_W:hm CJPJaJnHo(tHh_W:hm CJaJnH tH h_W:hm CJaJnH o(tH h_W:hm CJaJ h_W:hm h_W:hm CJOJPJ QJaJ/$d$Ifa$gd}r) d$Ifgd}r)bkd$$IflF]-#8!    44 la1yt}r)$d$Ifa$gd}r) d$Ifgd}r)bkd$$IflF]-#8!    44 la1yt}r)%xx$d$&dIfPa$gd}r) d$Ifgd}r)bkdS$$IflF]-#8!    44 la1yt}r)%&'()$d$Ifa$gd}r) d$Ifgd}r)bkd$$IflF]-#8!    44 la1yt}r))*+29$d$Ifa$gd}r) d$Ifgd}r)bkd' $$IflF]-#8!    44 la1yt}r)9:;<=$d$Ifa$gd}r) d$Ifgd}r)bkd $$IflF]-#8!    44 la1yt}r)=>MS[xx$d$&dIfPa$gd}r) d$Ifgd}r)bkd $$IflF]-#8!    44 la1yt}r)[\]^_yy#$d$Ifa$gd}r)Hd$If^H`gd}r)bkde $$IflF]-#8!    44 la1yt}r)_`ahnkk$d$&dIfPa$gd}r)%!Hd$If^H`gd}r)bkd $$IflF]-#8!    44 la1yt}r)`aghmno  %&'ajklvx&GKbBM~ڶڧڙډh_W:hm >*CJOJQJaJh_W:hm hF JCJaJh_W:hm CJaJnH tH h_W:hqCJaJo( h_W:hm h_W:hm CJPJaJnHtHh_W:hm CJaJh_W:hm CJaJo(h_W:hm CJOJQJaJ5nop &'q````$`dVDh^`a$gdm $d^a$gdm $`dVDh^`a$gdB. $da$gdm bkd9 $$IflF]-#8!    44 la1yt}r) |mm$d$Ifa$gd}r)bkd $$IflFp#      44 la1yt}r)%$!d$Ifa$gd}r) d$Ifgd}r) 9;<@qqbqqh_W:hm CJaJnH tH h_W:hm CJaJnH o(tH h_W:hm CJaJo( h_W:hm CJPJaJnHtH h_W:hm CJOJPJ QJaJh_W:hm CJaJ h_W:hm 'h_W:hm >*CJOJQJaJnH tH .h_W:hm >*CJOJPJQJaJnHo(tH$h_W:hm CJOJQJaJnH tH &{{'$ d$Ifa$gd}r) d$Ifgd}r)bkd $$IflFp#      44 la1yt}r)u]$d$&dIfPa$gd}r)$d$&d4$IfPa$gd}r) d$Ifgd}r)dkdq $$IfltFp#      44 la1yt}r)#$d$Ifa$gd}r) d$Ifgd}r)bkd $$IflFp#      44 la1yt}r)#$d$Ifa$gd}r) d$Ifgd}r)bkdC$$IflFp#      44 la1yt}r)9AI#$d$Ifa$gd}r) d$Ifgd}r)bkd$$IflFp#      44 la1yt}r)@ABGHIJloy~  -56;<=DEFjkpuvwɲڤ&h_W:hm hi4CJPJaJnHtHh_W:hm hi4CJaJh_W:hm CJaJnH o(tH h_W:hm h_W:hm CJPJaJnHtHh_W:hm CJaJo(h_W:hm CJaJh_W:hm CJaJnH tH 8IJy#$d$Ifa$gd}r) d$Ifgd}r)bkd$$IflFp#      44 la1yt}r)#$d$Ifa$gd}r) d$Ifgd}r)bkd$$IflFp#      44 la1yt}r) #$d$Ifa$gd}r) d$Ifgd}r)bkd$$IflFp#      44 la1yt}r)  5=E#$d$Ifa$gd}r) d$Ifgd}r)bkdU$$IflFp#      44 la1yt}r)EFnpv#$d$Ifa$gd}r) d$Ifgd}r)bkd$$IflFp#      44 la1yt}r)vwww#$d$Ifa$gd}r)Pd$IfWD^`Pgd}r)bkd)$$IflFp#      44 la1yt}r)#$d$Ifa$gd}r) d$Ifgd}r)bkd$$IflFp#      44 la1yt}r)!"&-:@AFGHIOP  ɰɟŸ|g|ɟŸ՟՟(h_W:hm CJOJPJQJaJnHtHh_W:hm CJOJQJaJ&h_W:hm hCJPJaJnHtH h_W:hm CJPJaJnHtH#h_W:hm CJPJaJnHo(tH h_W:hm h_W:hm CJaJo(h_W:hm CJaJh_W:hm CJaJnH tH h_W:hm CJaJnH o(tH #xx#$d$&dIfPa$gd}r) d$Ifgd}r)bkd$$IflFp#      44 la1yt}r) !#$d$Ifa$gd}r) d$Ifgd}r)bkdg$$IflFp#      44 la1yt}r)!":AGss$d$&dIfPa$gd}r)%!d$Ifgd}r)bkd$$IflFp#      44 la1yt}r)GHIP)}ldTd^`gdNdgds$RdVDb^Ra$gdm $dVDbWD^`a$gdm dgdm bkd;$$IflFp#      44 la1yt}r) )*moptuyz{̽t`tP*CJOJQJaJnH tH h_W:hm >*CJOJQJaJ&h_W:hm 5CJPJ\aJnHtHh_W:hm CJaJ4h_W:hpMSB*CJOJPJQJaJnHo(phtHh_W:hN5CJ\aJ)h_W:hN5CJPJ\aJnHo(tHh_W:hN5CJ\aJo()h_W:hm 5CJPJ\aJnHo(tHh_W:hm 5CJ\aJ h_W:hm h<^5CJ\aJ)*nopuz%$!d$Ifa$gd}r)d$IfWD^`gd}r)dgdm d`gdm #9TPL HD@<+{^z{|ww$d$Ifa$gd}r)d$IfWD^`gd}r)bkd$$IflF$&!    44 la1yt}r)   ? D E J K L \ m n s t y z { ~                        #h_W:hm CJPJaJnHo(tHh_W:hm CJaJnH tH h_W:hm CJPJaJnH tH h_W:hm CJaJnH o(tH h_W:hm CJaJo( h_W:hm h_W:hm CJaJ h_W:hm CJPJaJnHtH8ww#$d$Ifa$gd}r)d$IfWD^`gd}r)bkd$$IflF$&!    44 la1yt}r)uu#$d$Ifa$gd}r)sd$IfVDWD^`sgdm bkd$$IflF$&!    44 la1yt}r) uu#$d$Ifa$gd}r)sd$IfVDWD^`sgdm bkd$$IflF$&!    44 la1yt}r)  ? E K uu#$d$Ifa$gd}r)sd$IfVDWD^`sgdm bkdy$$IflF$&!    44 la1yt}r)K L n t z ll#$d$&dIfPa$gd}r)sd$IfVDWD^`sgdm bkd$$IflF$&!    44 la1yt}r)z { | } ~ uu#$d$Ifa$gd}r)sd$IfVDWD^`sgdm bkdi$$IflF$&!    44 la1yt}r)~     ll#$d$&dIfPa$gd}r)sd$IfVDWD^`sgdm bkd$$IflF$&!    44 la1yt}r)     uu#$d$Ifa$gd}r)sd$IfVDWD^`sgdm bkdY$$IflF$&!    44 la1yt}r)     uu#$d$Ifa$gd}r)sd$IfVDWD^`sgdm bkd$$IflF$&!    44 la1yt}r)     uu#$d$Ifa$gd}r)sd$IfVDWD^`sgdm bkdI$$IflF$&!    44 la1yt}r)        M R S X Y Z [ ] ^ _ p w x z                        . K S T [ \ ]         ʿﭛʿ#h_W:h}r)CJPJaJnHo(tH#h_W:hm CJPJaJnHo(tHh_W:hm CJaJ h_W:hm #h_W:h]CJPJaJnHo(tHh_W:hm CJaJo( h_W:hm CJPJaJnHtH;  M S Y ll#$d$&dIfPa$gd}r)sd$IfVDWD^`sgdm bkd$$IflF$&!    44 la1yt}r)Y Z [ \ ] uu#$d$Ifa$gd}r)sd$IfVDWD^`sgdm bkd9$$IflF$&!    44 la1yt}r)] ^    ll#$d$&dIfPa$gd}r)sd$IfVDWD^`sgdm bkd$$IflF$&!    44 la1yt}r)     uu#$d$Ifa$gd}r)sd$IfVDWD^`sgdm bkd)$$IflF$&!    44 la1yt}r)     ll#$d$&dIfPa$gd}r)sd$IfVDWD^`sgdm bkd$$IflF$&!    44 la1yt}r)     #$d$Ifa$gd}r) d$Ifgd}r)bkd$$IflF$&!    44 la1yt}r)  K T \ uu#$d$Ifa$gd}r)sd$IfVDWD^`sgdm bkd$$IflF$&!    44 la1yt}r)\ ]    ii$sd$IfVDWD^`sa$gdm sd$IfVDWD^`sgdm bkd $$IflF$&!    44 la1yt}r)     ud#$d$4$Ifa$gd}r)#$d$Ifa$gd}r)sd$IfVDWD^`sgdm bkd$$IflF$&!    44 la1yt}r)         & ' * , - 0 1 2 3 6 9 A B C ɾxiTFiFh_W:h 5CJ\aJ)h_W:h 5CJPJ\aJnHo(tHh_W:h 5CJ\aJo()h_W:hom5CJPJ\aJnHo(tH#h_W:hm CJPJaJnHo(tHh_W:hm CJaJnH tH h_W:hm CJaJnH o(tH h_W:hm CJaJ h_W:hm h_W:hm CJPJaJnHtHh_W:hm CJaJo(#h_W:h;dCJPJaJnHo(tH   ' 1 ll#$d$&dIfPa$gd}r)sd$IfVDWD^`sgdm bkd$$IflF$&!    44 la1yt}r)1 2 3 C D E J O |fRR%$!d$Ifa$gd{d$IfWD^{`gddgd]d^`gd d$gd bkdw$$IflF$&!    44 la1yt}r)C D E N O P a b c e f p z              ü竼竼uiS+h_W:hHCJOJ PJ QJ aJnHo(tHh_W:hHCJaJo(h_W:hHCJPJaJo( h_W:hHCJPJaJnHtHh_W:hHCJaJh_W:h]CJaJo( h_W:h]CJOJPJ QJaJ h_W:h]'h_W:h]>*CJOJQJaJnH tH h_W:h]>*CJOJQJaJh_W:h]CJaJh_W:h]5CJ\aJO P Q Y a uu$d$Ifa$gd{d$IfWD^{`gdekd$$IflF$&!    44 la1yta b c d e oo'$ d$Ifa$gd{d$IfWD^{`gdekdf$$IflF$&!    44 la1yte f    oo'$ d$Ifa$gd{d$IfWD^{`gdekd$$IflF$&!    44 la1yt     oo'$ d$Ifa$gd{d$IfWD^{`gdekdZ$$IflF$&!    44 la1yt             Ľ~~sb[sIs=h_W:h]CJaJo(#h_W:h]CJOJ PJ QJ aJo( h_W:h] h_W:h]CJOJPJ QJaJh_W:h]CJaJ#h_W:hHCJOJPJ QJaJh+h_W:hHCJOJPJQJaJnHo(tHh_W:hHCJaJo(h_W:hHCJaJ h_W:hH(h_W:hHCJOJPJ QJaJnH tH +h_W:hHCJOJPJ QJaJnH o(tH h_W:hHCJOJPJ QJaJ    ll'$d$&dIfPa$gd{d$IfWD^{`gdekd$$IflF$&!    44 la1ytmm'$ d$Ifa$gd{d$IfWD^{`gdgkdH$$IflOF$&!    44 la1yt ll$d$&dIfPa$gdPd$IfWD^`Pgdekd$$IflF$&!    44 la1yt4AQ_n|wwfwwTwwwfff#h_W:hICJPJaJnHo(tH h_W:hnCJPJaJnHtHh_W:hnCJaJo(h_W:hnCJaJh_W:h 5CJ\aJ)h_W:h 5CJPJ\aJnHo(tHh_W:h 5CJ\aJo(#h_W:h]CJPJaJnHo(tHh_W:h&CJaJh_W:h]CJaJ h_W:h] h_W:h]CJPJaJnHtH wggXXX$d^a$gdnd^`gd d$gd]$d^a$gd& d^gd]ekd@ $$IflF$&!    44 la1yt \jkt '(ƷsasOHHH h_W:hn#h_W:hn>*CJPJaJnHtH#h_W:hn>*CJPJaJnH tH h_W:hn>*CJaJ)h_W:hn5CJPJ\aJnHo(tHh_W:h 5CJ\aJ)h_W:h 5CJPJ\aJnHo(tHh_W:h 5CJ\aJo(#h_W:h]CJPJaJnHo(tHh_W:hnCJaJo( h_W:hnCJPJaJnHtHh_W:hnCJaJbbkd $$IflFp#      44 la1yt}r)$d$Ifa$gd}r) d$Ifgd}r)dgdndgd $d$^a$gd] #$d$Ifa$gd}r) d$Ifgd}r)bkd!!$$IflFp#      44 la1yt}r) (0#$d$Ifa$gd}r) d$Ifgd}r)bkd!$$IflFp#      44 la1yt}r)(/01Tijrs{|}ᮠkV(h_W:hnCJOJPJQJaJnHtH+h_W:hnCJOJPJQJaJnHo(tH#h_W:hnCJPJaJnHo(tHh_W:hnCJPJaJh_W:hnCJPJaJo($h_W:hnCJOJQJaJnHtHh_W:hnCJOJQJaJ h_W:hnCJPJaJnHtH h_W:hnh_W:hnCJaJh_W:hnCJaJo(01js|pp#$d$&dIfPa$gd}r)d$If^`gd}r)bkd!$$IflFp#      44 la1yt}r)|}~#$d$Ifa$gd}r) d$Ifgd}r)bkdS"$$IflFp#      44 la1yt}r)ss$d$&dIfPa$gd}r)%!d$Ifgd}r)bkd"$$IflFp#      44 la1yt}r)||$d$Ifa$gd}r)%!d$Ifgd}r)bkd'#$$IflFp#      44 la1yt}r)rr$d$Ifa$gd}r)%!d$IfWD^`gd}r)bkd#$$IflFp#      44 la1yt}r)rr$d$Ifa$gd}r)%!d$IfWD^`gd}r)bkd#$$IflFp#      44 la1yt}r)#$*+,emnuvwxz{|48GưƂvggvvgƛvvƂvvh_W:hnCJOJQJaJh_W:hnCJaJo(h_W:hnCJaJh_W:hnCJPJaJo((h_W:hnCJOJPJQJaJnHtH+h_W:hnCJOJPJQJaJnHo(tH h_W:hn h_W:hnCJPJaJnHtH#h_W:hnCJPJaJnHo(tHh_W:hnh-CJPJaJ($+rr$d$Ifa$gd}r)%!d$IfWD^`gd}r)bkde$$$IflFp#      44 la1yt}r)+,envpp#$d$&dIfPa$gd}r)d$If^`gd}r)bkd$$$IflFp#      44 la1yt}r)vwxyz||$d$Ifa$gd}r)%!d$Ifgd}r)bkd9%$$IflFp#      44 la1yt}r)z{|ss$d$&dIfPa$gd}r)%!d$Ifgd}r)bkd%$$IflFp#      44 la1yt}r)||$d$Ifa$gd}r)%!d$Ifgd}r)bkd&$$IflFp#      44 la1yt}r)ss$d$&dIfPa$gd}r)%!d$Ifgd}r)bkdw&$$IflFp#      44 la1yt}r);<#$}}}hQQ$ d7$8$H$^` a$gdn$ldWD^`la$gdn$ d7$8$H$^` a$gdndgdnbkd&$$IflFp#      44 la1yt}r)GIRWz!"#DSz/9;Nku!"%)*˹˹˹˹#h_W:hn>*CJPJaJnH tH h_W:hn>*CJaJ h_W:hCJPJaJnHtHh_W:hCJaJ#h_W:hnCJPJaJnHo(tH h_W:hnCJPJaJnHtHh_W:hnCJaJo(h_W:hnCJPJ aJh_W:hnCJaJ2$%*/019AbkdK'$$IflFp#      44 la1yt}r)$d$Ifa$gd}r) d$Ifgd}r)*./0ABEFV]^efg~òڟòڟò|òa4h_W:hvB*CJOJPJQJaJnHo(phtHh_W:hnCJOJQJaJ'h_W:hnCJOJQJaJnHo(tH$h_W:hnCJOJQJaJnHtH h_W:hnCJPJaJnHtHh_W:hnCJaJo(h_W:hnCJaJ h_W:hn#h_W:hn>*CJPJaJnH tH h_W:hn>*CJaJ&ABCDE#$d$Ifa$gd}r) d$Ifgd}r)bkd'$$IflFp#      44 la1yt}r)EFV^f#$d$Ifa$gd}r) d$Ifgd}r)bkd($$IflFp#      44 la1yt}r)fgrr#$d$Ifa$gd}r)%!d$IfWD^`gd}r)bkdw($$IflFp#      44 la1yt}r)ii#$d$&dIfPa$gd}r)%!d$IfWD^`gd}r)bkd($$IflFp#      44 la1yt}r)#$d$Ifa$gd}r) d$Ifgd}r)bkdK)$$IflFp#      44 la1yt}r)ss$d$&dIfPa$gd}r)%!d$Ifgd}r)bkd)$$IflFp#      44 la1yt}r)XYxiiiYB$d7$8$H$^`a$gd4qd^`gd4q$d^a$gd4q#9TPL HD@<+{^bkd*$$IflFp#      44 la1yt}r)N\_it~@HITsuwyY˹˧˧׏|$h_W:h4qCJOJQJaJnHtH h_W:h4qCJPJaJnHtH h_W:h4q#h_W:h4q>*CJPJaJnH tH #h_W:h4q>*CJPJaJnHtHh_W:h4q>*CJaJh_W:h4qCJaJo(#h_W:h4qCJPJaJnHo(tHh_W:h4qCJaJ,qbkd*$$IflFp#      44 la1yt}r)$d$Ifa$gd}r) d$Ifgd}r)d^`gd4q#$d$Ifa$gd}r) d$Ifgd}r)bkd*$$IflFp#      44 la1yt}r)#$d$Ifa$gd}r) d$Ifgd}r)bkdQ+$$IflFp#      44 la1yt}r) rr#$d$Ifa$gd}r)%!d$IfWD^`gd}r)bkd+$$IflFp#      44 la1yt}r)  +1CFGJKLOPV\]cdeZ]abfghyz}~̰̰̰n#h_W:h4qCJPJaJnHo(tH#h_W:h4q>*CJPJaJnH tH h_W:h4q>*CJaJh_W:hjACJaJ h_W:h4q h_W:h4qCJPJaJnHtHh_W:h4qCJaJh_W:h4qCJaJo($h_W:h4qCJOJQJaJnHtH'h_W:h4qCJOJQJaJnHo(tH+CGKii#$d$&dIfPa$gd}r)%!d$IfWD^`gd}r)bkd,$$IflFp#      44 la1yt}r)KLMNO#$d$Ifa$gd}r) d$Ifgd}r)bkd,$$IflFp#      44 la1yt}r)OPV]dqY$d$&dIfPa$gd}r)#$d$&dIfPa$gd}r)%!d$Ifgd}r)dkd,$$Ifl\Fp#      44 la1yt}r)def[\]}jZFPd$If^`Pgd}r)d^`gd4q$d^`a$gd4q$d7$8$H$^a$gd4q d^gd4qbkda-$$IflFp#      44 la1yt}r)]bghiqyyPd$If^`Pgd}r)bkd-$$IflFp#      44 la1yt}r)$d$Ifa$gd}r)yz{|}yy#$d$Ifa$gd}r)Pd$If^`Pgd}r)bkd/.$$IflFp#      44 la1yt}r)}~yy#$d$Ifa$gd}r)Pd$If^`Pgd}r)bkd.$$IflFp#      44 la1yt}r)  !-34:;<=hrtv   $ ; X       ۾Уh_W:h2|CJaJh_W:h2|>*CJaJ4h_W:h4qB*CJOJPJQJaJnHo(phtH#h_W:h4qCJPJaJnHo(tHh_W:h4qCJaJ h_W:h4q h_W:h4qCJPJaJnHtHh_W:h4qCJaJo(5yy#$d$Ifa$gd}r)Pd$If^`Pgd}r)bkd.$$IflFp#      44 la1yt}r)yy#$d$Ifa$gd}r)Pd$If^`Pgd}r)bkda/$$IflFp#      44 la1yt}r)pp#$d$&dIfPa$gd}r)Pd$If^`Pgd}r)bkd/$$IflFp#      44 la1yt}r)#$d$Ifa$gd}r)bkd50$$IflFp#      44 la1yt}r)-4;pX$d$&dIfPa$gd}r)#$d$&dIfPa$gd}r)Pd$If^`Pgd}r)bkd0$$IflFp#      44 la1yt}r);<=uv   ~~~ZK$d^a$gd2|#9TPL HD@<+{^$d7$8$H$^a$gd4q $da$gd4qbkd 1$$IflFp#      44 la1yt}r)         fbkds1$$IflFp#      44 la1yt}r)$d$Ifa$gd}r)Pd$If^`Pgd}r)$d^`a$gd2|           !!!!!!2!6!7!!c!g!h!i!j!k!z!!!!!!!!!!!!!!!!!!!!""5"9"?"ڽϠڬϠڬϠڬϠϠڽϠϔh_W:h2|CJ\aJo(h_W:h2|CJ\aJh_W:h2|CJaJo( h_W:h2|CJPJaJnHtH#h_W:h2|CJPJaJnHo(tHh_W:h2|CJaJ h_W:h2|h_W:h2|>*CJaJ#h_W:h2|>*CJPJaJnH tH 4     yy#$d$Ifa$gd}r)Pd$If^`Pgd}r)bkd1$$IflFp#      44 la1yt}r)   !!!yy#$d$Ifa$gd}r)Pd$If^`Pgd}r)bkd;2$$IflFp#      44 la1yt}r)!!2!7!=!yy#$d$Ifa$gd}r)Pd$If^`Pgd}r)bkd2$$IflFp#      44 la1yt}r)=!>!c!h!j!yy#$d$Ifa$gd}r)Pd$If^`Pgd}r)bkd 3$$IflFp#      44 la1yt}r)j!k!!!!pp#$d$&dIfPa$gd}r)Pd$If^`Pgd}r)bkds3$$IflFp#      44 la1yt}r)!!!!!yy#$d$Ifa$gd}r)Pd$If^`Pgd}r)bkd3$$IflFp#      44 la1yt}r)!!!!!pp$d$&dIfPa$gd}r)Pd$If^`Pgd}r)bkdG4$$IflFp#      44 la1yt}r)!!!""##vnvJ#9TPL HD@<+{^dgd2|$d7$8$H$^a$gd2|$d7$8$H$^a$gd2|bkd4$$IflFp#      44 la1yt}r)?"C"K"W"_"v"""""""## ##1#t#u#v#w#z#~############۽۽۽۽ɽɽ梓~p\&h_W:h2|5CJPJ\aJnHtHh_W:h5CJ\aJ)h_W:h5CJPJ\aJnHo(tHh_W:h5CJ\aJo(4h_W:h}r)B*CJOJPJQJaJnHo(phtHh_W:h2|CJaJo(#h_W:hCJPJaJnHo(tHh_W:h2|CJaJh_W:h2|CJ\aJh_W:h2|CJ\aJo(!##########ibkd5$$IflFd#      44 la1yt}r)$d$Ifa$gd}r) %d$Ifgd}r)dgd2|d^`gd ####################$$ $&$'$($E$ğ퓈zm[E+h_W:h2|CJOJPJQJaJnHo(tH#h_W:h2|CJPJaJnHo(tHh_W:h2|CJPJaJh_W:h2|CJPJaJo(h_W:h2|CJaJh_W:h2|CJaJo('h_W:h2|CJOJQJaJnHo(tH h_W:h2|CJPJaJnHtH h_W:h2|h_W:h2|>*CJaJnH tH #h_W:h2|>*CJPJaJnHtH$h_W:h2|CJOJQJaJnHtH#####$d$Ifa$gd}r) %d$Ifgd}r)bkd5$$IflFd#      44 la1yt}r)#####||$d$Ifa$gd}r)%!d$Ifgd}r)bkd5$$IflFd#      44 la1yt}r)##$ $'$#$d$Ifa$gd}r) %d$Ifgd}r)bkdY6$$IflFd#      44 la1yt}r)'$($F$N$U$xx#$d$&dIfPa$gd}r) %d$Ifgd}r)bkd6$$IflFd#      44 la1yt}r)E$F$M$N$T$U$V$W$Y$Z$[$b$c$j$k$l$$$$$$$$$$$$$% % %%%$%&%-%ͻ}}}}k[k[}}h_W:h2|>*CJaJnH tH #h_W:h2|>*CJPJaJnHtHh_W:h2|CJaJo(h_W:h2|CJaJh_W:h2|CJOJQJaJ h_W:h2| h_W:h2|CJPJaJnHtH#h_W:h2|CJPJaJnHo(tHh_W:h2|hv%BCJPJaJh_W:h2|CJPJaJo((h_W:h2|CJOJPJQJaJnHtH#U$V$W$X$Y$$d$Ifa$gd}r) %d$Ifgd}r)bkd-7$$IflFd#      44 la1yt}r)Y$Z$[$c$k$xx$d$&dIfPa$gd}r) %d$Ifgd}r)bkd7$$IflFd#      44 la1yt}r)k$l$m$$$$$$uff$d$Ifa$gd}r) d$Ifgd}r) d^gd2|$d^a$gd2|bkd8$$IflFd#      44 la1yt}r)$$$%%$d$Ifa$gd}r) d$Ifgd}r)bkdk8$$IflFd#      44 la1yt}r)% % % % %#$d$Ifa$gd}r) d$Ifgd}r)bkd8$$IflFd#      44 la1yt}r) %%%&%.%#$d$Ifa$gd}r) d$Ifgd}r)bkd99$$IflFd#      44 la1yt}r)-%.%/%a%f%g%h%%%%%%%%%%%%%%%%%%%&&&&&&&&&ݿ谿ݿݿwiwh_W:h?5CJ\aJ)h_W:h?5CJPJ\aJnHo(tHh_W:h?5CJ\aJo()h_W:hvd5CJPJ\aJnHo(tHh_W:h2|CJOJQJaJh_W:h2|CJaJo(#h_W:h2|CJPJaJnHo(tHh_W:h2|CJaJ h_W:h2| h_W:h2|CJPJaJnHtH!.%/%Z%a%g%#$d$Ifa$gd}r) d$Ifgd}r)bkd9$$IflFd#      44 la1yt}r)g%h%%%%#$d$Ifa$gd}r) d$Ifgd}r)bkd:$$IflFd#      44 la1yt}r)%%%%%tt#$d$&dIfPa$gd}r)d$Ifgd}r)bkdq:$$IflFd#      44 la1yt}r)%%%%%#$d$Ifa$gd}r) d$Ifgd}r)bkd:$$IflFd#      44 la1yt}r)%%%%%xx$d$&dIfPa$gd}r) %d$Ifgd}r)bkdE;$$IflFd#      44 la1yt}r)%%%&&&&''q^N0d^`0gdx.$0d^`0a$gdx.d^`gd?dgdvd$d7$8$H$^a$gd2|bkd;$$IflFd#      44 la1yt}r)&&&&&''''''''''''''''''''((̸̪̟|||hV|J|h_W:hx.5CJaJ#h_W:hx.5CJPJaJnHtH&h_W:hx.5CJPJaJnHo(tH h_W:hx.h_W:hx.>*CJaJnH tH h_W:hx.>*CJaJh_W:hx.CJaJh_W:hx.CJ\aJo(&h_W:hx.CJPJ\aJnHo(tHh_W:hx.CJ\aJ#h_W:hx.CJPJaJnHo(tH)h_W:hPf5CJPJ\aJnHo(tH''''''''bkd<$$IflFd#F    44 layt}r)$d$Ifa$gd}r) d$Ifgd}r)'''''#$d$Ifa$gd}r) d$Ifgd}r)bkd}<$$IflFd#F    44 layt}r)'''''#$d$Ifa$gd}r) d$Ifgd}r)bkd<$$IflFd#F    44 layt}r)'''''#$d$Ifa$gd}r) d$Ifgd}r)bkdE=$$IflFd#F    44 layt}r)''("()(/(l]]#$d$Ifa$gd}r)Td$IfVDWD^T`gdx.d$IfVDXWDj^`gdx.bkd=$$IflFd#F    44 layt}r)( ("((()(.(/(0(A(D(E(H(I(J(L(j(k(l(m(r(s(t(w(x(((((((((((((((,)-)B)G)H)I)мМuh_W:hx.CJPJaJh_W:hx.CJPJaJo(h_W:hx.5CJaJh_W:hx.5CJaJo(#h_W:hx.5CJPJaJnHtH&h_W:hx.5CJPJaJnHo(tH h_W:hx. h_W:hx.CJPJaJnHtHh_W:hx.CJaJh_W:hx.CJaJo(+/(0(A(E(I(}}#$d$Ifa$gd}r)d$If^gd}r)bkd>$$IflFd#F    44 layt}r)I(J(k(m(s({{#$d$Ifa$gd}r)d$IfWDO`gd}r)bkdw>$$IflFd#F    44 layt}r)s(t(u(v(w({{#$d$Ifa$gd}r)d$IfWDd`gd}r)bkd>$$IflFd#F    44 layt}r)w(x((((#$d$Ifa$gd}r) d$Ifgd}r)bkdK?$$IflFd#F    44 layt}r)(((((#$d$Ifa$gd}r) d$Ifgd}r)bkd?$$IflFd#F    44 layt}r)(((((uu#$d$Ifa$gd}r)d$IfVDnWD^`gdx.bkd@$$IflFd#F    44 layt}r)((B)H)N)uu#$d$Ifa$gd}r)d$IfVDnWD^`gdx.bkd@$$IflFd#F    44 layt}r)I)J)M)N)O)R)S)g)h)i)k)l)))))))))))))))**** *!*5*6*7*9*:*;*>*?*J*L*M*p*q*t*u*x*y*z**********õ֤ h_W:hx.CJPJaJnHtHh_W:hx.5CJaJo(h_W:hx.5CJaJ h_W:hx.h_W:hx.CJaJh_W:hx.CJaJo(#h_W:hx.CJPJaJnHo(tH:N)O)P)Q)R)#$d$Ifa$gd}r) d$Ifgd}r)bkd@$$IflFd#F    44 layt}r)R)S)i)j)k)#$d$Ifa$gd}r) d$Ifgd}r)bkd]A$$IflFd#F    44 layt}r)k)l))))uu#$d$Ifa$gd}r)d$IfVDWWD^`gdx.bkdA$$IflFd#F    44 layt}r))))))uu#$d$Ifa$gd}r)d$IfVDWWD^`gdx.bkd1B$$IflFd#F    44 layt}r)))** *}}#$d$Ifa$gd}r)d$If^gd}r)bkdB$$IflFd#F    44 layt}r) *!*5*7*:*}}#$d$Ifa$gd}r)d$If^gd}r)bkdC$$IflFd#F    44 layt}r):*;*<*=*>*#$d$Ifa$gd}r) d$Ifgd}r)bkdoC$$IflFd#F    44 layt}r)>*?*J*K*L*#$d$Ifa$gd}r) d$Ifgd}r)bkdC$$IflFd#F    44 layt}r)L*M*q*u*y*uu#$d$Ifa$gd}r)d$IfVDWWD^`gdx.bkdCD$$IflFd#F    44 layt}r)y*z****}}#$d$Ifa$gd}r)d$If^gd}r)bkdD$$IflFd#F    44 layt}r)*****#$d$Ifa$gd}r) d$Ifgd}r)bkdE$$IflFd#F    44 layt}r)*****#$d$Ifa$gd}r) d$Ifgd}r)bkdE$$IflFd#F    44 layt}r)****************+/+0+7+8+?+@+A+I+J+,,-----ָ֧çϛugSg&h_W:h4!CJPJ\aJnHo(tHh_W:hx.CJ\aJo(&h_W:hx.CJPJ\aJnHo(tH#h_W:hx.CJPJ\aJnHtHh_W:hx.CJ\aJ h_W:hx.CJPJaJnHtHh_W:huICJaJh_W:hx.CJaJo( h_W:hx.h_W:hx.CJaJh_W:hx.5CJaJ#h_W:hx.5CJPJaJnHtH *****uu#$d$Ifa$gd}r)d$IfVDWWD^`gdx.bkdE$$IflFd#F    44 layt}r)**0+8+@+ll#$d$&dIfPa$gd}r)d$IfVDWWD^`gdx.bkdUF$$IflFd#F    44 layt}r)@+A+B+I+J+--.~rbSA$d1$VDV^a$gd)$d^a$gdx.$ & Fd1$a$gdx. d^gdx.nd^n`gdx.dWD`gdx.bkdF$$IflFd#F    44 layt}r)-c.d....//20401  Pi<=ABFGHYҾҬҪҬ򖄖ym]m]Vy h_W:hx.h_W:hx.>*CJaJnH tH h_W:hx.>*CJaJh_W:hx.CJaJ"h_W:hx.CJ\aJnH o(tH &h_W:hx.CJPJ\aJnHo(tHU#h_W:hx.CJPJ\aJnHtH&h_W:h0CJPJ\aJnHo(tHh_W:hx.CJ\aJ&h_W:h_.CJPJ\aJnHo(tHh_W:hx.CJ\aJo(!..ؙٙ;<=Bsd$d$Ifa$gd}r) d$Ifgd}r)$d^a$gdx. nd^ngdx.;d^`;gdx.nWd^n`Wgdx.$;d^`;a$gdx.$nWd^n`Wa$gdx.$ & Fd1$a$gdx.$d^a$gd0 not the customers are State-owned Enterprises. Having due regard to the substance of the relationships, the directors of the Company are of the opinion that none of these transactions is a material related party transaction that requires separate disclosure.(b) As at 31 December 2013, the ultimate holding company provides guarantee in respect of bank loans to the Group amounted to RMB169,157,000 (2012: RMB90,000,000). (c) Compensation of key management personnelThe remuneration of directors and other members of key management during the year was as follows:20132012RMB000RMB000Short-term benefits4,2803,298Post-employment benefits2662534,5463,551The remuneration of directors and key executives is determined by the remuneration committee having regard to the performance of individuals and market trends.By Order of the BoardShandong Xinhua Pharmaceutical Company LimitedZhang DaimingChairman28 March 2014, Zibo, PRCAs at the date of this announcement, the board of directors comprises: Executive Directors:Mr. Zhang Daiming (Chairman)Mr. Du DepingMr. Zhao SongguoIndependent Non-executive Directors:Mr. Zhu BaoquanMr. Liu HongweiNon-executive Directors: Mr. Ren FulongMr. Xu Lie Mr. Zhao Bin PAGE PAGE 16BGHIQY d$Ifgd}r)bkd)G$$IflF]'#g    44 layt}r)$d$Ifa$gd}r)YZ[\]#$d$Ifa$gd}r) d$Ifgd}r)bkdG$$IflF]'#g    44 layt}r)YZ]^rwx}~TUVls]s+h_W:hm5B*CJOJQJ\aJph%h_W:hmB*CJOJQJaJph4h_W:hmB*CJOJPJQJaJnHo(phtH&h_W:h0CJPJ\aJnHo(tHh_W:hx.CJ\aJh_W:hx.CJaJnH o(tH h_W:hx.CJPJaJnHtHh_W:hx.CJaJo(h_W:hx.CJaJ h_W:hx.]^rx~#$d$Ifa$gd}r) d$Ifgd}r)bkdG$$IflF]'#g    44 layt}r)~xx#$d$&dIfPa$gd}r) d$Ifgd}r)bkdUH$$IflF]'#g    44 layt}r)#$d$Ifa$gd}r) d$Ifgd}r)bkdH$$IflF]'#g    44 layt}r)w_#$d$&dIfPa$gd}r)#$d$&d4$IfPa$gd}r) d$Ifgd}r)bkd)I$$IflF]'#g    44 layt}r)TUVlvmdB"$0TPL HD@< ^ a$$ ^ a$^gdvd $da$gdx.$d^a$gdx. nd^ngdx.bkdI$$IflF]'#g    44 layt}r)ĮrWB?A=C?@=QNUQNJFBJFXU\Y^[DAZWIF]ZOKHDWSQMMJKHSOD@YUVSLISPFCYV[W^ZROLHOLWTb_`\a^b^`]iftrfc}pn|ymjxupmvtywc`li~{}{wt}{rogdvsda~{xuebnkkgkholtqheqnpnspzw{x~}ƵG'IDATx}|yNg˲$Dz6d[r^ 8&!iP*`Ԙ˒lbh^ZQ@!M#'MI4mt/kvӦMO$nwvgyfgwgt7<3(Z8˱!}t%O_dKU}*meDW܇lL7{]+>IcMC|l4IzO̚*Irìi.! gKz8T*%,佫X ˏ<&K$]vUtɑ,VEzIyH.#Ϛ!tifPIѳf$]Nfx$]F䜳fX$]>.fpHl]Κatg&o#K>k.8ietgƾUFI9|֌4&(D2I$ʴ[K\Co~$]YgȎ*FC$A#eY/c#"OFj+ <#۠1kZǮWM?f5$=Y!R+K.>k*qبPެM`$oY _&I1k̊/ 6/~"G̚J]Y͠E-%B$cJME.s`SϒrĬ9ö"^}2JOfdGʶ*Fwt%YSYw-V21 1y oU2l"lJK=G5ڠ}>i&{1kF%03%)Iy?|Tjzώ|vK{Áw돳L&)sI:i<";ZKܔ{< 5$1FT=twLW|^2? 6{) _%R;I1fI~3Dv F)+I3kFf4b[jNv)I3k* 5lc557{"bcfMsWz_&[lJ@E"̚ K,iM%]r̬IUlr̙p +颐cfM ߽٨Ɇ7t1QQai˿.9fdUll)] @5mB*ëN* tQ~͗26w_pS Iw5km{ޕCL3u B]!G͚,6gt9fִ: qsѪ”%(Y(iD TW#fMA$)/pY AA8z=CfMQ`J/{]MYS:Naq&(D08J;0tCfMQ@ "4\ҝfȶsidz?t;"G͚DtGaJJrܬs"paL IE5yBRlLB ͚.BSl鱊1;K;O9kz~"bsz s[QG#gMe~6iDjcLI!GΚ~ؤS\m%]Κ~$N#)}BܬQ`]j]|sa\Q#y0Y >/ <ʔ>&FzQœt/8EXlFt<ʔ_k=+= 071ox ɕpAqQj] *>~.6Q,tzM (Q_6\#frRLQB]uIRvpzM eۣ|mwJ63;VVX RԣLQ']iѧ3O޵ˍznq(ybE>)ΉFIX88S:U ,U3sdθT`"NBBonaEBORVV+x2j ' s%NR08E=ƓGVhbf#i+zbiӪ8SR"DKnb5rSWMu;6rH[!V#3S0Ow.Bd.A#[̕`XPg #ȂE#/93fZeɌ\S{<03Ol#4 2)J{d<=`[Sԗ ˀ\S%-x,-|@u=݅}55FJ77(\dcs'`}IIFKgnFmNڳw8B?Hz,s-ډ-}ֽ-V,a \954O|\*Kѹ\nW"ZO_^6MSa&y <07t|-s<7{<2*C6m,^YZ=@9Q(iE0b+ANlzQ~O9Q_\jVv^X !*y{F0DiR#ϲӓO5||@c|ȋA^Ɍ=t*"GIgPݙ-M> 9RP86uimڰJsp>/;|(|=i :\2noi@ Wߍ}kj qg@>a19i?K]~되>>7xlgߗ@g sh.~K|~ xs>"¹7U­Ůһ4vvg^i4so8xgkSdpG+'rmS}̈́ð)wh39jkku?ʒa@VfN6:%BwSTjc9u h5#p%k _=ANWvm)eͯlW+RuKw)]zYv})K-_%)kxb[nZ TVdxN~Uwjb;? bPVWȵ!|,<}qP ~9kZgL/g}lIV6z tNyPw\ܵ!1[gtwA[h%#N0y@d z|+C ŕ5G.Yn1<'`MMM7}dy(B#,yKg\7S;w²n r<0w :ҹ0)oux9֖~e⯖gs4[_Sۿ[ rf;G^8}EO{뢂G\Y/XId(Wp=Lh+ve7(so+}Gi'Mp_kk'KD74mфG-1 >cUƱe9 +5?r/:i@~D Gu݅fIZ`UEN 'D%=u\ 3A~ YoaEٷs7Dޠ_E8@-J1|s )rOAO.мE%!185<Ӧi_r`/qc/*!wR?̱+[=aǎ0{̱~}ee];Mf-nz1_W<o5O_cc>YF3>xפ@r.GΏcM]G}EuT)My+78ϻﵱ7Wa=U=_sYjr uK7xCuQ_?Yf n% ؜G-Y`n9 R9؆۳˔F„܀?mG^ {:Fߘ2C7CTk=\@pFk}j&'jv r5qC[:+@ުv߈MarCij BNԓ~P-w9j| 4E"G9 eljUc9!~sS̊PSFF:"YeSC\yHf GL2;6h3c&TiWyf|;tk$o59Yh{w{QȉJN,tΐH#\2*ّ$ʥ ~G0M}"'߇ǽ#FCx#;]vkr"']yVjMN\wn^ZǡWZ#Oo3w,J1G%EBOM_!X#ׯͦۡ"'rLQ5r})mx }M(%r3>QH}/yfN^܌ur"ȹOf5Z.\F|ߩch !~ kn*e#7vReUS8%!G~e`[pCheeAUsn+dz.~#GF3ܟ 9fu<' tW:H<:Kg I;N]:֜op?vԼ,Bkm܍VE8'w c$a_SPTVn58pi.7Ȋ|֜N)meX>wK*)07f^xz)G4w0oVjtP\RQ^so= PկMAwoIң_:û]ul#t0tHq}g:v.;'ѻ\^Vz9WʽRm5ݪ~yv N}Y!Pr&lj&(9f4@k|9!KE\oEqo*<#Z8kcu#QMe"w,:p/ė%"'W+S3'rN"Cr{\]^-P:~pOqL /r[+:@0#ֳ!9bb0,~[;|oB-l$rS't| !G4>ޱ ANg\RSVtDåZ-rTuif=˿1ȭ$K!O8f;`ŽsݦFvzozpWލ+++^=aG>@W2۱ή^=":۷{Eeu}sǂX>h#'Jg 3'U y>K ;rMyUQ v77- ?r*3arCޛ}u7^=n^n7]Vjz~T,PT|' %zo^ IL]" *^e6rg2OCy|l oPVmR rK?1f>B7pvk^77eT$r*gFE/AFj69iF= )N75u cy~iFƧ s|n14#kꑎ,EwA"^(m<x$|Drn=2P Wʻ Sp J<񉲋Jܔ3U=F/5>JtM"@4j|:@ !,rE/*քU5lώU}Mmy=wMu%{nA܇+ߒnzkݼhMBt#`+iyWw T?%EeM}'jӖb76f5`D<$Z $}7uQdk"%Z CrŃ⏤79#㦪5ǥDxOQEWaTnePu}?L(*hc^*R^QbEP/{ |%.#;f?d ?iKz $"l+is=x(J|kc.85`(hJ(l_sY^c%NQHiЕĶXĻCY#+=raDF+CBb~X?ĉx >< ptAwEԜӇjZRI7f. qmZ8CbeA!x%%p/ =K5Q$ݴkG\#^UC6I7rfU;o6n^6 _)ꊝeml 1vi,w.x4̉J.8IoIýlw'kmb JSQ>c釐<7 HһGGZSKG{WD{s{i\^6 <$=ߍq3htcS<W} 4|lMbϛvU*=8N1g,3{6]"Iqԋ[$|V'[g 4rgrH:X^6rWoqH8*n+t0E}hW f%&PQ U籤CE<L%.Iq`JmDCBO> NotesdB*CJaJphO Body textc$>TPL HD@<Td1$7$8$H$^Ta$-B*CJOJQJ_HaJmH nHphsH tHHOH Subhead 1Td^T ;CJaJ~O~ Subhead 2B$'PL HD@<Q^`a$5B*\phDZ@D ~e,g$a$CJOJPJQJaJnHtH<O< write $a$CJPJnHtHpOpChar Char Char Char!d1$CJKHPJaJmHnHtHu.". yblFhe,g"CJaJ6 @26 u#9r G$CJaJ)@A uxP@RP u w%!d1$CJKHOJPJ QJaJtH 0b0 le,g&G$CJaJPOrP Anrede' 1$KHOJPJQJaJtH VOV W[CQ W[CQ(d1$CJKHPJaJmHnHtHudOd Default)1$7$8$H$-B*CJOJQJ_HaJmH nHphsH tH O med1HH  Balloon Text+CJOJQJ^JaJ4O4 cke1,B*OJQJph0`@0 HTML 0W@W-6]Be@B  HTML @P h/$<@&a$5CJ OJPJQJ\^JaJ K@ y|T0([@( 5uP[N~{T1\J@"\ oRh2$d8<@&a$"5CJ KHOJPJQJ\^JaJ -2 [e,g43 ` @ 1$3$5$7$8$G$0CJKHOJPJQJ^J_HaJmH nHsH tH6%@B6 [ON0W@W4G$ OJQJ^J.?@R. ~_g5dVD4^d4/@b4 Rh68WD8^`8<2@r< Rh 27d8VDWD8^d`8<3@< Rh 38d8VDWD8^d`8<4@< Rh 49d8VDXWD8^d`8<5@< Rh 5:d8VD WD8^d`8,1@, RhS ; & F0:@0 RhS 2 < & F0;@0 RhS 3 = & F0<@0 RhS 4 > & F0=@0 RhS 5 ? & F4D@4 Rhc~@xVD^8E@8 Rhc~ 2AHxVD^H8F@"8 Rhc~ 3BxVDX^8G@28 Rhc~ 4CxVD ^8H@B8 Rhc~ 5D4xVD^400@R0 Rhyv&{S E & F46@b4 Rhyv&{S 2 F & F47@r4 Rhyv&{S 3 G & F48@4 Rhyv&{S 4 H & F 49@4 Rhyv&{S 5 I & F $$vU_ 1J00vU_ 2KVD^00vU_ 3LHVD^H00vU_ 4MVDX^00vU_ 5NVD ^00vU_ 6O4VD^400vU_ 7P VD^ 00vU_ 8Q| VDx^| 00vU_ 9R VD@^ $2$ TybleW[SROAR Ss Char Char1$CJKHPJ_HaJmH nHsH tH*j12* Vybl;NU5\2OBa2 Us Char Char5\(^@r( nf(Qz)W,@@, ~{TXdVD4^d,L@, egYdVD ^dX$@X 6eON0W@W(Zd&+D/G$VDx^d OJQJ^J$ $"}_ 1[0 0"}_ 2\VD^0 0"}_ 3]VD^00"}_ 4^XVDX^X00"}_ 5_ VD ^ 00"}_ 6`VD^00"}_ 7aVD^00"}_ 8bxVDx^x00"}_ 9c@VD@^@6!6 "}_hd5OJQJ\^J8"@8 leCJOJPJ QJ^JaJ4#4 VhvU_f8VDWD8`8(+r( >\le,ggG$>T@> e,gWWhxUDVD]^8Y8 ech~gVi-D M I@ Oo`hoj8$d%d&d'd-DM NOPQVDWD ^8` OJQJ^J0,0 _evU_kVD^<.< _evU_hlxOJPJQJ^J(B@( ckee,gmx4M@4 ckeL)ۏnWDd`8C@8 ckee,g)ۏoxVD^8N@8 ckeL)ۏ 2pWD`0@0 cke)ۏqWD`2P@"2 ckee,g 2 rdx4Q@24 ckee,g 3sxCJaJBR@BB ckee,g)ۏ 2tdxVD^DS@RD ckee,g)ۏ 3uxVD^CJaJ*O@* lʑhv$a$6Oq6 short_text1CJaJ8O8 medium_text1CJaJ4O4 long_text1CJaJvOv T Report Text-z$d1$5$7$8$9DH$^a$KHPJ aJmH sH tH JOJ T body text{xx1$CJKHaJtH VOV TRQk=|d1$WD`CJKHOJPJ QJaJtH O z hps`` sQ*B* ph@fOf 4jp Char Char1 Chard1$CJKHOJPJQJaJtH &O!& e_4hps atnJO1J %IA^ Char Char3OJPJ QJ_HmH sH tH ROAR #IA^ Char Char4$CJKHPJ_HaJmH nHsH tH"W@Q" 3Pp5\VObV JvnUk=d1$VD^CJKHOJPJ QJaJtH JOqJ -s Char Char2OJPJ QJ_HmH sH tH NON i Char Char6 CJKHPJ_HmH nHsH tHO nordinary-output target-outputdd1$[$\$KHOJPJQJ^JnHtH4O4 nhigh-light-bg4FOF SAHPa2dB*OJPJQJnHphtHH)H)OPI)009P00qrtuv"CD !,19:BLV`asz JRY`abcdefg'(BKT]^     ! I N R S j {    $ 2 3 l z    H V d k y z   1 6 G H Z k | '68GHIJijotx}ELSUZ[05:AFGL_dhz %&@FLW]^_` &;<R`n *5DSTqghyzklz{#$de  H"I""#$#:#;#$$$%%%g&h&''((,)-) * ***\+]+++p,q,//0011113334T5U566f6g6(7)7o8p888@9A9: :;;'<(<>>@@%@&@BBCCCCDDRFSFHHHHhJiJKK`KaKLLMMyOzOOOtPuP2Q3QARBRRRTTTTTT VVFWGWYYZZZZZZ[[B\C\\\V]W]n]o]]]]]]]^ ^ ^4^5^6^7^n^t^{^|^^^^^^^^^_!_'_(_H_I_O_P_________________````#`*`1`2`Q`W`]`^`d`k`r`s````````````````` a aaaHaPaXaYaaaaaaaaaaaaabbxcycccddeeee4g5ggggghhhhii4j5jPjQjjjjjll*m+mBmCmnn5o6ooooooooooooooop p1p2pOp`pqpppppppppp qq.q?qPqQqmq{qqqqqqqqqqqrr)r8rGrVrWrrrrrrrrrrrrrr-s/s1s3s5s6sSs`sns{sssssss tt!t1tAtQt_t`t|tttttttttt u uCuPu]ujuwuxuuuuuuuuuvvvv6vDvRv`vnvovvvvvvvvvv www$w%w&w'w(w)wGwLwQwVw[w\w|wwwwwwwwwwww xx%x3xAxBxxxxxxxx yyyyyyy0y1yyyzzGzHzIzOzTzYzZz[z\zdzlzmznzozpzqzrzzz{zzzzzzzzzzzzzzzzzzzzzzzz { {{{{*{+{4{={>{`{a{k{u{v{{{{{{{{{{{{{{{{{{{{{ |||||/|1|:|B|C|D|E|F|G|H|\|^|e|l|m|n|o|p|q|r||||||||||||||||||||||||||}}}}}+}-}6}?}@}A}B}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}~ ~ ~ ~ ~J~K~L~M~N~~~~~~~~~~~789?GHIJKLM "#*12LMTZ[\]^_`abipqrǀȀɀʀˀ̀̀΀ '(23=>WX`aijŁƁ́΁%&./CDKLST]^deklɂʂقڂۂ܂݂ނ#$&'CEMNVWÃăԃՃۃ܃ $%-.6789:;<=>?IJTUijklmn <=?@GHTU[\`amnvwɅʅ˅̅ͅ΅υЅ ()*+,:;CKLUV`jkÆĆΆ؆ن *+,-./0HIJKLeflstŇƇևׇ߇cd}~VW[\q0!45>hir׍@Aabrs()PQ`a{|'(=lmӣԣݣ!Ude¤MNd PQܮݮ/0RS !23z{<qr&'lm{|tu'()*+H}~;<!"#)*+3;CKS[\]^_`abcdlmnopqrs "-789:;<=>?@OV\bijqrstuvwxyz "#$%&'./012345678\]^_tuv(2:BJLVWkqy )*123456789:MNOPQRYZopqrst}~/0'()*+,-./>HPX`jk&'()*456789:;<UVWXYcdefz{| #+3;EFdefghpqrstuvwx01234>?@lmn .JKQRS[cks{|}~'.4;CD<AEMRZ[hi+,9Oklrst|ZagikrsMNOder !)*z<@CILRS$*+,\]^st*048<BC ()*CD456;@ABJRSTUVW[eopw &'()V]de*2:;<=>?@GNOy#$%&3:@Aekqrstuvw~TUrsPR LSYZ JPVW 5;=>]cijklmnZ[uv DJPQ#$\cjkDJPQRSTU+3;<is}~FHOPQRSTU[bcd01YZ  -./49:;CKLMNOPlt|}.5<=jpwxopqv{|}         ' / 0 1 3 4           &'TX^_cd 5;=>[_efghijy&'(-234<DEFGHIV\bc~   !"19ABelst678=BCDLTUVWXYirz{ %&'-./0789:enu{|8?FG3:AB^elm9?AB|!!+%,%%%%&b&c&d&i&n&o&p&x&&&&&&&&&&&&&&&&&&&&&&&&{'|'}''''''''<(=(R(o(}(((((((((( )))))))!)")$)%)')()1)2)3)?)@)A)B)C)D)E)F)I)000000000000000000000 0 00 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 v0 0 0 0 0 00000000 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000 00 00 00 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 00 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000 00 00 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000 000 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 00000 00 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000 00 00 0 0 0 0 0 v 0 0 0 v 0 0 0  0 0 0  0 0 0  0 0 0 0 0 0 0  0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0  0 0 0 0 0 0 0 0 0 0 0 000000000000000000)000000000000000000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 00000000000 %0 %0 %0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 #0 #0 0 00000 0 %0 %0 0 0 0 %0 %0 0  0 %0 %0 0  0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0  0 %0 %0 0  00 %0 %0 0 0 0 %0 %0 0  0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 %0 0  0 %0 %0 0  0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 00000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 '00 0 0 0 0 0 0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0  0 0 0 0 %0 0 0 0 0 %0 0 0 0 0 0 0 0 0 0 '0'000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000000000000000000000000000000 0 0 0 0 0 0 0 0 0 0 0 00 00 0 00 0 0 0 0 0 0 0 0 0 00 0 0 00 0 0 0 0 0000000000000000000000000000000000000000000  000000 0 0 00000000000000  0   0   0   0   0   0   0 000 00 000 00 0 000 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 000 00 0 000 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000 0 00 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000 0 00 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 0|0 0 00 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 0 00 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 0 00 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  %0 0  %0 %0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000000000 %0 %0 0 0 0 0 0 0 '0 '0 0 0 '0 '0 0  0 0 0  0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000 %0 %0 0 0 0 0 0 0 '0 '0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 #0 #0 0 %0 0 0 0 000 %0 %0 0 0 0 0 0 0 '0 '0 0 0 0 0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0  #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 %0 0 0 0 000000 %0 %0 0  0 0 0  #0 #0 0  #0 #0 0  #0 #0 0  #0 #0 0  #0 #0 0  #0 #0 0  #0 #0 0  #0 #0 0  #0 #0 0  #0 #0 0  #0 #0 0  #0 #0 0  #0 #0 0  #0 #0 0  #0 #0 0 0 #0 #0 0  #0 #0 0    0  #0 #0 0  #0 #0 0 000 %0 %0 0  0 0 0  '0 '0 0  '0 '0 0  '0 '0 0  '0 '0 0  '0 '0 0  0 0 0 000000000000 0 0 0 0 0 0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 %0 0 0 0 %0 0 0 0 % 0 0 0 % 0 0 0 % 0 0 0 0 #0 #0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 0000000 0 0 0 0 0 0 0 0 #0 #0 0 0 #0 #0 0 % #0 #0 0 % #0 #0 0 0 #0 #0 0 %0 0 0 0 00000000 0 0 0 0 0 0 0 0 #0 #0 0 0 #0 #0 0 % #0 #0 0 % #0 #0 0 0 #0 #0 0 %0 #0 0 0 000000 0 0 0 0 0 0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 #0 #0 #0 0 0 #0 0 0 00000000 0 0 0 0 0 0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 0 0 0 0000000%0 0 0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 %0 #0 #0 0 %0 #0 #0 0 %0 0 0 0 %0 0 0 0 0000 0 0 0 0 0 0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 %0 0 0 0 00000000 0 0 0 0 0 0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0  #0 #0 0 0 #0 #0 0  #0 #0 0  #0 #0 0 0 #0 #0 0 0 #0 #0 0  #0 #0 0  #0 #0 0 0 #0 #0 0 0 #0 #0 0  #0 #0 0  #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0  #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0  #0 #0 0  #0 #0 0 00 000 000000000 0 0 0 0 0 0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 00000000000)0)000000 0)000 0 )00)0)0 0 0 0@0ȑ00<@0ȑ00<@0ȑ00<@0ȑ00<@#0@#0@0@#0@#0@0ȑ00<0000ȑ0qrtuv"CD !,19:BLV`asz JRY`abcdefg'(BKT]^     ! I N R S j {    $ 2 3 l z    H V d k y z   1 6 G H Z k | '68GHIJijotx}ELSUZ[05:AFGL_dhz %&@FLW]^_` &;<R STqghyzklz{#$de  $#:#;#$$$%%%g&h&'((,)-) **\+]+++p,q,//00@%@ ^ ^6^7^t^{^|^^^^^^^!_'_(_I_O_P_________________````#`*`1`2`Q`W`]`^`d`k`r`s````````````````` a aaaHaPaXaYaaaaaaaaaaaaaiooooop p1p2p`pqpppppppppq.q?qPqQq{qqqqqqqqqq)r8rGrVrWrrrrrrrrrrr/s1s3s5s6s`sns{ssssss tt1tAtQt_t`ttttttttt u uPu]ujuwuxuuuuuuuvvvvDvRv`vnvovvvvvvvv www%w&w'w(w)wLwQwVw[w\wwwwwwwwwwwx%x3xAxBxxxxxx yyyyyYzZzlzmzqzrzzzzzzzzzzz{{={>{u{v{{{{{{{{{||B|C|G|H|l|m|q|r|||||||||||}}+}-}6}?}@}}}}}}}}}}}}} ~ ~M~N~~~~~GHLM 12Z[_`abipqǀȀ̀΀ =>ij́΁./STklɂʂ݂ނ&'VWÃă 67<=TUmnGH`aɅʅυЅ +,KL`jk؆ن*+/0KLstŇƇ45hi@AlmӣԣdeMN'(*+}~)*[\cdrs78?@qryz./67VW129:YZ}~'(./jk45;<cd EFpqwx234>?QR{|CDZ[rsrs)*RS*+BC()45@ARSVWop()de:;>?NO%&@AqruvYZVW =>ijmnPQ#$jkPQTU;<is}~FHOPQRSTbc9:KLOP|}<=wx{|     ' / 0   &'^_=>efij23DEHIbc  !"ABstBCTUXYz{%&/09:{|FGABlmABn&o&&&&&&&&&&&&&(())I)00000000000000000000000000000@0K00@0K00@0@0K00@0K00@0 @0K00@0K00@0 @0K00 @0K00@0l @0 K0 0 @0 K00@0 @v0 K0 0@0 K0 0@0 000000000 00 00 00 0 @0 K00@0 K009@0 @0 K00@0 K009@0 @0 K00@0 K009@0 @0 K00@0 K009@0 0 00000000000000 @0 @0 @0 @0 @0 @0@0K01a@0@0@0@0 @0K01\ @0@0@0@0 @0 @0 K01Q @0@0@0 @0 @0 K01K @0 @0@0 @0@0@0@0@0@0 @0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0 @0@0@0@0 K007@0 @0@0@0@0K007@0 00000 00 00 0 00 0 @0 @0 00 @0 K00:@0 @0 @0 K01 @0K00:@0@0@0@0@0K00:@0@0 @0 @0 @0K00:@0@0@0@0@0K00:@0 @0@0@0@0@0@0 @0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0 @0 @0 @0 @0 @0 @0 00000 00000  0 00000 @0 K00@0 @0 K00@0 @0 @0 @0 K0 0 @0 @0 K0 0@0 @0 K0O2{PK0O2z K0O2y K00@0 0000000000000000000000000000000000ʑ0E1iFx@000000000ʑ0P1`Q00000K016K00 K00H13K00K000\1N]BK00K0000G%@0K0 000F%@0K0 0'0 0E%@0K00'0 0D%@0K00K0000B%@0K00K00@0@0K00K00@0@0K00K00@2 @2 K00 @0 @0 @0 K0 0 K00@ @ K0 0K00@0@0K00K00@0@0K00@0 @0 @0 K00K0"0  K00K0$0@0! @0! K00K0&0@0@0K00@0 @0 @0 K00K0*0@0 @0 K00K0,0@Ẍ́ @Ẍ́ K00K0.0K0%0:K0%0:K0 0!K000K040 aqab#bd @0K01h<K00 K0%0:&l5K00@0 @0 @0@0K00@0 @0 @0@0+@0 @0 @0 @0@0@0(( @0 @0 @0@0@0 D @0 @0 @0@0@0 @0 @0 @0@06b2"!!$ @0 @0 @0@0@0 @0 @0 @0@0@0 @0 @0 @0@0E6!x @0 @0 @0@0@0 @0 @0 @0@0A1ZZ| @0 @0 @0@0bBb2 @0 @0 @0@0@0$ @0 @0 @0@00`99< @0 @0 @0@0@ @0 @0 @0@0@+tDDD @0@0@0@0ز۲hp @0@0@0@0 @0@0@0@0B2 @0@0@0@0@80`@> @0@0@0@0@ @0@0@0@00 @0@0@0@0 @0@0@0@0@0  @0@0@0@0@0 c @0@0@0@0@= @0@0@0@0@0 @0 @0@0@0@`0 ʑ062=7dZK00ʑ082=9ZK00ʑ0:2=;ZK00ʑ0<2== [K00ʑ0>2=?D[K00ʑ0@2=A|[K00ʑ0B2=C[K00ʑ0D2=E[K00ʑ0F2=G$\K00ʑ0H2=I\\K00ʑ0J2=K\K00ʑ0L2=M\K00ʑ0N2=O]K00ʑ0P2=Q<]K00ʑ0R2=St]K00ʑ0T2=U]K00ʑ0V2=W]K00ʑ0X2=Y^K00ʑ0Z2=[T^K00ʑ0\2=]^K00ʑ0^2=_^K00ʑ0`2=a^K00ʑ0b2=c4_K00ʑ0d2=el_K00ʑ0f2=g_K00ʑ0h2=i_K00ʑ0j2Ak`ʑ0j2@ʑ0j2?ʑ0j2=K00‘0o2p`K00L ‘0q2r`K00L ‘0s2taK00L ‘0u2vHaK00L ‘0w2xaK00L ‘0y2zaK00L ‘0{2|aK00L ‘0}2~(bK00L ‘02`bK00L ‘02bK00L ‘02bK00L ‘02cK00L ‘02@cK00L ‘02xcK00L ‘02cK00L ‘02cK00L ‘02 dK00L ‘02XdK00L ‘02dK00L ‘02dK00L ‘02e‘02‘02‘02K00 ʑ02eJ$x! ʑ02eJ$x! ʑ02eJ$x! ʑ024fJ$x! ʑ02lfJ$x! ʑ02fJ$x! ʑ02fJ$x! ʑ02gJ$x! ʑ02LgJ$x! ʑ02gJ$x! ʑ02gJ$x! ʑ02gJ$x! ʑ02,hJ$x! ʑ02dhJ$x! ʑ02hJ$x! ʑ02hJ$x! ʑ02 iJ$x! ʑ02DiJ$x! ʑ02|iJ$x! ʑ02iJ$x! ʑ02iJ$x! ʑ02$jJ$x! ʑ02\jJ$x! ʑ02jJ$x! ʑ02jJ$x! ʑ02kJ$x! ʑ02(wK00ʑ0?3W@`wK00ʑ0A3WBwK00ʑ0C3WDwK00ʑ0E3WFxK00ʑ0G3jH@xK00 ʑ0I3jJxxK00 ʑ0K3jLxK00 ʑ0M3jNxK00 ʑ0O3jP yK00 ʑ0Q3jRXyK00 ʑ0S3jTyK00 ʑ0U3jVyK00 ʑ0W3jXzK00 ʑ0Y3jZ8zK00 ʑ0[3j\pzK00  @ 00K00  @ 00 ʑ0a36ʑ0a34K00 00 K00 ʑ0a3jb{K00 ʑ0c3jdP{K00 ʑ0e3jf{K00 ʑ0g3jh{K00 ʑ0i3jj{K00 ʑ0k3jl0|K00 0m3jnh|K00 ʑ0o3jp|K00 ʑ0q3jr|K00 ʑ0s3jt}K00 ʑ0u3jvH}K00 ʑ0w3jx}K00 ʑ0y3jz}K00 ʑ0{3j|}K00 ʑ0}3j~(~K00 ʑ03j`~K00 ʑ03j~K00 ʑ03j~K00 ʑ03jK00 ʑ03j@K00 ʑ03jxK00 ʑ03jK00 ʑ03jK00 ʑ03j K00 ʑ03jXK00 ʑ03jK00 ʑ03jȀK00 ʑ03jK00 ʑ03n8ʑ03mʑ03lʑ03jK00 ʑ03jāK00 ʑ03jK00 ʑ03j4K00 ʑ03jlK00 ʑ03jK00 ʑ03j܂K00 ʑ03jK00 ʑ03jLK00 ʑ03jK00 ʑ03jK00 ʑ03jK00 ʑ03j,K00 ʑ03jdK00 ʑ03jK00 ʑ03jԄK00 ʑ03j K00 ʑ03jDK00 ʑ03j|K00 ʑ03jK00 ʑ03j셛K00 ʑ03j$K00 ʑ03j\K00 ʑ03jK00 ʑ03n̆ʑ03mʑ03lʑ03jK00 ʑ03jXK00 ʑ03jK00 ʑ03jȇK00 ʑ03jK00 ʑ03j8K00 ʑ03jpK00 ʑ03jK00 ʑ03jK00 ʑ03jK00 ʑ03jPK00 ʑ03jK00 ʑ03jK00 ʑ03jK00 ʑ03j0K00 ʑ03jhK00 ʑ03jK00 ʑ03j؊K00 ʑ03jK00 ʑ03jHK00 ʑ03jK00 ʑ03jK00 ʑ03jK00 ʑ03j(K00 ʑ03j`K00 ʑ04jK00 ʑ04jЌK00 ʑ04jK00 ʑ04j@K00 ʑ0 4j xK00 ʑ0 4j K00 ʑ04j荛K00 ʑ04j K00 ʑ04jXK00 ʑ04jK00 ʑ04jȎK00 ʑ04jK00 ʑ04j8K00 ʑ04jpK00 ʑ04jK00 ʑ04j K00 0!4j"K00 0#4jK00 B:2::: 0%4jK00 ʑ0'4j(K00 ʑ0)4j*K00 ʑ0+4j,0K00 ʑ0-4J.hK00ʑ0/4J0K00ʑ014J2ؑK00ʑ034J4K00ʑ054J6HK00ʑ074J8K00ʑ094J:K00ʑ0;4J<K00ʑ0=4J>(K00ʑ0?4J@`K00ʑ0A4JBK00ʑ0C4JDГK00ʑ0E4JFK00ʑ0G4JH@K00ʑ0I4JJxK00ʑ0K4Mʑ0K4Lʑ0K4JK00ʑ0O4 P K00 ʑ0Q4 RXK00 ʑ0S4 TK00 ʑ0U4 VȕK00 ʑ0W4 XK00 ʑ0Y4 Z8K00 ʑ0[4 \pK00 ʑ0]4 ^K00 ʑ0_4 `K00 ʑ0a4 bK00 ʑ0c4 dPK00 ʑ0e4 fK00 ʑ0g4 hK00 ʑ0i4 jK00 ʑ0k4 l0K00 ʑ0m4 nhK00 ʑ0o4 pK00 ʑ0q4 rؘK00 ʑ0s4 tK00 ʑ0u4 vHK00 ʑ0w4 xK00 ʑ0y4 zK00 ʑ0{4 |K00 ʑ0}4 ~(K00 ʑ04 `K00 ʑ04 K00 ʑ04 КK00 ʑ04 K00 ʑ04 @K00 ʑ04xK00ʑ04K00ʑ04蛛K00ʑ04 K00ʑ04XK00ʑ04K00ʑ04ȜK00ʑ04K00ʑ048K00ʑ04pK00ʑ04K00ʑ04K00ʑ04K00ʑ04PK00ʑ04K00ʑ04K00ʑ04K00ʑ040K00ʑ04hK00ʑ04K00ʑ04؟K00ʑ04ʑ04ʑ04K00ʑ0400 ʑ0400 ʑ04 00 00|00 @ 08 00g00 00 @ 08 00 00 00 0 00 00 00 A 0LA ʑ04K00ʑ04pK00ʑ04pСK00ʑ04pK00ʑ04p@K00ʑ04pxK00ʑ04pK00ʑ04p袛K00ʑ04p K00ʑ04pXK00ʑ04pK00ʑ04pȣK00ʑ04pK00ʑ04p8K00ʑ04ppK00ʑ04pK00ʑ04pछK00ʑ04pK00ʑ04pPK00ʑ04pK00ʑ04pK00ʑ04pK00ʑ04p0K00ʑ04phK00ʑ04sʑ04rʑ04pK00ʑ04pK00ʑ04pHK00ʑ04pK00ʑ04pK00ʑ04pK00ʑ04p(K00ʑ04p`K00ʑ05pK00ʑ05pШK00ʑ05pK00ʑ05p@K00ʑ0 5p xK00ʑ0 5p K00ʑ05p詛K00ʑ05p K00ʑ05pXK00ʑ05pK00ʑ05pȪK00ʑ05pK00ʑ05p8K00ʑ05ppK00ʑ05pK00ʑ05p ૛K00ʑ0!5p"K00ʑ0#5p$PK00ʑ0%5p&K00ʑ0'5L(K00 ʑ0)5L*K00 ʑ0+5L,0K00 ʑ0-5L.hK00 ʑ0/5L0K00 ʑ015L2حK00 ʑ035L4K00 ʑ055L6HK00 ʑ075L8K00 ʑ095L:K00 ʑ0;5L<K00 ʑ0=5L>(K00 ʑ0?5L@`K00 ʑ0A5LBK00 ʑ0C5LDЯK00 ʑ0E5LFK00 ʑ0G5LH@K00 ʑ0I5Jx@0ʑ0K5L@0ʑ0M5N谛@0ʑ0O5P @0ʑ0Q5RX@0ʑ0S5T@0ʑ0U5Vȱ@0ʑ0W5X@0ʑ0Y5Z8@0ʑ0[5\p@0ʑ0]5^@0ʑ0_5`ಛ@0ʑ0a5b@0ʑ0c5dP@0ʑ0e5f@0ʑ0g5h@0ʑ0i5j@0ʑ0k5l0@0ʑ0m5nh@0ʑ0o5p@0ʑ0q5rش@0ʑ0s5t@0ʑ0u5vH@0ʑ0w5x@0ʑ0y5z@0ʑ0{5|@0ʑ0}5~(@0ʑ05`@0ʑ05@0ʑ05ж@0ʑ05@0ʑ05@@0ʑ05x@0ʑ05@0K05,@0 K05d@0 0 %%%(V ([?&5s!"#$N&1'()Z*z+v/>012356789<LXZ] ddgZh`i jjjllmno@rsuPwxyzV{)}L}c}}j_tnTrgɤ!ʳ I\lUMX&Uj8`@   C  (G* ?"#E$-%&(I)*-Y`!"#%&')*+,-/03EVYZ[bjtz #-4?IUaos"(058CMPUY[_fnpx}AlNz32t&?=lp5D_ "q+l7BN\~gjj/kwkkklPlilllllm&m9mammmmnnnosxH}}}~`~~K ^=?jTу"x؄݄:b_ц%CkpΈ)Wzω %Nt@chmPPU֍$Ugj|ێ HZqЏO_aeg}ϐڐ 5Ciwؑ!;ObpȒ!359;QSWk}ÓߓDIޔ'\yЕ1Z=ܠee_Uȳ/b[{1L&'fg%&-.MNqr HJPQ#1@Noz|T=IKPesuz $&+@NPUj/16^BR5^y(Rq&Z_a.QB^dnpVo~ #;TlpW9cgw%)9=[_nI Ev!G)z K z ~     Y ]     \   1 O a e   0|+vz$AEfKOd]y};   !=!j!!!!####'$U$Y$k$$% %.%g%%%%%'''''/(I(s(w((((N)R)k))) *:*>*L*y*****@+.BY]~!     !$(.12456789:;<=>?@ABCDFGHIJKLMNOPQRSTUWX\]^_`acdefghiklmnopqrsuvwxy{|}~    !"$%&'()*+,./012356789:;<=>@ABCDEFGHJKLMNOPQRSTVWXYZ[\]^_`bcdefghijklmnpqrtuvwxyz{|}~     !#$%&')*+,-./1234679:;<=>?@ABDEFGHIJKLNOQRSTVWXZ\]^`abcdeghijklmoqrstuvwyz{|~  !(!!t  ,b$l?xK-}*;@ (  t  c 6A!SHANDON"?B S  ?H0(  rH)]t OLE_LINK6 OLE_LINK13 OLE_LINK14 OLE_LINK100 OLE_LINK101_Hlk252804176 OLE_LINK30_Hlk252956248z'I)~p3I)Fm CI)PI)<*urn:schemas-microsoft-com:office:smarttagschmetcnv l1 01 307312830aFalseHasSpaceNegative NumberType SourceValueTCSCTrueUnitName   vISLN&&&&,,11l4v444 5555<<<<-=6=AAIIJJ)A)B)F)I)))))))!)")$)%)')()0)3)>)A)B)F)I)v rsJg^! I 3 l H E[0^_`Tq''@%@ZZ] ^n^|^^^^^_(_I_P____`#`2`Q````` aHaYaabjjooos-sss uCuqvv$w)wDxxxxyy1yIzzz{zzz { {*{+{{{r||}+}A}} ~~~~~9M qrɀ΀'(WXjCD]^lW$% =mnЅ:;Ćeftևׇd~\q>i(=mWe¤Nd3^6+H8_@D<[ZO*z<S,^CD)Ve*Oy)AeLZJW 5>]n Q$\kDU+<i~FPUd -/}=jxq 0  'T_5(Be8{':e8G3B| !d&&''(((((())))))!)")$)%)')()A)B)I)))))))!)")$)%)')()A)B)I)|0b?}8.>~ڟL=R<4-I:H VGw=<  VD WD8^`. TTVDXWD8^T`. VDWD8^`.   VDWD8^ `. VD WD8^`OJQJo(l TTVDXWD8^T`OJQJo(l VDWD8^`OJQJo(l   VDWD8^ `OJQJo(lhhWD8^h`. hhWD8^h`OJQJo(l0^`0PJo(. D\D^D`\hH)  \ ^ `\hH.  \ ^ `\hH. 0\0^0`\hH) \^`\hH. x\x^x`\hH. \^`\hH) \^`\hH.H^H`o(() ^` 0 ^` .`  ^` ` .@  ^@ ` 0  ^ ` . ^` . ^` 0 ^` . ^` OJPJQJo($   ^` OJQJo(n p ^p` OJQJo(u P  ^P ` OJQJo(l 0  ^0 ` OJQJo(n  ^` OJQJo(u  ^` OJQJo(l  ^` OJQJo(n  ^` OJQJo(u   ^ ` CJOJQJo(hHl ^` OJQJo(hHne e^e` OJQJo(hHuE  E ^E ` OJQJo(hHl%  % ^% ` OJQJo(hHn ^` OJQJo(hHu ^` OJQJo(hHl ^` OJQJo(hHn ^` OJQJo(hHu,^`OJPJQJ^Jo(-j\^j`\OJQJo(hHn\^`\OJQJo(hHu\^`\OJQJo(hHlV\^V`\OJQJo(hHn \^ `\OJQJo(hHu \^ `\OJQJo(hHlB\^B`\OJQJo(hHn\^`\OJQJo(hHu  ^` OJQJo(  ^` OJQJo(n  ^` OJQJo(u b  ^b ` OJQJo(l B  ^B ` OJQJo(n " ^"` OJQJo(u  ^` OJQJo(l  ^` OJQJo(n  ^` OJQJo(u$0$^$`0PJo(() \^`\hH) @\@^@`\hH. \^`\hH.  \ ^ `\hH) , \, ^, `\hH.  \ ^ `\hH. t\t^t`\hH) \^`\hH. @ ^@` OJQJo(  ^ ` OJQJo(hHn  ^ ` OJQJo(hHu  ^ ` OJQJo(hHl  ^ ` OJQJo(hHn ^` OJQJo(hHu ^` OJQJo(hHl` ^`` OJQJo(hHn@ ^@` OJQJo(hHu ^` OJPJQJo(hH$  ^` OJQJo(hHnp p^p` OJQJo(hHuP  P ^P ` OJQJo(hHl0  0 ^0 ` OJQJo(hHn ^` OJQJo(hHu ^` OJQJo(hHl ^` OJQJo(hHn ^` OJQJo(hHu^`o(. r  r ^r ` hH0 R  R ^R ` hH. 2 2^2` hH.  ^` hH0  ^` hH.  ^` hH.  ^` hH0  ^` hH.@ ^@` OJQJo(hHl  ^ ` OJQJo(hHn  ^ ` OJQJo(hHu  ^ ` OJQJo(hHl  ^ ` OJQJo(hHn ^` OJQJo(hHu ^` OJQJo(hHl` ^`` OJQJo(hHn@ ^@` OJQJo(hHuD^D`OJPJQJ^Jo(-$\^$`\OJQJo(hHn\^`\OJQJo(hHul\^l`\OJQJo(hHl \^ `\OJQJo(hHn \^ `\OJQJo(hHuX \^X `\OJQJo(hHl\^`\OJQJo(hHn\^`\OJQJo(hHudd^d`PJo(. D\D^D`\hH)  \ ^ `\hH.  \ ^ `\hH. 0\0^0`\hH) \^`\hH. x\x^x`\hH. \^`\hH) \^`\hH. ^` OJPJQJo($   ^` OJQJo(n p ^p` OJQJo(u P  ^P ` OJQJo(l 0  ^0 ` OJQJo(n  ^` OJQJo(u  ^` OJQJo(l  ^` OJQJo(n  ^` OJQJo(u~}| G`wxWnjeT        l'                :ؘ        ΋        h2                h2                                  2s        HT        Ԙx        h62        ]dM        4l*e-=B9=-DbP//%piB~L/y    )9Ru+71ueQQR>VP{7V.l*@0S0*>l_2N!MrcwWB5WB7+870EUZB9/%Z (tj]`q)/y I,+j?7,`q)x/.22.25*Z3+87x/.+7( mue-=b%@@0=-D*Z3B~L ()9R<8hkEU2R>V:1W{7V}:1W7>iZ*>wm6Zpitj]ul_m6Z!MrcS<8hkRfw( mu%@Rfw/&yI,+w}j?1ues!1&68{:[<5Z:40QX|llomq&`OObfhhl5=Ft!|=VM}Y+U|. 0UptfyD o 0 A 1I a Yg m z  ! *n A: Z\ oa Ui %*EFem}0/4(Ds [<9L[>\#2.2@IR]i$?MbCi]kIJnfQth@.&X]  Q!1#$Gmhil}v{ko4q=~%ns}a5&SSoVz @pKN?`TGe|uK8O8 N [ ^ 7m !L9!u""s""N"U"#!#~0#?#Q#X#$M$$ %T%e%i%\~%]P&'''3'T'['g'(#(x+(-(-1(~(7)F$)|6)A)`)}r)**,*T<*C*o*$+["+H+|+ ,3,i,q,{,I-6+-mT-]-5.O._.a.-/B/0I0L0H]0!f0#l0?)1~81F1o1122EN2X2<_2~233^3444654e_4la4{v4565#)5,595X5wc5z5qW7:78pO8ET8W8Z8[8x8n9x ::(:_W:=y:; ;dG;X<<7<5=W=q=H>>>wC>3T>Z>]>O%?h,?@?A?Y?@5@:R@?U@^@xn@AA% AAH3A:A6XA{kAoACB* Ca,Ca1C8C8^C6DX*D7DinDE4EJE0F:)F`)F8F;FNFG)GHiG>HH7H->HSAHxWHpHhyHaIIXIuIhJzKK_lV_Qs_`\`b a}aJb_b4Ec&scd;d1Yd~`dvdUeR'e/e4eDeHe$`e]4fAf*tfg'g2;gJgzgq|g#h!Kh=Nhbh iMi4iati_|i0jq#j4jHj2l'lbslm*mAmimz n%ynzn+o`oaouoO(pApJp4jpyp q!qqAqi`qjqDrqrmr s"sp-sNs{Xshsqs"tKStgtrtuGJuWuvvJvwv=!w=wPwQw^wDxox%yy.3yZiyy/Azzz{0{eu{8|?|-}U>}jy} z}E~hl~w~C VX(PiN3PUi[d T~e1|0GPvb1twHz= )D2| #Fo)9Nmn}?.1@@7n-stRvz o9qm gRGNN %45dW8hKP/CY_hk} ^0gd a=\gRh} CUx:ml!+uG Pu&I3Jhdh-!;[%hes}aR;q@Jc`` as K ]{^"x$&'X&. F7az xq~+`KnU9;<Hl q'f*yB+Zcdx.UB#A0?RS3eg|]Wj!kB.|.=%=CYe-Ay2 ,,0t;gm~@:*RSM|.Poq2Q)M"5[9"Fh~00AjAbs')1 A`dFUVlsb[?4+J08OnJ6Pg|"4GjWp 3#BxeHw\`'8$2u} !O.qRPfh/3  +Li<)$6O cv#&':~Xa{ kR':@D!I MLUksz AjV,4BiX}c~,~-%9up);.f[r*~P[q (5%n9~A]'-6M\al}T"T:h. C!0V+ O6R"'[ ispR*1[5]`rd&'"C]Nj(pL/'>2U2AJW=]=^?ju'~ :YaY#(?uP-R18Iu) LyeZm ]$:')1`,-?DrOl"h%00<bBn*$I,3Ce'S]qks@)SSrJYZ]eg/Hc]Y (oE  &^,/u7r:FLO {4.FJpLdV E;z)f;s!B\\u6 4`V aZkBp4!U`broAsxyC\dhn| 6{6Tkm8gIKUkv=0>_`$vH ZhN0W}kKp!:(EPob{ ,9:BLV`asz JRY`a'(BKT]^   I R S j {    $ 2 3 l z    H V d k y z   1 6 G H Z k | '68GHJijoxELSUZ[05:AFGLh %&@FLW]^ &;<R`n *5DSTq "#//b1CRFHZZZ]]]]] ^ ^4^5^6^7^n^t^{^|^^^^^^^^^_!_'_(_H_I_O_P_________________````#`*`1`2`Q`W`]`^`d`k`r`s````````````````` a aaaHaPaXaYaaaaaaaaaaaaaehioooooooooooooop p1p2pOp`pqpppppppppp qq.q?qPqQqmq{qqqqqqqqqqqr)r8rGrVrWrrrrrrrrrrrrrr-s/s1s3s5s6sSs`sns{sssssss tt!t1tAtQt_t`t|tttttttttt u uCuPu]ujuwuxuuuuuuuuuvvvv6vDvRv`vnvovvvvvvvvvv www$w%w&w'w(w)wGwLwQwVw[w\w|wwwwwwwwwwww xx%x3xAxBxxxxxxxx yyyyyyzzGzHzIzOzTzYzZz[z\zdzlzmznzozpzqzrzzz{zzzzzzzzzzzzzzzzzzzzzzzz { {{{{*{+{4{={>{`{a{k{u{v{{{{{{{{{{{{{{{{{{{{{ |||||/|1|:|B|C|D|E|F|G|H|\|^|e|l|m|n|o|p|q|r||||||||||||||||||||||||||}}}}}+}-}6}?}@}B}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}~ ~ ~ ~ ~J~K~L~M~N~~~~~~~~~~~79?GHIJKLM "#*12LMTZ[\]^_`abipqrǀȀɀʀˀ̀̀΀ '(23=>WX`aijŁƁ́΁%&./CDKLST]^deklɂʂقڂۂ܂݂ނ#$&'CEMNVWÃăԃՃۃ܃ $%-.6789:;<=>?IJTUijklmn <=?@GHTU[\`amnvwɅʅ˅̅ͅ΅υЅ ()*+,:;CKLUV`jkÆĆΆ؆ن *+,-./0HIJKLeflstŇƇևׇ߇cdW[\q0!45>hir׍@A_'(=lmӣԣݣ!de¤MNd PQr6tu'()*+H}~!)*+3;CKS[\]^_`abcdlmnopqrs "-789:;<=>?@OV\bijqrstuvwxyz "#$%&'./012345678\]^t(2:BJLVWkqy )*123456789:MNOPQRYZopqrst}~R'()*+,-./>HPX`jk&'()*456789:;<UVWXYcdz{| #+3;EFdefghpqrstuvwx01234>? .JQRS[cks{|}~'.4;CD<AEMRZ[h+9Okrst|ZagikrsMNOdr !)*z<@CILRS$*+\]^s*048<BC ()456;@ABJRSTUVW[eopw &'()V]de*2:;<=>?@GNOy#$%&3:@Aekqrstuvw~TR LSYZ JPVW 5;=>]cijklmn[v DJPQ#$\cjkDJPQRSTU+3;<is}~FHOPQRSTU[bc-./49:;CKLMNOPlt|}.5<=jpwxopqv{|}         ' / 0         &'TX^_ 5;=>[_efghijy&'(-234<DEFGHIV\bc~   !"19ABelst678=BCDLTUVWXYirz{ %&-./0789:nu{|8?FG3:AB^elm9?AB| &b&c&d&i&n&o&p&x&&&&&&&&&&&&&&&&&&&&&&&|'''<(=(((()))I)3"!7KTY!7 _ _< _ _sp0sp0y_0a0 q*1f771fY7<<1f7uH7777771f7 71f1f7Y7!777777Y77!77y>usO Qt@)0|vvEELLLaLb'$H)`@` `@``4@``<@`n`@`0@UnknownGz Times New Roman5Symbol3& z ArialC .PMingLiUe0}fԚ7&{ @Calibri;[SOSimSunGTimes LT Std[SO3Times] Times-BoldTimes New Roman?5 .MingLiU0}fԚU Arial Unicode MSArial[ (DFPFangSongW4-B5PMingLiU;ўSOSimHei?5 z Courier New;& Helvetica5& zaTahoma7&  Verdana;Wingdings F#= X,X,!xxd((2qHX?8|2 2006 ANNUAL RESULTS ANNOUNCEMENTWonderful SkyhggSfl                   Oh+'0(8 HT t  $2006 ANNUAL RESULTS ANNOUNCEMENTWonderful Sky$generated by an Adobe applicationNormal707Microsoft Office Word@bJ@9@Tb@LWJX,՜.+,0 `h Wonderful Skyx('   !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=?@ABCDEGHIJKLM\Root Entry F0/WJ^Data J1TableGWordDocumentSummaryInformation(>DocumentSummaryInformation8FCompObjm  FMicrosoft Office Word ĵ MSWordDocWord.Document.89q